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Abstract
A rapid and inexpensive method for the production of protein is crucial for the
biopharmaceutical industry. The bottleneck in the case of genetically engineered systems
lies in the recovery of active and properly refolded proteins from inclusion bodies. The
correct refolding of a protein from its denatured state is dependent on several parameters
including the concentration of the protein, the refolding buffers utilized, the approach
employed and finally the type of refolding additives, if any, used in the process.
In this study, an emerging class of refolding additives, namely, ionic liquids were
investigated for the refolding of denatured lysozyme protein. Lysozyme was used as a
model system due to its rapid refolding kinetics and the fact that enzyme based assay
could be carried out to measure the refolding yields. The ionic liquids selection was
hypothesized based on the selection of cation and anion that constitute the ionic liquid.
The efficacy of Imidazolium based ionic liquids as refolding additives was compared to
conventional refolding approach that contains urea and redox-couple cysteine/cystine.
Using response surface methodology (RSM) and central composite design (CCD), an
empirical model was developed and validated by experimental results. Different refolding
strategies were also evaluated; dilution refolding, adsorptive on column packed bed
refolding and adsorptive on column fluidized bed refolding.
Experimental results indicate that in comparison to the conventional refolding buffer,
among different ionic liquids examined, ionic liquid 1-ethyl-3-methylimidazolium
([EMIM]+ Cl) has a pronounced effect on the refolding yield and time required to refold
the denatured lysozyme. The optimal conditions were identified in this study as 150
μg/ml of denatured lysozyme in presence of 75 mM [EMIM]+ Cl in 50 mM HEPES
buffer (pH 7.5). On-column refolding studies indicate that in comparison to the packed
bed system, the fluidized bed ion-exchange system approach, with [EMIM]+ Cl as the
elution-refolding buffer could tolerate higher concentration of denatured lysozyme (up to
25 mg) with refolding yield ca. 90% and fractional mass recovery ca. 82%. This was due
to potentially lower mass transfer limitations in the fluidized bed compared to the packed
ii

bed. Thus, the versatility of ionic liquids coupled with on-column adsorptive refolding
can possibly be the solution to the large scale downstream processing of proteins.
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Chapter 1

1 Introduction
1.1 General Introduction
The biotechnology industry is estimated to be $93.0 billion industry with a current annual growth
rate of 5.2% and projected rate of 8.9% in the coming five years (IBIS 2013). Proteins account
for an important spectrum of products in this industry that have applications in medicine as
biopharmaceuticals. The production, biochemical engineering and processing of these proteins,
is thus an important consideration in biotechnology.
Industrial scale manufacturing of proteins can be categorized as a two-phase process – upstream,
which is expression and production of recombinant proteins in host cells and downstream, which
is the recovery and purification of the protein. Often, overexpression of proteins results in the
production of aggregates or inclusion body proteins that are inactive. Recovery of the active
protein from genetically expressed proteins is thus limited by several unit operations, starting
from centrifugation and filtration of the inclusion body proteins to the renaturation of the
solubilized
In the early 1980s, the ‘bottleneck’ in the bio-therapeutics industry centered on the large-scaleproduction of proteins. Production titers have since sky rocketed from what was considered
standard, 1g/L, to 10g/L and more recently to 27+g/L antibody titer by Crucell’s Per.C6® cell
line (Scott, 2008). Production of intracellular inclusion bodies, even at high titre has shifted the
aforementioned ‘bottleneck’ to downstream processing and specifically recovery of native
proteins from solubilized inclusion body proteins. The rate-limiting step in the downstream
processing of proteins is thus the renaturation of nascent polypeptides to form active, native
proteins.
Chow et al (2006) published a database – REFOLD that summarized the literature published
upto 2006 encompassing the different refolding strategies employed. Of the published articles,
44% of the articles discussed dilution refolding, 17% dialysis and 16% a combination of dilution
and dialysis. Approximately 15% of them discussed the use of different on-column refolding
1

strategies such as immobilized metal affinity chromatography, size exclusion, ion exchange,
and hydrophobic interaction etc.
Irrespective of the in vitro methodology employed, protein refolding additives have a significant
impact and critical to the successful downstream processing of proteins. Traditional refolding
additives such as low concentrations of chaotrope (e.g. 2 M urea), amino acids and amino acid
derivatives (L-arginine, glycine, arginamide), salts (e.g. ammonium sulfate), polymers (e.g.
polyethylene glycol PEG, polyvinypyrrolidone PVP) have exhibited limited success. Since their
first use as protein renaturation agents for denatured lysozyme by Summers and Flowers in 2000,
the application of ionic liquids as protein refolding additives is being investigated by several
groups worldwide.

1.2 Objectives
The overall objective of this study was to investigate the effect of a new class of protein
refolding additives, specifically; the imidazolium based ionic liquids as refolding additives for
on-column adsorptive refolding of denatured lysozyme. Lysozyme was chosen as the
representative protein due to its relatively fast refolding kinetics and the fact that an enzymebased assay can be applied to measure protein refolding yields.
Specific objectives:
The overall objective was further divided into the following specific sub objectives:
[1] First the conventional approaches currently applied for lysozyme protein refolding were
compared. These included the traditional dilution refolding and comparison with an ion
exchange based adsorptive refolding technique. Next ionic liquids were applied as
refolding additives in a conventional dilution-refolding format and the various factors
that affect refolding yield of lysozyme were investigated.
[2] The identification of the optimal conditions for refolding denatured lysozyme, with the
aid of ionic liquid(s) was next attempted using response surface methodology and central
composite design.

2

[3] Finally, ionic liquids and in particular the ionic liquid [EMIM] Cl was investigated
for both the elution and refolding of denatured lysozyme in two different ion exchange
column configurations, i.e. packed bed and fluidized bed ion-exchange systems.

1.3 Thesis structure
The thesis is divided into the following chapters:


Chapter 2: Literature review.

An exhaustive, up-to-date review of the published literature is presented in this chapter. Factors
that affect protein refolding at a molecular level, in-vitro, are discussed. This is used to better
understand the role of refolding additives, specifically ionic liquids. The potential for
development of ionic liquids as refolding additives is evaluated and an unbiased, comprehensive
review of the topic is presented.


Chapter 3: Materials and Methods.

This chapter provides details of the materials and methods that are common to all the proceeding
chapters. Details about the fluidized bed ion exchanger and its mode of operation are provided in
this chapter. Materials and methods pertinent to individual chapters are presented accordingly in
those chapters.


Chapter 4: A comparative study of refolding lysozyme using conventional strategies.

This chapter begins by validating the requirement of refolding additives and low concentration of
denatured protein for dilution refolding of denatured lysozyme. Next, it compares the refolding
yield and fractional mass recovery, as a function of increase in protein concentration, for two
different on-column modes of operation – packed bed and fluidized bed.


Chapter 5: Investigation of dilution refolding of denatured lysozyme using imidazolium
ionic liquids.

This chapter identifies the ionic liquid parameters, composition and concentrations of ionic
liquid, that influence the refolding yield of lysozyme. Refolding yield is presented as function of
3

time, with change in concentration and composition of the ionic liquids tested. Influence of
chaotropicity and kosmotropicity of the individual ions of the ionic liquid on the refolding yield
is also discussed.


Chapter 6: Application of response surface methodology and central composite design for
the optimization of lysozyme refolding by [EMIM] Cl

A quick overview on the theory of response surface methodology and central composite design is
provided. Experimental design and results thereof that aid and abet in the identification of
optimal refolding conditions for denatured lysozyme by [EMIM] Cl are discussed in this chapter.
A validated, empirical model based on the results is provided.


Chapter 7: Adsorptive protein refolding with the aid of [EMIM] Cl in a packed
bed/fluidized bed ion exchanger

The applicability and influence of [EMIM] Cl as an elution and refolding buffer for adsorptive
refolding of denatured lysozyme is examined. Refolding yield and fractional mass recovery, due
to incorporation of [EMIM] Cl in elution buffer, is presented as function of mode of operation
and increase in concentration of protein load. Comparison on the efficacy of [EMIM] Cl as a
refolding/elution enhancer to other ionic liquids is also reviewed by means of experimental
results.


Chapter 8: Concluding remarks and recommendations

Based on the experimental results acquired in this thesis, final concluding remarks and pertinent
recommendations are provided.

1.4 Major contributions
The experimental results in this thesis can be summarized in the form of the major
contributions, as follows:
[1] Experimental results obtained demonstrate the use of ionic liquids, specifically
imidazolium based ionic liquids as refolding additives for denatured lysozyme without
the support of other refolding agents such urea and cysteine/cystine.
4

[2] For the first time, response surface methodology and central composite design were
implemented to identify the optimal conditions for refolding denatured lysozyme using
[EMIM] Cl.
[3] Refolding of denatured lysozyme on on-column fluidized bed ion exchanger
i.

A novel fluidized bed ion exchange system was proposed and investigated for the
adsorptive refolding of denatured lysozyme

ii.

For the first time, ionic liquid was incorporated in the elution and refolding
studies of denatured lysozyme in a packed bed and fluidized bed ion exchanger

iii.

With the aid of [EMIM] Cl in elution buffer, in comparison to packed bed,
fluidized bed mode of operation tolerates higher concentration of protein load (up
to 25 mg) without unfavorably affecting the refolding yield and mass recovery

1.5 Nomenclature
[EMIM] Cl : 1-ethyl-3-methylimidazolium chloride

1.6 References
IBISWorld US - Industry, Company and Business Research Reports and Information, 2013.
IBISWorld US - Industry, Company and Business Research Reports and Information,
clients1.ibisworld.com.proxy1.lib.uwo.ca. IBIS World.
Scott, C., 2008. Proactive Debottlenecking. BioProcess International 2–7.
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Chapter 2

2 Literature Review: Ionic liquids as refolding additives
An exhaustive, up-to-date review of the published literature is presented in this chapter. Factors
that affect protein refolding at a molecular level, in-vitro, are discussed. This was used to better
understand the role of refolding additives, specifically ionic liquids. The potential for
development of ionic liquids as refolding additives is reviewed.

2.1 Abstract:
Globally, purification of proteins is steadily moving towards a single-unit-system that can handle
higher concentrations of protein while maintaining the productivity and overall cost efficiency of
the process. The bottleneck of protein production has shifted downstream, specifically, recovery
of active proteins from inclusion body proteins. In principle, recovery is a two step process;
solubilization of the inclusion body followed by refolding or renaturation of the unfolded,
dissolved protein to its active, refolded state. Protein refolding, in-vitro, is a kinetically
competitive process, which if not executed in the appropriate environment could result in
formation of aggregates and/or misfolded proteins, thereby substantially reducing productivity.
Renaturation can be achieved either by use of suitable additives that suppress aggregation and
enhance structural stability of native protein, and/or chemicals that allow the formation of
disulfide bridges. Protein refolding aids encompass a variety of chemicals – amino acids (Larginine), chaotropic salts at non-denaturing concentrations (urea, guanidine hydrochloride),
polyols, polymers, amino acid -esters and -amides, molecular chaperones (GroEL, GroES), etc.
Ionic liquids, ‘green alternatives to organic solvents’, can be designed to serve variety of
functions ranging from organo-catalysis to active pharmaceutical ingredient. In the past decade,
reports of their ability to suppress protein aggregation and enhance structural stability against
thermal denaturation have emerged that make them suitable targets as protein refolding
additives. A comprehensive review of their mechanism of action has been provided by first
understanding the fundamentals of protein refolding, need for refolding additives and the
consequent effect of solutes as protein refolding additives.
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2.2 Background Information:
Not more than a decade ago the “capacity bottleneck” in the bio-therapeutics industry centered
on the large-scale-production of proteins. Production titers have since sky rocketed from what
was considered standard, 1g/L, to 10g/L, and more recently to more than 27 g/L antibody titer by
Crucell’s Per.C6® cell line (C. Scott, 2008). In this regard, bacterial expression such as in
Escherichia coli (one of the most extensively studied and used prokaryotic organisms) offers
several advantages including growth on inexpensive carbon sources, rapid biomass
accumulation, amenability to high cell-density fermentations and simple process scale up
(Baneyx & Mujacic, 2004; Jungbauer, Kaar, & Schlegl, 2004; Mergili, Eiberle, & Jungbauer,
2010). However, more often than not, over-expression leads to the accumulation of insoluble
polypeptide aggregates, often termed as “inclusion body”. Inclusion body proteins are
amorphous, electron refractile, devoid of biological activity, dense particles of aggregated
proteins. They can be found in both the cytoplasm and the periplasm of the bacteria, depending
on if they were engineered to secrete the proteins or not (Clark, Schwarz, & Rudolph, 1999;
Singh & Panda, 2005; Vallejo & Rinas, 2004; Q. M. Zhang, Wang, Liu, & Wang, 2008). There
are several advantages associated with expression of proteins as inclusion bodies (Burgess, 2009;
Clark, 2001; Singh & Panda, 2005; Su, 2011; Vallejo & Rinas, 2004):
a)

The expression levels are often very high, up to 30% of the total cell protein.

b)

The proteins are largely protected from proteolytic degradation by host cell enzymes.

c)

Inclusion body proteins usually have higher density (~1.3 mg/ml) than many cellular

proteins in vivo. Easy isolation of inclusion bodies from cells due to differences in their size and
density as compared with cellular contaminants
d)

Homogeneity of protein of interest in inclusion bodies, which helps in reducing the

number of purification, steps to recover the pure protein.
Nonetheless, the production of intracellular inclusion bodies (even at high titre) has shifted the
aforementioned “bottleneck” to downstream processing, specifically recovery of native proteins.
Protein refolding is a competitive process between folding and aggregation of proteins. As a
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unimolecular process, protein folding is considered to be a first order reaction. While, on the
other hand, aggregation is a second- or higher- order reaction, severely influenced by the
concentration of the denatured protein.
However, the production of intracellular inclusion bodies even at high titre has shifted the
aforementioned “bottleneck” to downstream processing and recovery of produced proteins. The
pressure to develop better separation and purification protocols that combat the new process- and
product-related impurities and higher titre levels without compromising on the safety, efficacy
and quality of the product is continually increasing. The purification of proteins is steadily
moving

from

pooling-elution-fractions-of-multiple-runs

on

a

single

column

towards

development of columns that can handle higher protein concentrations. In order to do so, it is
pertinent to develop approaches that incorporate clarification, separation and purification.
In-vivo, the cell has developed safety mechanisms, in the form of molecular chaperones, to
combat the issue of misfolding and aggregation that might occur due to premature termination of
translation of proteins, environmental stress and/or failure for newly synthesized polypeptide to
reach it’s native conformation. These molecular chaperones can be divided into three functional
subclasses; folding chaperones (e.g. DnaK, GroEl), holding chaperones (e.g. IbpA/B) and
aggregating chaperones (e.g. ClpB). Each of the subclasses serves a unique function. Folding
chaperones, rely on ATP-driven conformational changes to mediate the net refolding/unfolding
of substrates. Holding chaperones, hold the partially folded state of the proteins until folding
chaperones are available to execute their activity. And lastly, aggregating chaperones promote
the solubilization of aggregated proteins. (Hartl, 1996; Hartl, Bracher, & Hayer-Hartl, 2011;
Kriegenburg, 2012; Obalinsky, 2006; Sinnige, Karagöz, & Rüdiger, 2001; Wittung-Stafshede,
2011) Some of these molecular chaperones, GroEl, GroEs, DnaK, have recently been examined
and adopted for in-vitro refolding of denatured protein(Hartl & Hayer-Hartl, 2009). In-vitro, the
focal point of research for the past several decades has been to develop better refolding additives
that mimic the action of molecular chaperones in-vivo, while at the same time meet the
economies of scale and production requirements.
Ionic liquids are organic salts whose melts are composed of discrete cations (Table 2.1), based
on methylimidazolium, N-butylpyridinium, N-methyl-N-alkylpyrrolidinium, and anions (Table
2.2), such as hexafluorophosphate [PF6]-, tetrafluoroborate [BF4]-, alkylsulfates [R-SO4]-, halides
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such as chloride [Cl]-, nitrate [NO3]- etc,. Some noteworthy characteristics of ionic liquids
include low to negligible vapor pressure, high thermal stability, non-ionizing, non-flammable
properties, ability to dissolve wide range of organic, inorganic, organo- metallic compounds and
polymers, electric conductivity, high electro elasticity, liquid crystal structures, potential to be
reused and recycled, and immiscibility with either water or organic solvents (Hardacre, Holbrey,
& Nieuwenhuyzen, 2007; Hough & Rogers, 2007; Turner, 2005; van Rantwijk & Sheldon,
2007). Also ionic liquids can be ‘tailored’ such that altering their structure affects its physicochemical properties, which further enhances or impairs their functionality. Although, no thumb
rule has been set to determine the physico-chemical properties of any novel ionic liquid,
quantitative structure activity relationship (QSAR) is being investigated (Das & Roy, 2013;
Jastorff et al., 2003). Many applications of ionic liquids have already been reported e.g. use as
lubricants, additives, in organic and in-organic chemistry, separation technology, and
biopharmaceuticals (Abbott & McKenzie, 2006; Freire et al., 2012; Greaves & Drummond,
2008; Han & Row, 2010; H. Lin, de Oliveira, & Veith, 2011; MacFarlane & Seddon, 2007; G.
W. Meindersma, Maase, & De Haan, 2000; Rodrigues, Prosinecki, Marrucho, Rebelo, & Gomes,
2011; Zhu et al., 2006). In recent years, their use in refolding of denatured proteins has emerged.
In order to assess their applicability, we must first understand the downstream processing of
proteins and factors that influence protein refolding
.

Table 2.1 List of commonly used cations of an ionic liquid
Cation

Full name
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Abbreviation

H3C
+

N

R

1-alkyl-3-methylimidazolium

[Cnmim]+

1-alkyl-3-methylpyrolidnium

[Cnpyim]+

N-alkylpyridinium

[Cnpy]+

Tetraalkyl-ammonium

TRA

Tetraalkyl-phosphonium

TRP

N

H3C

R

+

N

+

N
R

R
R

N

+

R

R
R
R

+

P

R

R

Table 2.2 List of commonly used anions in ionic liquids
Anion

Full name
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Cl−

Chloride

Br−

Bromide

BF4−

Tetrafluoroborate

PF6−

Hexafluorophosphate

RSO3−

Alkylsulphate

2.3 Downstream processing for protein recovery
Production of an active refolded protein from a mass of nascent polypeptide chains, often
aggregated to form inclusion body proteins, involves several stages as elucidated in Figure 1.
Irrespective of the cellular process used to express proteins, extraction of the protein is the first
and foremost step. Cell lysis followed by separation using ultra-centrifugation and other such
techniques are commonly employed to extract the inclusion body proteins. Filtration is ensued by
solubilization of the inclusion body protein by employing high concentrations of chaotropic salts,
such as urea and guanidine hydrochloride, detergents such as Triton X 100, deoxycholate and
sodium-N-lauroyl sarcosine (SLS) (Burgess, 2009; Cabrita & Bottomley, 2004; Singh & Panda,
2005), and reducing agents such as dithiothrietol (DTT), ß-mercaptoethanol that break the
disulfide linkages of the protein and completely solubilize and denature the inclusion body
proteins.
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Figure 2.1 Purification strategy for recovery of bioactive proteins
Recovery of folded proteins from denatured, solubilized inclusion bodies is thus dependent on
multiple unit operations and involves a large number of parameters as shown in Figure 2.2
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Figure 2.2 Ishikawa diagram eliciting the parameters that affect protein refolding yield and
protein activity
Refolding of solubilized proteins involves approaches such as batch dilution, dialysis and pulse
renaturation. These are traditionally employed methods that can be labor intensive, costineffective, difficulty to automate and scale-up and often result in higher ratio of aggregates to
active refolded proteins(Chen, Lin, Wu, & Liu, 2012; Mannall, Titchener-Hooker, Chase, &
Dalby, 2006; Shiraki, 2010).
(Jungbauer et al., 2004) review some of the noteworthy contributions in the field of on-column
protein refolding strategies. It is evident a variety of preparatory modes of on-column refolding
have been designed and tested for recovery and purification of refolded proteins from IBPs;
expanded bed (EB), simulated moving bed (SMB), membrane chromatography etc. In
comparison to packed bed and dilution refolding, EB & SMB offer significant advantages in
terms of process efficiency, solvent and media utilization, reduced number of post-refolding
processing steps such as separation, polishing, viral filtration and above all else flexibility to
work with higher concentrations of protein titre. However, EB systems encounter fouling of
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resin, protein/lipid build-up, and ligand loss and matrix disintegration rendering them a
cost-ineffective option for industrial application. Although, SMB addresses some of the EB
issues, it also suffers limitations owing to cost of construction, operation and maintenance
(Chase & Draeger, 1992; Ferré et al., 2005; Freydell et al., 2010a; Gu et al., 2002; Lyddiatt,
2002; B.-J. Park, Lee, Mun, & Koo, 2006). High pressure refolding, although in its embryonic
stages of development, is also being considered as potential refolding strategy at the industrial
scale. Notable key advantages of the high pressure refolding method are: (1) performs
solubilization and refolding/disaggregation of protein simultaneously, (2) requires little or no
chaotropic agents, (3) is often independent of protein concentration, and (4) can disaggregate and
refold proteins rapidly (Qoronfleh, Hesterberg, & Seefeldt, 2007). However, so far the published
literature on the use of high-pressure protein refolding has been under extreme conditions; low
protein concentration (0.65 mg/ml of growth hormone), high pressure 2000 bar, 65 °C for 24
hours, creating the element of doubt for scale up at industrial level (St John, 2001). Thus, there is
a constant need to develop newer refolding strategies that are - economical, robust, cost- and
process- efficient and generic.

2.4 Analysis of refolding efficiency
Irrespective of their final use, it is important that the produced-refolded protein meets the quality
control and quality assurance standards. Besides high purity, activity of the compound, which is
closely related to its native structure, is a critical quality control. Activity assays combined with
circular dichroism (CD) spectroscopy and/or fluorescence spectroscopy are classified as
adequate means to prove the identity of the product (Bekhouche, Blum, & Doumèche, 2012;
Diego, Lozano, Gmouh, Vaultier, & Iborra, 2004; Helal & Melzig, 2013; Hennessey & Johnson,
1981; Kelly, Jess, & Price, 2005; Y. C. Lee & Yang, 2002). Typically, CD and fluorescence
spectra of unfolded, native and refolded protein are compared and the latter ones have to show
equal features to meet the activity criteria.
The correct formation of disulfide bonds can also be determined by chromatography techniques
such as reverse phase chromatography, hydrophobic interaction chromatography and ionexchange chromatography. Analytical size exclusion chromatography is often employed to
detect and separate the aggregated and misfolded proteins from correctly folded proteins
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(Freydell, Van Der Wielen, Eppink, & Ottens, 2010b; Gu et al., 2002; Jungbauer et al.,
2004). More recently, progressive proteomic techniques such as atomic force
spectroscopy(Peterman & Wuite, 2011), light scattering (Gast, Damaschun, Misselwitz, &
Zirwer, 1992; Peterman & Wuite, 2011), calorimetery (Baldwin & Rose, 2013; Farber,
Darmawan, Sprules, & Mittermaier, 2010; C. Scott, 2008), ATR-FTIR spectroscopy (Baneyx &
Mujacic, 2004; jungbauer, Kaar, & Schlegl, 2004; Mergili et al., 2010; Shivu et al., 2013; J. M.
Walker, 2012) have been suitably adopted to study protein refolding kinetics, protein-protein
interactions and oblige as a stronger validation protocol.

2.5 Role of refolding additives on protein refolding
Proteins are most soluble in aqueous solution when they are in their native, folded state. It is well
established that protein refolding is a kinetically competitive process between the intermolecular
hydrophobic interactions resulting in aggregates versus the intra-molecular interactions yielding
native proteins. As a unimolecular process, protein folding is a first-order reaction with respect to
protein concentration, while the aggregate formation is a second- or higher- order process caused
by intermolecular interactions. Competition between the folding and aggregates determines the
efficiency of the in-vitro refolding step.
Figure 2.3 depicts a simplified protein refolding kinetic model. In this model, the unfolded
protein (U) undergoes the early phases of folding to form a transient intermediate (I) with nativelike secondary structure and partial tertiary structure. This model can be further simplified to a
parallel of reaction of the formations of the native state protein (N) and aggregates (A) from
transient intermediate.
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Figure 2.3 Kinetics of protein refolding. Key: U: unfolded and reduced protein; I:
Intermediate stage; N: Native state
Aggregation results from non-specific interactions between hydrophobic regions or partially
refolded structures of different polypeptides, it is usually irreversible, hence it’s critical that this
step is suppressed so as to achieve high yields of native and active protein (Buswell &
Middelberg, 2002; X.-Y. Dong, Huang, & Sun, 2004; Ferrone, 1999; Gast et al., 1992;
Konermann, 2011; Nölting, 2006).
Competition between folding and aggregation can be expressed by the following equations:
dI
dt

-kN I-kA In ………………………………………………………………………Equation 2.1

When t= 0, I= U0 and N= 0
dN
dt

kN I…………………………………………………………………….Equation 2.2

where, Uo represents the initial unfolded protein concentration, t - the refolding time (min), kN
and kA - folding and aggregation kinetic constants, respectively and n - reactor order of aggregate
formation.
It is this competition between aggregates and/or misfolded proteins and native proteins that make
recovery of active proteins from IBPs challenging and also the bottleneck step in downstream
processing of proteins.
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The refolding process is modulated, in vivo, by molecular chaperones (also known as heat
shock proteins) that ensure the production of native, active protein. Absence or lack of molecular
chaperones in humans gives rise to neurodegenerative diseases such as Alzheimer’s’ disease,
Parkinson’s and various other prion diseases (Clark et al., 1999; Goedert, Clavaguera, & Tolnay,
2010; Jucker & Walker, 2011; Singh & Panda, 2005; T. Zhang & Ye, 2007). For a detailed
understanding of the protein misfolding and its relationship with human diseases, the reader is
directed to review by Chiti and Dobson (2003), in addition to other articles cited here (Burgess,
2009; Chiti & Dobson, 2006; Clark, 2001; F. Li, Dong, & Zhuang, 2009; Singh & Panda, 2005;
Su, 2011; Vallejo, 2004)
In vitro the slightest deviation in up-stream process and/or product parameters such as pH,
concentration of protein, temperature changes, mechanical stress such as shear strain, surface
adsorption or foaming etc., can alter the structure of the protein and consequently promote
‘salting out’ and/or misfolding or aggregation (Hamada, Arakawa, & Shiraki, 2009; Ito et al.,
2012; Karuppiah & Sharma, 1995; X. U. T. Lin, 2010; Mergili et al., 2010; Tsumoto, Ejima,
Kumagai, & Arakawa, 2003; Yamaguchi, Yamamoto, Mannen, Nagamune, & Nagamune, 2012;
L. Yang, Dong, & Yan, 2008). Often, production of proteins as inclusion body proteins
(aggregates) is preferred owing to ease of separation, protection from proteolytic degradation and
higher protein content. Once solubilized, inclusion bodies are open chain, polypeptides with
hydrophobic core exposed to the solvent media. Gradual removal of denaturants (solubilization
agents) generates an environment conducive to protein refolding.
Essentially during refolding proteins are not properly converted to the native state instead
assume a partially folded state for a prolonged period of time (Biggar, Dawson, & Storey, 2012).
Intermediates with hydrophobic regions that are exposed to the solvent play a crucial role in the
partition between native and aggregated conformations. Folding intermediates are comprised of
significant elements of the secondary structure but little of the native tertiary structure. Due to
the expanded volume of these intermediates, the hydrophobic regions, which are usually buried
in the native state, are exposed to the solvent. When so exposed, hydrophobic regions on separate
polypeptide chains can be in contact with one another and can interact. This causes the
intermediates to be diverted from the correct folding pathway, resulting in aggregate formation
and loss of protein.
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Thus, it is apparent that in order to achieve high refolding yield the protein structure must
either be stabilized to minimize deviation and/or the structures that are not in the native state
must be solubilized to avoid protein-protein interaction (aggregation/misfolding). This can be
achieved by addition of solutes/refolding additives. In principle, solution/refolding additives can
be classified into two categories a) denaturants – indirectly promote refolding by weakening the
inter- and intra- hydrophobic bonding

b) protein stabilizers- enhance protein refolding by

modifying the water of hydration and thereby stabilizing the native structure.
Table 2.3 summarizes refolding aids typically utilized for production of proteins from nascent
polypeptides and/or inclusion bodies. Chaotropic salts at non-denaturing concentrations (for urea
below 2.5 M) anion- and non-ionic detergents, amino acids and its derivatives, osmolytes,
amphiphilic polymers and varying salts have been used as refolding aids in the past.
Of these, the most popular refolding additives are urea (123 research articles since 2010) and
arginine (48 research articles since 2010), as per number of research articles published and
accessed via Scopus on July 23, 13. For detailed discussions on the mechanism of action of
commonly used solution additives the reader is referred to what has already been covered by
other authors (Hamada et al., 2009; Karuppiah & Sharma, 1995; Tsumoto, Ejima, Kita, &
Arakawa, 2005; Yamaguchi et al., 2012; C. Yang, Yu, Dong, & Sun, 2012; Yasuda, Murakami,
Sowa, Ogino, & Ishikawa, 1998)

Table 2.3 Summary of commonly used protein refolding additives
Sr.
Nature
Mechanism of action
Advantages &
No.
1

References

Limitations
Chaotropic Salt
Guanidine



Solubilize
hydrophobic moieties
exposed to the solvent
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Urea at concentrations
below 3M promotes
refolding

(Gu et al.,
2002; Hamada
et al., 2009;

Hydrochloride
Urea

2



Detergent
SDS (sodium
dodecyl sulphate)
Triton X-100
Laroylsarcosin
Tween -20
CHAPS (3-[(3cholamidopropyl)di
methylammonio]-1propanesulfonate.)



in folding
intermediates or
misfolded species.



Significantly enhances
viscosity of the solution
generating issues in
chromatographic
purification of the
protein

Hardacre et al.,
2007; Khademi
and Mostafaie,
2010; Stumpe
and
Grubmüller,
2009)

SDS is an anionic
detergent that imparts
negative charge to
entire protein.
Above critical micelle
concentration, SDS
completely denatures
protein. Binds to the
hydrophobic region of
the polypeptide



SDS monomer can bind
to the protein so tightly
that dilution or dialysis
does not completely
dissociate SDS
molecules.
Development of
artificial chaperone
protein refolding;
solubilization of protein
using SDS ensued by
stripping off detergent
by use of Cyclodextrin.
Toxicity of detergent
imminent threat
Method is not versatile

(Daugherty et
al., 1998;
Gautam et al.,
2012; Hendrick
and Hartl,
1995; Rozema
and Gellman,
1996;
Yamaguchi et
al., 2012;
Yasuda et al.,
1998)

Expensive
Moderately toxic
Arginine ethylester
tends to be hydrolyzed
to alcohols and amino
acids at high
temperatures or alkaline
pH

(Arakawa et al.,
2003; Hamada
and Shiraki,
2007; C. R. R.
Lange, 2009;
Meng et al.,
2001;
Nakakido,
2009; Samuel
et al., 2008;
Tsumoto et al.,
2005)






3

Amino Acid and



amino-acid


derivatives
Arginine
Arginamide
Arginine ethylester
Proline
Glycine

Increases solubility of
aggregation prone
molecules.
Also suppresses heatinduced aggregation of
protein (exception
arginine ethylester)





Table 2.3 cont’d
Sr.

Nature

Mechanism of Action

Advantages &

No
4

References

Limitations
Polymers
 high
molecular
weight
polyethylene



PEG binds to the first
refolding intermediate to
perturb self-association
of aggregate-prone
intermediates. Also
decreases thermal




Expensive
Not – biodegradable

(Meng et al., 2001;
Swartz, 2001;
Yamaguchi et al.,
2012; C. Yang et al.,
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glycol (PEG)
 polyvinyl
pyrrolidone
(PVP)
 glycerol
 sorbitol

5

SALTS
 Ammonium
sulphate,
 Trimethyl
ammonium
oxide
(TMAO)
 magnesium
chloride/calci
um chloride,
 sodium
citrate/sulfate
.





stability
PVP binds to earlymolten globule like
refolding intermediate,
thus, prevents
aggregation and
enhances refolding.

Modify the interfacial
tension between the
protein surfaces and bulk
solvent, leading to
alteration of protein
solubility

2012; L. Yang et al.,
2008)




Final effect dependant on
protein concentration and
salt concentration

(Alibolandi and
Mirzahoseini, 2011;
Chen et al., 2012;
Rajan et al., 2010;
Wang, 2005)

An emerging class of refolding additives, the sixth category not included in the table above, is
‘Ionic liquids’. By definition, ionic liquids are ionic salts that are liquid at temperatures below
100 ˚C. Since the synthesis of ethylammonium nitrate (m.p. 12 ˚C) by Paul Walden in 1914,
ionic liquids have evolved substantially and found application as lubricants, catalysts, in organic
and in-organic chemistry, separation technology, and biopharmaceuticals etc. These have been
reviewed in-depth by others and do not fall under the purview of our discussion. A brief
overview on the history and nomenclature is provided in the section below.

2.6 History and Nomenclature of Ionic liquids
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‘First-generation’ ionic liquids are mainly composed of N,N’-dialkylimidazolium and Nalkylpyridinium cations, and metal-halide anions. Due to hygroscopic nature of these anions,
first-generation ILs have to be handled under inert gas, thus limiting their applications. ‘Secondgeneration’ ionic liquids, in comparison, are usually more stable in air and water and can be used
on bench-top. This is widely attributed to the replacement of large- and oxygen-reactive anions
by halides such as chloride, bromide, iodide or anions such as BF4-, PF6- and C6H5CO2. The
activity, kinetic- and thermal- stability of different enzymes such as oxidases, lipases or
cellulases in the presence of second-generation ILs has been successfully studied, and synthesis
of various products has been carried out (W. G. W. Meindersma and De Haan, 2012;
Moniruzzaman et al., 2010; Moon et al., 2006; Turner, 2005; van Rantwijk and Sheldon, 2007) .
‘Third-generation’ of ionic liquids emerged in the early 2000s; are more task specific, chiral, and
based on more hydrophobic-, biodegradable- anions and cations(Hough and Rogers, 2007;
Hough et al., 2007; Turner, 2005). (Hough and Rogers, 2007)review the synthesis and
application of some of these ILs such as ranitidine docusate (histamine H2-receptor antagonist,
emollient) and didecyldimethylammonium ibuprofen (antibacterial anti-inflammatory).
Ionic liquids derived from 1-alkyl -3-methyl imidazolium and 1-alkylpyridinium cation are
referred to as [Cn mim]+, where the index ‘n’ stands for the number of carbons in one of the
linear alkyl chains and ‘mim’ stands for N-methylimidazolium. 1-ethyl and 1-butyl derivatives
are often referred to as [EMIM]+ and [BMIM]+ respectively. C-2 methylation of the
imidazolium moiety leads to even more possibilities of different cation types. These cations are
abbreviated [Cndmim]+ for 1-alkyl-2,3-dimethylmethylimidazolium and [Cnpy]+ for 1alkylpyridinium cation (Earle and Seddon, 2000; Plechkova and Seddon, 2008; Stark and
Seddon, 2000). As per IUPAC nomenclature, a square bracket is drawn around polyatomic ions,
and monoatomic anions are denoted without brackets. Thus [C4 mim]Cl- is correct while [C4
mim][Cl]- is not; [C4 mim][NTf2] is correct, [C4 mim]NTf2 is not. The cation (if organic) must
always be enclosed by square brackets.
While knowledge of ionic liquids that moderate protein refolding is crucial, it cannot be achieved
without an understanding of the terms ‘water of hydration’, kosmotrope and chaotropes.

2.7 Water of hydration and structural stability of proteins
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Proteins are linear macromolecules with a non-repetitive, specific covalent structure capable
of forming a three-dimensional structure owing to amino-acid sequences that fold to generate
compact domains. The nature and arrangement of the amino-acid side chains along with the
protein backbone is responsible for the individual characteristics of the macromolecule (Chase &
Draeger, 1992; Ferré et al., 2005; Freydell et al., 2010a; Gu et al., 2002; Lyddiatt, 2002; B.-J.
Park et al., 2006; Vasantha, Attri, Venkatesu, & Devi, 2012).
In principle, when in solution, water in the vicinity of proteins can be classified into three
categories(Attri, Venkatesu, & Kumar, 2012; Bekhouche et al., 2012; Collins, Neilson, &
Enderby, 2007; Degreve et al., 2004; Rand, 2004; Zaccai, 2004):
(a) Internal water -buried in the bio-molecular structure,
(b) Water of hydration - at the surface of the biomolecule, and
(c) Bulk or free water -which, technically, no longer feels the influence of the dissolved
biomolecule.
Of these, ‘water of hydration’ is of prime importance when studying protein refolding. During
the course of any protein reaction the total surface area of the protein in contact with water
changes. This is accompanied by a change in the number of water molecules with which it
interacts, i.e., its extent of hydration. The water of hydration ‘Wh’ is the effective number of
water molecules in a fluctuating cloud that interacts more or less favorably with the protein
surface. Through Figure 2.4, (Timasheff, 2002), explained the ‘water of hydration’. It
commences with an ideal situation, where free water molecules in pure water would be in
equilibrium with the transient cluster (Figure 2.4.A). Next, upon introduction of a protein
molecule (Figure 2.4.B), based on their associated free energies, the water molecules are either
attracted to-, repelled from-, or indifferent to-, the surface of the protein. This translates in to the
corresponding changes in the freedom of motion of the individual molecules, as depicted in
Figure 2.4.C. For example, molecule ‘a’ (shaded grey) is repelled while molecule ‘b’ (shaded
black) fluctuates between strong attraction and freedom. In Figure 2.4.D, each arrow on the
water molecule represents the time average of its net non-random extent of motion in the same
direction as that of the protein. Molecule ‘a’ being repelled from the surface is not transported.
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Molecule ‘b’, however, due to its fluctuation between being attracted and repelled, migrates
at a slow rate. The sum of the contributions of all the water molecules whose motion is
momentarily (and non-randomly) oriented in the same direction as that of the protein molecule is
the measured protein hydration, which divided by the molecular weight of the water results in the
‘number’ of water molecules, Wh, that interact with the protein molecules.
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Figure 2.4 Illustration elucidating the concept of water of hydration (adapted from
Timaseff, 2002).
Figure 2.4.A, ideal state where free water molecules are in equilibrium with transient cluster of
water molecules. When a protein is introduced, Figure 2.4.B, water molecules interact with it
with different free energies; represented by the vertical bars- downward pointing bars indicate
attraction, upward indicate repulsion and absence of bars indicates indifference. In Figure 2.4.C,
corresponding changes in the freedom of translational and rotational motions of the water
molecules can be visualized. The consequences are seen in Figure 2.4.D. The large vector
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(arrow) on the protein indicates its motion induced by the applied field (gravitational in
sedimentation, electro kinetic in electrophoresis, chemical potential gradient in diffusion).
Molecules with no vector are neutral thermodynamically and are indifferent to the transport of the
protein molecule.

In the absence of hydrating water, proteins lack activity. The cloud of water molecules around
proteins is affected up to at least a nanometer from its surface or 2 nm between neighboring
proteins. Some of these water molecules interact with the protein surface, reorienting both
themselves and the surface groups whereas other water molecules link these to the bulk in an
ordered manner while continuing to remain in a dynamically active state. Thus, when in solution
proteins possess a conformational flexibility, which encompasses a wide range of hydration
states. Equilibrium between these states depends on the activity of the water within its
microenvironment; that is, the degree of freedom that the water has to hydrate the protein.
It has been reported chemical solutes, including but not limited to ionic liquids, affect several
characteristics of protein – stability, folding and aggregation - in a number of different ways
(Ball, 2013; Record et al., 2013; van der Post et al., 2013). For many decades, several different
studies have investigated these effects and with the evolution in scientific technology and
analytical methods resulted in two different perspectives – the historical approach- Hofmeister
series, and the more recent ‘new’ or evolved approach.

2.1.1

Effect of chemical solutes on proteins

The historical approach, which considers the concept ‘order makers’ and ‘order breakers’ as
Hofmeister effects (chaotropicity, Kosmotropicity), is still considered by several scientists
(Nostro & Ninham, 2012; Schwierz, Horinek, & Netz, 2013; Szalontai et al., 2013; Tietze et al.,
2013) and a brief discussion is provided in the following section. A more recent revision
indicates that this is an oversimplified approach lacking information at the sub-molecular level of
interaction between hydrated state of individual solutes and proteins. Thereby implying that our
traditional understanding of the concepts of chaotrope and kosmotrope could in fact be
misleading.
Hofmeister (1888) developed the series bearing his name based on the concentrations of various
salts (cations and anions) needed to ‘salt-in’ or ‘salt-out’ the proteins in solution (López-León,
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Santander-Ortega, Ortega-Vinuesa, & Bastos-González, 2008; Peterman & Wuite, 2011). In
principle, the ions in the series were arranged in the order of their ability to change water
structure. Kosmotropes or “order makers” were those ions that exhibited strong interactions with
water molecules and were therefore capable of breaking the water-hydrogen bonds (Gast et al.,
1992; Peterman & Wuite, 2011; Tietze et al., 2013; H. Zhao, 2005). As per Hofmeister series,
sulphate anion, for example, is a strong kosmotropic anion. Because of its strong interaction with
water SO42− competes effectively for the water molecules originally associated with the protein
molecule. This encourages the protein molecule to minimize its surface area exposed to the
solvent, thereby favoring the acquirement of its native compact state due to the restored driving
force of the hydrophobic effect. On the other hand, chaotropes are known as “order-breakers”
because they exhibit strong interactions with protein vs. water. Chaotropic anion, such as cyanide
for example, selectively partitions in water allowing the protein a degree of structural freedom
that subsequently encourages protein extension and denaturation.
Recently, the ideas of the structure-maker/breaker concept have been revisited . The results
indicated that the perturbation to water's structure appeared to be confined to the first solvation
shell of the ion (Baer & Mundy, 2013; Collins et al., 2007). Thus, the revised theories, move
away from the effect of individual ions or solutes on the bulk-water phase and instead focus on
the direct interaction of individual ions (cation/anion) with the protein. In general, they are
thought to affect structural stability of proteins in three main ways (Ball, 2013; Nostro &
Ninham, 2012; Y. Zhang & Cremer, 2010) :


Interaction with the protein backbone and side chains through ion-pairing



Alteration of both surface tension and hydrogen-bonding network surrounding
proteins



The hydrophobic interaction of ions with water and proteins

Of special mention is the study by Collins et al (2007) since it addresses the issues with the
micro-aqueous environment of the protein (Collins, 1997; Collins et al., 2007). They describe
three different independent layers of hydration that occur at a protein surface; a) the solvation
layer in close proximity to the protein surface, b) the transition layer, and c) the bulk layer
that forms the solution. It is estimated that the solvation layer and bulk layer compete for
hydrogen bond with the transition layer. The specific structure, charge and composition of
26

the protein determine the solvation layer, while the composition and properties of the
bulk solution determine the behavior of the bulk layer. The first and third layers compete for
hydrogen bonding with the second layer. (Nostro & Ninham, 2012). Thus, addition of ions or
neutral solutes to the bulk layer affects the capability of the transition layer to solvate the
protein surface. In particular, a kosmotrope in the bulk layer ‘deflects’ the transition layer
molecules from participating in the hydration of the protein thereby minimizing the solvent
exposed area. Whereas, the presence of a chaotropic solute in the bulk layer promotes the
solvation of the protein by the transition layer; the solution becomes a better solvent for the
protein, which unfolds, exposing more surface to the solvent. (Collins et al., 2007; Nostro &
Ninham, 2012).
Thereafter, Pegram and Record (2008) proposed a solute partitioning model (SPM) that
interprets chemical effects of nonelectrolyte solutes and Hofmeister salts on all aqueous
processes (Pegram & Record, 2008). Molecular thermodynamic analysis of surface tension and
hydrocarbon solubility data using SPM was employed to interpret the solute and salt effects on
surface tension and on solubility of uncharged molecule quantitatively in terms of surface
hydration, solute partition coefficient, the ratio of local to bulk solute concentration, and the
extent to which the solute salt or ion accumulates at the surface. In general, it was observed that
anions accumulated indifferently in proximity of the amide groups and increased solubility,
while excluded solutes decreased solubility.
Similar studies by Mason et al (2009) investigated through molecular dynamic simulations the
interaction between model peptide and tetrapropylammonium sulfate and guanidium chloride
(Mason et al., 2009; Nostro & Ninham, 2012). Their results suggests that the Hofmeister series
could be better understood by assessing the capability of ions to affect hydrogen bonding, salt
bridges, and hydrophobic interactions in the protein and how these effects are altered by the
counter- ion.
Thus, water of hydration of proteins, ion-specific interaction of solute molecules with protein
surface and backbone have a cumulative effect on the refolding of proteins. A widely adopted
and accepted policy to characterize these ion-specific effects is by the Jone-Dole viscosity Bcoefficient of individual ions in solution.
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2.1.2

Characterization of ions based on Jone-Dole viscosity BCoefficients

Jone-Dole realized that some ions make water more viscous (kosmotrope) and some others make
it more fluid (chaotropes) when compared to the viscosity of pure water at the same temperature
(Jenkins & Marcus, 1995; Marcus, 1994; Nostro & Ninham, 2012). Please note hereafter for the
purpose of this review article, kosmotrope is defined as the solute that increases the viscosity of
solvent and chaotrope as the solute that reduces the viscosity of the solvent.
For a wide range of concentrations (between 0.005 M and 1 M) the specific viscosity of water
solution can be fitted to the empirical equation, Equation 2.3, as expressed below.
Equation 2.3 η/η0 = 1 + Ac1/2 + Bc + Dc2 …
where η is the dynamic viscosity of the solution and η0 dynamic viscosity of solvent, c is
the molar concentration of the electrolyte, A reflects the viscous drag due to the ionic
atmosphere, which delays the motion of the ion and makes the solution more viscous. Bcoefficient depends on the ion-solvent interactions and is related to the volumes of the ions. The
ion-specific B-coefficient can be negative (for chaotropes <η0) or positive (for kosmotropes, η
>η0). The term Dc2 is needed only in very concentrated solutions (Jenkins & Marcus, 1995;
Pusey, Paley, Turner, & Rogers, 2007; Z. Yang, 2009; H. Zhao, 2006).
Based on their viscosity B-coefficients in water Table 2, characterizes some of the commonly
used ions in ionic liquids as either chaotrope or kosmotrope. This information could assist in the
the selection and design of ionic liquids as protein refolding additives.
.

Table 2.4 Characterization of ions commonly used in ionic liquids based on their viscosity
B-coefficient
Ion

Viscosity B28

Kosmotrope

Reference

Coefficient

/Chaotrope

(Equation
2.3)

Acetate (OAc-)

0.246

Kosmotrope

(Jenkins & Marcus, 1995;
Marcus, 1994)

Cyanide (CN-)

0.022

Chaotrope

(H. Zhao, 2006)

Fluoride (F-)

0.107

Kosmotrope

(H. Zhao, 2006)

-0.005

Chaotrope/

(Jenkins & Marcus, 1995;

Kosmotrope

Marcus, 1994; van Rantwijk &

Chloride (Cl-)

Sheldon, 2007)

0.206

Kosmotrope

2-

Sulfate (SO4 )

(Jenkins & Marcus, 1995;
Marcus, 1994; Zeuner et al.,
2011)

Ammonium (NH4+)
Tetramethylammonium (CH3)4 N+

-0.027

Chaotrope

(H. Zhao, 2006)

0.123

Chaotrope

(Lai, Li, Lü, & Yang, 2011; H.
Zhao, 2006)

N-ethylpyridinium [Etpy]

0.482

Chaotrope

(H. Zhao, 2006)

1-ethyl-3-methylimidazolium

0.491

Kosmotrope

(H. Zhao, 2006)

[Emim]
Using the Jones-Dole viscosity B-coefficients as scaling factors for the strength of water-water
interactions, (Collins et al., 2007) demonstrated contact-ion pair formation is actually dominated
by hydration-dehydration. This was reverberated by Zhao and Marcus as illustrated in Figure 2.4,
(Marcus, 1994; H. Zhao, 2006). Hinckley noticed that the enzyme activity of laccase C from
Trametes sp. decreased dramatically with the increase of concentration of 4-methyl-Nbutylpyridinium tetrafluoroborate ([4-MBPy]BF4-): 10% IL reduced half of the activity and 20%
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IL reduced the activity more than 9-fold. It was postulated that the high chaotropicity of
BF4- ions might be an important factor causing the deactivation (B.-K. Liu, Wu, Xu, & Lin,
2007).

2.8 Role of ionic liquids as protein refolding additives
Addition of any solute to an aqueous protein solution, results in lowering of ‘water of hydration’
thereby allowing the water/solute molecules to interact with the protein, consequently affecting
its stability and solubility (Kohno & Ohno, 2012). Ionic liquids, also known as ‘designer
solvents’, in general consist of a salt where one or both the ions are large, and the cation has a
low degree of symmetry which tends to reduce the lattice energy of crystalline form of the salt
and thereby it’s melting point (Earle & Seddon, 2000). Ionic liquids are known to affect protein
activity by either a) stripping off the internal water associated with the protein, b) penetrating
into the micro-aqueous environment to interact with the protein by changing protein dynamics,
conformational and/or protein’s active site, or c) by interacting with the substrates and products
either by direct reaction with them or by altering the portioning between the aqueous and nonaqueous phases.
Recent molecular dynamics simulations of biomolecules in ionic liquid/water mixtures or
‘hydrated ionic liquids’ shed light on the interactions of ionic liquid in aqueous bio-molecular
solutions (Attri et al., 2012; Haberler, Schröder, & Steinhauser, 2012; Hunt, 2006). One such
simulation study of 1-ethyl-3-methylimidazolium trifluoromethanesulfonate/water mixture in the
presence (and absence) of ubiquitin and zinc protein motif (Haberler, Schröder, & Steinhauser,
2011), demonstrated that the anion and cation of an ionic liquid have individual kosmotropic and
chaotropic characteristics, respectively, encumbering the characterization of the whole ionic
liquid as a kosmotropic or chaotropic salt.
The fact that ionic liquids dissolve and dissociate into individual ions rather than exist as an
intact molecule is an obvious advantage over molecular organic solvent. Miscibility of the ionic
liquid or its partition coefficient in water has a considerable effect on aqueous protein solutions.
Upon dissociation, the individual component ions of ILs interact with water via ion-dipole
interactions and their hydration state is then dependent on the type of ion and fraction of water
present in the mixture. Consequently, this determines if the ion is behaving as a kosmotrope or
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chaotrope. Each ion, cation and anion, in solution will interact with the protein in solution
and either stabilize or destabilize the protein structure and conformation, as has been illustrated
in Figure 2.7. So far, studies have shown that anions influence protein stability and activity via
its hydrogen bonding forming capacity and nucleophilicity properties (Attri & Venkatesu, 2012a;
Buchfink, Patil, Rudolph, Lange, & Tischer, 2010; Lange, Patil, & Rudolph, 2005; Vidya &
Chadha, 2009; Weingärtner, Cabrele, & Herrmann, 2011). While changes in the alkyl chain
length of the cations influence the viscosity, hydrophobicity and polarity of the ionic liquid, all
of which have an effect on the solubility, stability and activity of targeted protein molecule (Bae,
Chang, Koo, & Ha, 2012; Lange et al., 2005; Xiao et al., 2009; Yamamoto, Yamaguchi, &
Nagamune, 2011).
.
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Figure 2.5 Flow chart that illustrates the application of ionic liquids as protein refolding
additives.
Ionic liquids when dissolved in aqueous protein solution dissociate into individual ions; either of
which can behave as a kosmotrope or a chaotrope. For the purpose of enhancing proteinrefolding yield in a downstream process, an ideal ionic liquid would be one that has a
kosmotropic anion and a chaotropic cation

2.8.1 Ionic liquid parameters that influence protein refolding
The first example of an enzyme in an IL was reported in 1984 when Magnuson and co-workers
demonstrated the activity and stability of alkaline phosphatase in aqueous mixtures of ethyl
ammonium nitrate (EAN). In 2000, Summers and Flowers reported the effective role of EAN as
a protein aggregation suppressor which resulted in enhanced recovery and refolding of denatured
lysozyme (Summers & Flowers, 2000). Since then, ionic liquids have been used to stabilize
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protein activity, to inhibit or reduce aggregation, and to improve the ‘in vitro’ refolding of
denatured proteins (Attri et al., 2012; Attri & Venkatesu, 2011; 2012b; 2012a; Attri, Venkatesu,
& Kumar, 2011a; Attri, Venkatesu, Kumar, & Byrne, 2011b; Bae et al., 2012; Byrne & Angell,
2009; Byrne, Belieres, & Angell, 2009; Lange et al., 2005; Yamamoto et al., 2011) . There are
several associated advantages of using proteins specifically enzymes in ionic liquid media;
enhanced operational and thermal stability, increased solubility of sparingly soluble substances,
ease of immobilization of enzyme in highly viscous ionic liquids, alteration of substrate
specificity, ease of enzyme recovery by filtration or centrifugation, ease of substrate and product
recovery simply by evaporation and/or mixing with non-polar organic solvents and/or
supercritical carbon-dioxide (Moniruzzaman et al., 2010). For example, many ILs (based on
BF4−, PF6−and Tf2N−) in comparison to organic solvents have exhibited relatively less
denaturation, higher enantioselectivity and higher catalytic activity of several enzymes (Naushad,
ALOthman, Khan, & Ali, 2012; van Rantwijk & Sheldon, 2007). Alterations in the anion
dramatically affect the chemical behavior and stability of the ionic liquid while the changes in
cation have a profound effect on the physical properties, such as melting point, viscosity, and
density (Matthews, 2001; Schwierz et al., 2013).

2.8.1.1 Effect of anion and cation
In comparison to anions of same charge density, cations are usually observed to show a less
dominant effect, because anions are more polarizable and hydrate more strongly (Schwierz et al.,
2013). Additionally, cations seem to present their impact indirectly via interaction with anions,
and the kosmotropic behavior of anions could be lessened in the presence of kosmotropic
cations. It was hypothesized that kosmotropic cations, as opposed to the chaotropic ones, have a
higher tendency of ion-pairing with the kosmotropic anions, thus reducing the abundance of the
free anions in solution to play their kosmotropic role. This was supported by the “law of
matching water affinity” which states in aqueous salt solutions, the interactions of ions in the
order of decreasing strength are as follows: kosmotrope–kosmotrope > kosmotrope–water >
water– water>chaotrope–water>chaotrope–chaotrope (Degreve et al., 2004; Hess & van der
Vegt, 2009; Schwierz et al., 2013; Vlachy et al., 2009; Z. Yang, 2009; Zaccai, 2004).
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In principle, the law of matching water affinity suggests that oppositely charged ions tend to
form contact ion-pairs in solution if they have equal affinities for water but will separate if their
water affinities are very different. Thus, in an aqueous solution, a kosmotropic anion and a
kosmotropic cation will bind together due to the strong interactions between them. A chaotropic
anion and a chaotropic cation also tend to form an ion-pair because the relatively stronger water–
water interactions will keep the two chaotropes together. Therefore, an optimal stabilization of
enzymes or other biological macromolecules is usually achieved through the use of salts
containing kosmotropic anions and chaotropic cations.
In general, it’s been observed that ILs with highly-fluorinated and charge-delocalized anions are
highly hydrophobic and immiscible with water, while those with halides, phosphate or
carboxylate anion are more miscible with water (Kohno & Ohno, 2012). A kosmotropic anion
strongly interacts with water to stabilize the protein while a chaotropic anion exhibits strong
interaction with the protein’s chaotropic moieties and results in destabilization. (Bae et al., 2012)
investigated the refolding of lysozyme with imidazolium based ionic liquids by varying anion
and alkyl chain length of the cation. They report highest refolding yield in the presence of
chaotropic cation [EMIM]+ or [BMIM]+, and kosmotropic anion [MS]. Lange examined the
effect of N-‘alkyl-N-methylimidazolium chlorides on the denaturation of lysozyme induced by
heat and guanidinium chloride (GuHCl). All the tested ILs were found to reduce the melting
temperature of the enzyme, suppress the protein aggregation, and lower the midpoint
concentration for GuHCl-induced protein unfolding, with a higher tendency corresponding to a
longer alkyl chain length. While the anion, more often than not, follows the Hofmeister series,
there are a few exceptions and usually occur in the presence of komstropic cation, such as
[BMIM]+. The initial reaction rate of lipase-catalyzed enantioselective hydrolysis of d,lphenylglycine methyl ester (Moon et al., 2006) in the IL-containing aqueous buffer varied in the
order of [BMIm][BF4-] > [BMIm]Cl-> [BMIm]Br- > [BMIm]NO3- >[BMIm]HSO4-. The lower
enzyme activity in the presence of a more kosmotropic IL anion in this situation could possibly
be explained by the higher tendency of the kosmotropic cation to ion-pair with its kosmotropic
counter-anion, thus reducing its abundance in the aqueous bulk solution to play its
stabilizing/activating role, as per the law of matching water affinities.
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Ionic liquids having long alkyl chains in their cation behave like surfactant in aqueous
solutions and have a strong impact on the stability and activity of the protein (B.-K. Liu et al.,
2007; Xiao et al., 2009). (Kohno & Ohno, 2012) reviewed the properties of ionic liquids/water
mixtures and assert long alkyl chain lengths of cation dramatically reduces its miscibility with
water. (Yamamoto et al., 2011) observed that increase in alkyl chain length of N-alkylpyridinium
chloride and N-alkyl-N-methylpyrrolidinium chlorides destabilizes’ lysozyme. These results
were corroborated with results reported by Lange et al., whose study indicated imidazolium
cation with a longer hydrophobic alkyl chain has a higher preference of destabilizing the enzyme
due to (1) its strong interaction with the kosmotropic moieties, such as the carboxylic groups, on
the enzyme surface, and (2) its hydrophobic interaction with the inner hydrophobic moieties of
the enzyme molecule, leading to the disruption of the enzyme’s native conformation.
Investigation of the influence of a series of N′-alkyl, and N′-(ω-hydroxyalkyl)-Nmethylimidazolium chlorides on the behavior of hen egg white lysozyme (HEWL) and an
antibody fragment ScFvOx indicated that in comparison to hydrophobic imidazolium cation
carrying long alkyl chain, terminal hydroxylation of alkyl chain, made the salt more compatible
with protein stability (Lange et al., 2005). (Constantinescu, Weingärtner, & Herrmann, 2007)
used differential scanning calorimetry (DSC) to characterize the thermal denaturation of RNase
A with addition of ILs holding Br− and Cl− as the common anions. Almost all ILs tested rendered
the enzyme to have its transition temperature lowered, in the order of K+ > Na+ > [C1,1,1,1 N]+ >
Li+ > [C2,2,2,2 N]+ ≈ [EMIM]+ > [BMIM]+ > [C3,3,3,3 N]+ > [HMIM]+ > [C4,4,4,4 N]+ , which is
satisfactorily consistent with the decreasing kosmotropicity order of the cations.
In summary, although it is safe to say a kosmotropic anion and chaotropic cation are the most
desirable characteristics in an ionic liquid for protein refolding studies, these are not the sole
determining factors. Other parameters such as viscosity of the ionic liquid that can be modified
by addition of water or modulation of the temperature, also plays an instrumental role in
designing the ionic liquid for biochemical processes .

2.8.1.2 Effect of viscosity of ionic liquids on protein refolding
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The knowledge of the viscosity of ILs is of prime importance from an engineering point of
view as it plays a major role in stirring, mixing and pumping operations; in addition, it also
affects other transport properties such as diffusion. ILs are generally viscous liquids with
viscosities ranging typically from 10 to 500 mPa s at ambient temperature (Y. Zhang & Cremer,
2006). This is comparable with the values obtained for oils, that is to say two or three orders of
magnitude higher than viscosities of traditional organic solvents. Viscosity decreases with
increase in temperature making ILs easier to apply at super ambient conditions. Using a vibrating
densimeter and rheometer, Jacqueim et al (2006), studied the density and viscosity of six
different ionic liquids [BMIM]PF6-, [BMIM] BF4-, [BMIM]NTf2-, [EMIM] NTf2-, [EMIM]
EtSO42- and butyltrimethylammonium bis(trifluoromethylsulfonyl)imide as a function of
temperature. For the ILs studied they observed that the imidazolium-based ionic liquids density
decreases with increasing alkyl chain length in cation or anion, while the viscosity remains
constant with increasing shear rates (from 0 to 200 s-1)(Jacquemin, Husson, Padua, & Majer,
2006). This linear relationship between the shear stress and the shear rate corresponds to a
Newtonian behavior. It is also noteworthy that the alkylammonium-based IL exhibited a higher
viscosity than the imidazolium-based ILs with the same anion; furthermore, the viscosities of the
latter ILs increased with the length of the alkyl chain on the imidazolium ring. Amongst the
anions studied, the NTf2- anion lowered the viscosity while the PF62- anion significantly
increased the viscosity.
Simulations have shown that imidazolium ILs with side chains above butyl (and up to C12) exist
in the pure liquid phases as micro-structured fluids, in which nonpolar domains are formed by
the alkyl chains and, at the same time, the charged parts form ionic domains which tend to be
continuous (channels) (Xiao et al., 2009). This segregation into domains was not observed for
Emim+ based ILs, since the non-polar part is too small, and in structural terms they just showed
charge ordering like ‘‘simple molten salts’’. The formation of the microstructures is likely to be
responsible for the increase in viscosity and for the decrease in ion mobility (meaning a decrease
in conductivity and in diffusion). Therefore, it is not a strong interaction between the non-polar
parts that is giving rise to a more viscous fluid. In ILs with longer side-chains, the non-polar
parts are being driven into domains, excluded by the strong electrostatic attraction between the
anions and charged parts of the cations.
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(Mannall, Myers, Liddell, Titchener-Hooker, & Dalby, 2009) suggest the addition of high
viscosity glycerol and polyethylene glycol to the refolding buffer enhances refolding yield by
inhibiting aggregation process and reducing the diffusivity of proteins in solution. In a similar
manner, van Rantwijk and Sheldon explain that the high viscosity of ionic liquids slows down
the conformational changes of proteins, allowing enzymes to maintain their native structure and
activity. (Zeuner et al., 2011) observed that higher viscosity of [BMIM]PF6- compared to [OHMMIM]PF6- is likely to cause lower reaction rates through mass transfer limitations in furuloyl
esterase from Aspergillus niger. Zhao’s study of the CALB (Candida antarctica Lipase B)
catalyzed trans-esterification of ethyl butyrate and 1-butanol in more than 20 ILs suggests that IL
viscosity might affect the reaction rates in some cases.

2.9 Ionic liquids as protein refolding additives - Examples
Summers and Flowers paved the way for protein refolding using ionic liquids when they reported
the successful use of ethyl ammonium nitrate to suppress aggregation of denatured hen-egg
white lysozyme. Ever since, several groups worldwide have ventured into this emerging
paradigm. While some have invested their time and effort towards decoding the mystery towards
the mechanism of action of ionic liquids as refolding additives (Attri & Venkatesu, 2012a; Byrne
et al., 2009; Esquembre et al., 2013; Fujita, MacFarlane, & Forsyth, 2005; Greaves &
Drummond, 2008; Mangialardo, Gontrani, Leonelli, Caminiti, & Postorino, 2012; Mann,
McCluskey, & Atkin, 2009; Stock et al., 2004; Weibels, Syguda, Herrmann, & Weingärtner,
2012), many others are exploring the vast variety of ionic liquids to find the ideal ‘novel designer
liquid’ that holds the potential to solve the bottleneck of the downstream process (Buchfink et
al., 2010; Fujita et al., 2005; Hough & Rogers, 2007; Mester, Wagner, & Rossmanith, 2012;
Ohno & Fukumoto, 2007; Pusey et al., 2007; RAkita, n.d.; Ranke et al., 2004; Turner, 2005).
Few of the most recent and relevant, successful refolding studies have been summarized in table
2.5. As can be seen from the table, a common trend has been to study the effect of the ionic
liquid as a refolding additive by using it in lieu of urea or guanidine, in the presence of redoxcouple, such as cysteine/cystine or GSSG/GSH and at very low final protein concentration (less
than 0.5mg ml-1) primarily attained by dilution or dialysis several fold into the refolding buffer.
What is interesting to note is that irrespective of the ionic liquid studied, kosmotropicity of the
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anions, alkyl chain length of the cation and thereby its hydrophobicity and finally molarity
of the ionic liquid in the final solution play a critical role in determining the refolding yield or
efficiency of the system. Thus far, barring a few exceptions (e.g. [HMIM]+), the studies indicate
increasing the concentration (molarity) of the ionic liquid beyond 1M results in a decrease in the
refolding yield.

Table 2.5 Summary of recent research findings of ionic liquids as refolding additives
Ionic Liquid

Refolding protocol

Noteworthy findings
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Ref

Ethylammonium

25 mg/ml of denatured

Addition of 5% EAN to

(Summers

nitrate(EAN)

lysozyme diluted with

lysozyme solution in

and Flowers,

143mM Tris sulfate buffer,

buffer appears to stabilize 2000)

pH 8.5 containing 4mM

enzyme against

GSH and 4mM GSSG

irreversible thermal

varying concentration of

denaturation

EAN. Final concentration
of lysozyme : 1.6mg/ml.
Duration of incubation : 24

Proposed mechanism:
Ethyl group of EAN
interaction with

h

hydrophobic parts of
protein and protects it
from intermolecular
association.
Desalting with centriprep
centrifugal filters
N′-alkyl and N′-(ω-

1:60 dilution with refolding Refolding Yield increased (Lange et

hydroxy-alkyl)-N-

buffer (3mM GSH, 0.3mM

with increasing

methylimidazolium

GSSG, 1mM EDTA, 0.1M

concentrations up to 1M

chlorides

Tris/HCl (pH 8.2)

{Exception: 0.5M HMIM

containing Ionic liquids.

Cl}

al., 2005)

Final concentration of
lysozyme : 0.28mg/ml
Incubation : 18h – 24h
Table 2.5 cont’d
Ionic Liquid

Refolding protocol

Noteworthy findings
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Reference

N’-substituted-3methylimidazoliu
m
tetrafluoroborate

1:100 dilution with refolding
buffer containing 0.1M
Tris/HCl pH 8.1, 3mM GSH,
0.3mM GSSG and varying
concentrations of ionic liquid

Chaotropicity of
(Bae et al.,
imidazolium-based
2012)
cations decreased with
increase in alkyl chain
length. Kosmotropicity of
anions : methylsulfate ~
sulfate > Acetate >
CF3COO->Chloride>
tetraborofluorate

N-alkyl-Nmethylimidazoliu
m cation based
ionic liquids

Lysozyme: 1:60 dilution with
refolding 3 mM GSH, 0.3
mM GSSG, 1 mM EDTA, 0.1
M Tris/HCl, pH 8.2
containing varying
concentration ionic liquid.
Incubate: 18 -24h. Final
concentration of protein :
0.28mg ml-1.
rPA: 1:20 dilution with
refolding buffer 7 mM GSH,
0.7 mM GSSG, 1 mM EDTA,
0.1 M Tris/HCl, pH 8.5)
containing varying
concentration of ionic liquid.
Incubation : 8h.

Variation of the anion
(Buchfink et
has a profound effect on al., 2010)
the renaturation of
proteins, lysozyme and
rPA. Strongly
destabilizing anions with
higher alkyl substitutions
were unable to promote
refolding. The influence
of the anion as refolding
enhancers for rPA
represented by the
following series: Cl− >
MDEGSO4 − > EtSO4 −
> acetate > tosylate >
Et2PO4− ≈ HexSO4−.
Most effective refolding
additive amongst those
tested was : [EMIM] Cl-

2.10 Purity and Toxicity concerns of Ionic liquids
Purity of a raw material is of prime importance in any process. Downstream processing of
proteins involves removal of product- and process- related contaminants. It is therefore essential
that raw materials, in this case, ionic liquids being used be of the highest purity. The commonly
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found contaminants in ionic liquids are halides, water, organic compounds or inorganic
salts. (Scammells, Scott, & Singer, 2005) provide a comprehensive review of these impurities
and state that they not only affect the physicochemical properties of the ILs but also pose a threat
to the success of a reaction. For example, trace quantities of halide anions could deactivate the
catalyst in transition metal catalyzed reactions (i.e. hydrogenations). An awareness of this issue
is growing steadfast and methods to measure and remove such impurities from ILs are being
developed (Austen Angell, Ansari, & Zhao, 2011; Hough & Rogers, 2007; Huddleston et al.,
2001).
Primarily due to their non-volatile nature and low impact on human health, ionic liquids are
increasingly being referred to as ‘green alternatives to organic solvents’. Studies on effect of ILs
on environment have shown that the toxicity profile of ILs varies across trophic levels and
organisms (Jastorff et al., 2003; Pham, Cho, & Yun, 2010; Ranke et al., 2004; Swatloski et al.,
2004; Zhu et al., 2009). Literature findings indicate toxicity of ILs with eight-carbon-alkyl chains
attached to imidazolium and pyridinium rings is higher than most organic solvents (acetone,
acetonitrile, methanol etc.) (Pham et al., 2010; Stepnowski, Skladanowski, Ludwiczak, &
Laczynska, 2004; Wood & Stephens, 2010). In contrast, study published by (Pernak,
Sobaszkiewicz, & Mirska, 2002) advocate ILs with ten, eleven, twelve and fourteen carbon
atoms in an alkoxy group of imidazolium cation exhibits very high antimicrobial property, while
the anion has very little influence. A plausible explanation for this deviation could be increased
hydrophobicity of cations, which accentuates permeation into cell membrane & cell death.
Enhanced hydrophobicity of ionic liquids by virtue of changes in cation is being exploited for the
synthesis of novel-target-specific third generation of pharmaceutically active ILs.

2.11 Economic feasibility
Meyer and Werbitzky state the global chemistry market is estimated at $2.92 billion and
expected to grow to $3.24 billion by 2015 and to $4.012 billion by 2020, with industrial
biotechnology and pharmaceutical biotechnology representing more than $50 billion and $70
billion, respectively (Meyer & Werbitzky, 2011). Approximately 6000 companies, globally, are
active in pharmaceutical sector with an estimated compounded annual growth rate (CAGR) is
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more than 20%. About 25 % of the industrial biotechnology is fine chemicals, with the need
to develop ‘green chemicals’ or ‘green process’ being the prime focus. Meyer and Werbitzky
(2011) rightfully define ‘green chemistry’ as the guiding principle to encourage the development
of manufacturing processes and products with the lowest possible environmental impact or
footprint. As discussed earlier, research findings have demonstrated that ionic liquids are
effective substitutes for common organic solvents where control of volatile organic compound
emissions is critical (Hough & Rogers, 2007; Meyer & Werbitzky, 2011; RAkita, n.d.; Rogers,
Seddon, & American Chemical Society Meeting 224th : 2002 : Boston, 2003). It is this
negligible vapor pressure that permits the removal of products by distillation without further
contamination by the solvent, thereby facilitating recycling of ionic liquids and reduction in
operation costs of the process (Tavares, Rodríguez, & Macedo, 2013).
Due to their specific handling and poor handling production and application of first generation
ionic liquids has been expensive. In comparison, although second generation ionic liquids are
more stable, Gorke et al (2010) attribute their high cost to individual building blocks and
subsequent downstream processing (Gorke, Srienc, & Kazlauskas, 2010). Over the years,
changes in production strategy by means of ecological and economic optimization (ECO), has
resulted in the evolution of task-specific ionic liquids. The third-generation of ionic liquids, are
similar in cost to organic solvents, simple to prepare, biodegradable, and the purity of the starting
materials determines the purity of the final product while the choice of anion and cation
determines its toxicity profile (Gorke et al., 2010; Tavares et al., 2013). Reinhardt et al., (2008)
evaluated the greenness of [C6MIM][BF4], citric acid/N,N’-dimethyl urea, methanol,
cyclohexane, acetone and methanol/water for Diels-Adler reaction of cyclopentadiene and
methyl acrylate by means of ECO. In general, conventional solvents are easily available and
relatively cheap, and in order to be in the same range, Reinhardt estimate the price of ionic
liquids to be less than or equal to USD 30 kg-1 (Reinhardt, Ilgen, Kralisch, König, & Kreisel,
2008) .
At present, only a limited type and number of ionic liquids are produced in bulk quantities, most
of which are used in chemical synthesis. Table 5, lists comparative prices for ionic liquids in use
today. With increasing demand, and potential for application in biopharmaceutical industry,
BASF estimates the expects the prices to be below USD 40 kg-1, for quantities ranging in metric
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tons (BASF, 2013). Deep-eutectic solvents, like those manufactured by Scionix, are cheaper
than imidazolium based ionic-liquids owing to the cost price of its principal component-choline
chloride, which is manufactured in metric tonnes on a regular basis.
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Table 2.6 Current market price of ionic liquids and other commonly used proteinrefolding additives
Sr.
No.

Ionic liquid

Price (USD per
kg)

Source

110a

BASF

907b

Io-li-tec

369c

Sigma Aldrich

100a

BASF

459b

Io-li-tec

1060c

Sigma Aldrich

294b

Io-li-tec

297c

Sigma Aldrich

4 1-butyl-3-methylimidazolium acetate

964c

Sigma Aldrich

5 1-hexyl-3-methylimidazolium tetrafluoroborate

1972b

Io-li-tec

6 1-methyl-3-propylimidazolium iodide

887b

Io-li-tec

7 Ethylammonium nitrate

899b

Io-li-tec

8 1-butyl-1-methylpyrolidinium trifluoromethane sulfate

2320b

Io-li-tec

9 1-ethyl-3methylimidazolium thiocyanate

870b

Io-li-tec

10 1-ethyl-3-methylimidazolium tetrafluorosulfate

1435b

Io-li-tec

11 Glyceline (choline chloride: glycerol)

57d

Scionix, UK

12 Oxaline (oxalic acid: choline chloride)

57d

Scionix, UK

13 Ethaline (ethylene glycol : choline chloride)

57d

Scionix, UK

14 L-cystine

585c

Sigma Aldrich

15 Cysteine

543c

Sigma Aldrich

16 L-arginine

340c

Sigma Aldrich

1 1-ethyl-3-methylimidazolium chloride

2 1-ethyl-3-methylimidazolium acetate

3 1-butyl-3-methylimidazolium chloride
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Footnote Table 2.6 .: Price: USD per kilogram. a: Calculated based on quotation received for 1000kg, as of
September 2013. b: Calculated based on standardized price listed for 5kg in their in-house newsletter, Ionic
liquids Today, dated December 2012. c: As per price listed on the Sigma-Aldrich website for 1kg of ionic
liquid, as of September 2013. d: Standardized price listed on their website, based on order quantities greater
than 50kg but less than 1 metric ton. Greater Britain Pound converted to USD as per foreign exchange on
20th September 2013.

When evaluating the economic and process feasibility of a chemical, it is important to
note that there are lots of ways to look at cost-analysis and purchase price is only one part
of the equation. Cost related to personal-protective equipment, emission control hardware
and monitoring equipment, waste disposal and treatment, and the potential to recycle the
chemical have a cumulative effect on the process feasibility and must not be ignored.

2.12 Conclusion
Production and purification of a therapeutic protein is a task that faces many challenges;
upstream titre, aggregation of protein, membrane fouling, buffer contamination, efficient
recovery of protein, purification of protein, and protein stability etc. However, the biggest
challenge and bottleneck today is the cost-effective and process-efficient recovery of
protein from inclusion body proteins. One or combination of several chromatographic or
non-chromatographic methods can help achieve this. Irrespective of the methodology
employed, protein refolding is complicated and dependent on several process- and
product- related parameters. Hence, the use of a refolding additive is not only imperative
but also critical to the success of the reaction. In theory, since protein refolding is a
kinetically competitive process, it may be promoted by stabilizing the native state or
suppressing the unspecific aggregation of unfolded peptide and/or intermediate-nativestructure formed during the process.
Since their inception into the scientific community in 1886 ionic liquids have carved a
niche for themselves in the controversial field of ‘green chemistry’ (Byrne, Wang,
Belieres, & Angell, 2007). While the characteristics that these ‘designer liquids’ are nonvolatile and that they have low impact on human health classifies them as ‘green
alternatives to organic solvent’, the fact that most of them are not completely
biodegradable and highly toxic across several trophic levels tells a cautionary tale. The
more recent third generation of ionic liquids developed are ‘target-specific’ chemical
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agents that address the issues of biodegradability and toxicity, and some even serve as
active pharmaceutical ingredients (Hough et al., 2007; Hough & Rogers, 2007).
The three dimensional structure of a protein is quintessential for its activity, which is
maintained by disulfide bonds, hydrogen bonding and hydrophobic (Van der Waals
contribution) interactions. In general, protein refolding additives function by either
penetrating the micro-aqueous environment of the protein and stabilizing the protein
(chaotropic cation) or by competing with the water associated the protein thereby limiting
its exposure to the solvent and consequently driving the protein to its native state
(kosmotropic anion). This dichotomy of preferential binding/exclusion originates from
the Hofmeister series that is explicitly used to justify the effect of ionic liquids and other
solute molecules on proteins. It is well documented that dependent on their
physicochemical characteristics such as nucleophilicity, hydrophobicity and viscosity
ionic liquids affect protein dynamics by their H-bonding and electrostatic and
hydrophobic interactions with the protein.
The experimental data obtained thus far on the potential of ionic liquids as refolding
additives is limited to very low protein concentrations. Of course, with the exception of
the study by Byrne et al., who report long term stabilization against aggregation and
hydrolysis of >200mg ml-1 of lysozyme in trimethylammonium methane sulfonate (Byrne
et al., 2007). As can be seen in Table 3, almost all studies have been based on the
concept of ‘dilution refolding’, which albeit easy to adapt, is tedious, inefficient and
difficult to scale up to industrial levels. Lange et al., by reporting the improved refolding
yield by ionic liquids over traditional refolding additives such as L-arginine has
demonstrated the potential of ionic liquids for industrial application (Lange et al., 2005).
However, employing dilution refolding would be counter-productive at that scale. Hence
a thorough investigation on the applicability of ionic liquids in chromatographic refolding
strategies such as ion exchange, size exclusion, simulated moving bed and expanded bed
chromatography is the need of the hour. In addition, the recovery efficiency and
reusability of the ionic liquid (as a refolding additive) in the process, the bearing of ionic
liquids on ‘clean-in-place’ protocols for chromatographic downstream processes,
adaptability of the ionic liquid-assisted protein refolding process to in-house equipment
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are all parameters that need to be examined and studied exhaustively to facilitate the
smooth transition of ionic liquids from academic research to industrial application.

2.13 Nomenclature
Abbreviation Full form
IBPs Inclusion body proteins
QSAR Quantitative structure activity relationship
DTT Dithiothreitol
SLS Sodium-N-lauroyl sarcosine
CD Circular Dichroism
Attenuated Total Reflectance- Fourier Transfrom InfraRed
ATR- FTIR Spectorscopy
ATP Adenosine triphosphate
4-MBPy]BF4- 4-methyl-N-butylpyridinium tetrafluoroborate
EAN Ethylammonium nitrate
Ils ionic liquids
GuHCl guanidinium chloride
ScFvOx Small chain antibody fragment
HEWL Hen egg white lysozyme
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Chapter 3

3 Materials and Methods
This chapter describes all the common materials and methodology applied in this thesis.
Commonly used analytical techniques are also presented. Subsequent chapters hereafter
describe relevant materials and methods pertinent for that chapter only.

3.1 Materials
Lyophilized lysozyme from chicken-egg-white powder containing more than 90% protein
(greater than or equal to 40,000 U/mg solid) was purchased from Sigma-Aldrich,
(Oakville, Canada). Micrococcus lysodeikiticus (ATCC No. 4698), L-cysteine, cystine,
ethylenediaminetetraacetic acid (EDTA), urea and sodium chloride were purchased from
Sigma Aldrich (Oakville, Canada). Solutions of N-(2-hydroxyethyl)piperazine-N’-(2ethanesulfonic acid) (HEPES) in distilled water (1M) and DL-dithiothrietol (DTT) (1M)
solution (DTT) (1M) were also purchased from Sigma-Aldrich (Oakville, Canada).

3.2 Equipment
Grenier Bio-One 96 well, clear, flat-bottom, UV-Star® microplate was purchased from
VWR International (Mississauga. Canada.) The detailed specification of which is given
in Appendix A.
All packed-bed protein adsorption studies were performed on pre-packed HiTrap cation
exchange columns connected to an KTA FPLC equipped with the UNICORN software
version 5.01 from GE Healthcare (Uppsala, Sweden). Specifications of the HiTrap
column are provided in Appendix B.
Pre-packed HiTrap cation exchange columns (1 ml and 5 ml) were purchased from GE
Life Sciences (Quebec, Canada). The HiTrap columns were pre-packed with Sepharose
Fast Flow (FF) cation exchange resin media. The Sepharose FF media is made of
particles with a macroporous gel structure and has neutral hydrophilicity based on chains
of agarose that are arranged in bundles. Sepharose fast flow (FF) resin particles, with an
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average particle diameter 90 μm, were used for all fluidized-bed ion-exchange lysozyme
refolding studies.
The fluidized bed system used for adsorptive protein refolding was constructed in-house
from Borosil® glass. A schematic diagram of the fluidized bed system is provided in
Figure 3.1. The system consisted of a jacketed conical column connected to an air inlet.
As illustrated in Figure 3.1, air was passed through the column (1); its flow was adjusted
with a valve (2) and measured by an air flow meter (3). A sintered glass filter of pore size
40 to 60 μm (4) was at the bottom of the column, and placed 0.5 mm above the air-inlet
pipe, ensured the resin remains fluidized throughout the duration of the operation.
Sepharose FF resin beads were placed in the column and fluidized using a gentle airflow
rate. Water was circulated in the fluidized bed by means of a peristaltic pump (10) for
temperature control. Ports 6 and 7 served as water in-let and out-let ports for the water
jacket surrounding the column. Port 5 was the discharge port for clean-in-place (CIP)
protocols.
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Figure 3.1 Schematic: Fluidized bed ion-exchanger for the refolding studies of
denatured lysozyme.
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3.3 Analytical Methods
3.3.1 Protein quantification
The concentration of both native and denatured lysozyme were monitored in 96 well
micro-plates using UV absorption spectrophotometer (Tecan 200pro, Männedorf
Switzerland) at A280nm. The protein concentration was determined using the BeerLambert law with molar extinction coefficients of 2.63 and 2.37 ml mg-1 cm-1 for native
and denatured lysozyme, respectively.
The path-length (cm) of a well in a micro plate was experimentally calculated by the
method suggested by Greiner Bio-one application note (GmbH, Germany) (Application
Note, 2008). The sample path length was defined by Equation 3.1 below, and is the ratio
of the difference in absorption of aqueous sample (path length unknown) measured at 977
nm and 900 nm to that of water (or reference buffer) with 1cm path-length measured at
the same wavelengths.
Sample path length (cm)

A977(sample) -A900(sample)
A977(reference) -A900(reference)

……………..… Equation 3.1

3.3.2 Lysozyme activity assay
Lysozyme enzymatic activity was measured using Microcococcus lysodeikitius (ATCC
No. 4698) in a microwell plate using Tecan 200pro multimode spectrophotometer
(Männedorf, Switzerland). A cell suspension of the bacteria was prepared by dispersing 9
mg of the bacteria in 30 ml of potassium phosphate buffer (0.06M at pH 6.2 units). The
initial absorbance at 450nm was adjusted between 0.5 – 0.7 unit (Lee & Yang, 2002). An
aliquot of cell suspension (190 μl) was accurately dispensed into each well of the
microplate. To this, sample solution (10 μl) containing lysozyme (native, denatured or
refolded) was added. Using Tecan microplate reader, with intermittent shaking, the initial
rate of decrease in absorbance at 450 nm was measured every 5 seconds over a period of
2 min. The activity of lysozyme was calculated from the initial slope of the time course
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by linear regression of data points. The specific activity of the sample (units min-1 ml-1)
was computed by dividing the initial slope of the lysozyme activity by the concentration
of lysozyme in reaction mixture. Equation 3.2 represents the specific activity of the
solution.
Specific activity (units min-1 ml-1)

A450nm/min
concentration of lysozyme(mg)

…….Equation 3.2

3.4 Performance indicators:
Definition of parameters used to determine refolding efficiency and process efficiency
are given below as follows.

3.4.1.1 Refolding Yield
Refolding yield was defined as the percentage of specific activity (units min-1 ml-1 ) of
sample (or refolded protein) over the specific activity (units min-1 ml-1) of the native
lysozyme. It is computed using Equation 3.3
Refolding ield

Specific activitysample
Specific Activitynative

x 100

. Equation 3.3

3.4.1.2 Fractional mass recovery:
The ratio of total mass of protein (mg) recovered in elution to the total mass of protein
(mg) loaded on to the ion-exchanger was defined as fractional mass recovery. It was
calculated as per Equation 3.4 below.
Fractional mass recovery

elute Celute
in ected Cfeed

………………………….…..Equation 3.4

where, Velute and Vinjected represent volume of protein (ml) eluted and injected,
respectively. Celute and Cfeed indicate the concentration of protein (mg/ml) in the elute and
feed, respectively.
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3.5 Nomenclature
Abbreviation

Full form

ATCC American type culture collection
EDTA Ethylenediaminetetraaceteic acid
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
DTT Dithiothreitol
SP FF Sepharose Fast Flow
CIP Clean-in-place
Velute Volume of elute (ml)
Vinjected Volume injected (ml)
Celute Concentration of protein in elute (mg/ml)
Cfeed Concentration of protein in feed (mg/ml)

3.6 References
Application Note. (2008). Application Note. greiner-bio-one.co.jp. Greiner Bio-One.
Retrieved from http://www.greinerbioone.com/en/row/articles/literatures/application_notes/#2620
Lee, Y. C., & Yang, D. (2002). Determination of lysozyme activities in a microplate
format. Analytical Biochemistry, 310, 223–224.
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Chapter 4

4

A comparative study of refolding lysozyme using
conventional strategies.
This chapter begins by validating the requirement of refolding additives and low
concentration of denatured protein for dilution refolding of denatured lysozyme. Next, it
compares the refolding yield and fractional mass recovery, as a function of increase in
protein concentration, for two different on-column modes of operation – packed bed and
fluidized bed.

4.1 Introduction:
Production of correctly folded and biologically active proteins in Escherichia coli can be
a challenging process (Fang & Huang, 2001; Su, 2011). Often, proteins are recovered as
insoluble inclusion bodies and need to be denatured and refolded into the correct
structure. To address this, various process operations have been developed. Dilution
refolding is the simplest and most-commonly used method, and involves refolding
initiation by reducing the denaturant concentration. By carefully controlling the protein
concentration at a low level, the formation of protein aggregates can be minimized. In
large-scale protein refolding this leads to a high cost for reagents and buffers and an
additional con- centration step is often required for further processing after dilution (Gu
et al., 2002; Leong & Middelberg, 2005.; Oganesyan, Kim, & Kim, 2004). Developing
high efficiency and low cost protein refolding methods is a highlighted research focus in
biotechnology. With speed being a driver for both structural biology and
biopharmaceutical development, only a limited set of refolding strategies can be tested
for any given protein. Technology for protein refolding should therefore be:


Scale invariant – to ensure that results from screening can be translated to
preparative systems and manufacture without significant changes in the
technology used;



Easily automated – to address the issue of speed and to enable high-throughput
processing of samples;
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Generic for a broad range of similar proteins – so that the technology does not
have to be reinvented for each new gene sequence;



Economical – to ensure that resources are not being wasted if a large number of
gene sequences or protein variants is being examined, and possibly to ensure
streamlined transfer to manufacture.

These parameters are easily addressed with the use of on-column protein refolding
processes and thus form the crux of research being conducted in the field of protein
refolding and purification worldwide. On-column adsorptive refolding of denatured
proteins is mainly achieved by size exclusion, ion exchange, or affinity processes. Ion
exchange refolding of proteins permits the selective and controlled adsorption and elution
of target protein and alleviates the aggregates formed in size-exclusion chromatography
due to sharp decrease in denaturant concentration.
Considering the importance and need for the gradual removal of denaturants and gradual
change in pH, an ion-exchange protein-refolding system was developed to improve the
refolding recovery at high-protein concentration. This study aims to investigate the
effectiveness of column refolding of denatured lysozyme under two different modes of
operation – packed and fluidized bed.

4.2 Materials and methods:
All materials and analytical methods, and also equipment design and operation, pertinent
to the study presented in this chapter, have been discussed and described in Chapter 3.
The following section describes in detail the experimental methodology utilized.

4.2.1 Experimental methodology
4.2.1.1Preparation of denatured lysozyme
Native lysozyme was dissolved in 50 mM HEPES, pH 7.0 to prepare a stock solution.
Denaturation buffer contained 6M urea, 32 mM DTT, 1 mM EDTA in 50 mM HEPES
buffer pH 8.1. Denatured lysozyme was prepared by diluting an appropriate volume of
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native lysozyme in denaturation buffer and incubating in a water bath at 37° C for a
period of 2 hours. The activity of the lysozyme was tested to ensure it was completely
denatured.

4.2.1.2 Dilution refolding of denatured lysozyme
Three different buffers were investigated. Buffer A 50 mM HEPES, pH 8.1, Buffer B
2 M urea in 50 mM HEPES, pH 8.1 and Buffer C 2 M Urea, 0.03 mM cysteine, 0.3 mM
cystine in 50 mM HEPES, pH 8.1 were prepared fresh on the day of the study. Denatured
lysozyme stock solution was diluted with each of the refolding buffers to give a final
enzyme concentration between 0.1 mg/ml and 2.0 mg/ml. The reaction mixtures were set
aside, on bench-top shakers at 120 rpm, for a period of 3 hours. At time points, half hour,
1 hour and 2 hours appropriate volume of sample was aliquoted and analyzed for protein
concentration and enzyme activity. The experimental results obtained are presented and
discussed later.

4.2.1.3 Adsorptive refolding of denatured lysozyme in a packed bed
ion exchange system
Figure 4.1 demonstrates the steps discussed below that were followed for the adsorptive
refolding of denatured lysozyme in an ion-exchange system.

Figure 4.1 Schematic representation of adsorptive on-column refolding of denatured
lysozyme
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The pre-packed HiTrap SP FF column (5ml), connected to AKTA FPLC, was
equilibrated with ten column volumes of equilibration buffer (50 mM HEPES, pH 8.7,
2M urea). The flow rate throughout the experiment was set at 0.4 ml/min. Denatured
lysozyme solutions, in the range of 1 mg/ml to 10 mg/ml, were prepared. A protein
loading of 2.5 ml of denatured lysozyme (at varying concentrations) was applied on to
the column. After rinsing with five column volumes of equilibration buffer, the column
was eluted by gradient elution. Elution was started by gradually increasing ratio of
elution buffer/equilibration buffer from 0:100 to 100:0 at 0.4 ml/min within 12 column
volumes. The composition of elution buffer was 50 mM HEPES, pH 8.1 containing 2 M
urea, 0.03 mM cysteine, 0.3 mM cystine and 1M sodium chloride. Fractions were
collected at every step and analyzed for protein concentration and lysozyme activity. The
column was washed, cleaned-in-place (CIP) and regenerated for the next cycle.

4.2.1.4 Adsorptive refolding of denatured lysozyme in fluidized bed
mode
A volume of exactly 5 ml of the Sepharose Fast Flow resin slurry, suspended in 50 mM
HEPES (pH 7.0), was accurately aliquoted and dispensed in the fluidized bed column.
The resin particles were equilibrated with 50 ml of equilibration buffer (2 M urea in 50
mM HEPES, pH 8.7) for a period of 30 minutes, by a steady-flow of air at 0.01 LPM
flow rate. At the end of equilibration, fluidization was halted and the buffer was
dispensed out of the column with the aid of peristaltic pump. Next, 10 ml of denatured
lysozyme solution, at varying concentrations 1 mg/ml to 10 mg/ml, was loaded onto the
re-fluidized resin particles. After 15 minutes of adsorption, the resin was allowed to settle
and the buffer was dispensed out of the column with the aid of the peristaltic pump.
Following this, the re-fluidized resin particles were washed with 25 ml of equilibration
buffer for period of 10 minutes. After separating the washed-resin particles from the
buffer, the resin particles were re-fluidized. Elution of bound lysozyme was initiated
when the resin particles were allowed to interact with 100 ml of elution buffer (50 mM
HEPES, pH 8.1 containing 2 M urea, 0.03 mM cysteine, 0.3 mM cystine and 1 M sodium
chloride) for duration of 30 minutes. The elution pool was collected and analyzed for
protein concentration and lysozyme activity. The resins were cleaned-in-place and
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regenerated before use in the next cycle. Performance indicators, fractional mass
recovery and refolding yield, were used to assess the efficiency of the process.

4.3 Results and Discussion
4.3.1 Refolding of denatured lysozyme by batch-dilution refolding
In principle, protein refolding was initiated by the gradual removal of denaturant, which
initiated the collapse of the unfolded molecule and the formation of secondary or tertiary
structure. This collapse exposed the hydrophobic core of the protein and therefore the
molecule was susceptible to aggregation. Protein aggregation, often the rate-limiting step,
is a second or higher order reaction and primarily dependent on the concentration of
protein and the composition of redox environment. Chaotropic agents such as urea and
guanidium chloride at non-denaturing concentrations solubilize protein aggregates and in
effect enhance protein refolding. Addition of redox agents such as cysteine/cystine or
GSH/GSSG, increase the rate of oxidation and break the non-native disulfide bonds. Thus
refolding of a denatured protein to its native state is primarily dependent on, the type and
concentration of refolding additives, the concentration of the protein and the duration of
incubation. Figure 4.2 shows the experimental results obtained by variation of refolding
buffer over a period of 2 hours at different concentrations of lysozyme.
Three different refolding buffers were investigated. Buffer A contained no refolding
additive, Buffer B contained the chaotropic agent urea, and Buffer C contained both the
chaotropic agent (urea) and redox couple (cysteine/cystine). Thus, a range of redox
environments was investigated. The volume of the reaction mixture kept constant (10 ml)
and the volume of denatured lysozyme was adjusted so appropriately to have varying
concentrations of lysozyme, from 0.1 mg/ml to 2 mg/ml, in the final reaction mixture.
Refolding by dilution lowers refolding protein concentration to minimize the propensity
of inter-molecular interactions of protein refolding intermediates (Basu, Li, & Leong,
2011). Figure 4.3, shows that increase in concentration of the lysozyme adversely
affected the refolding yield, irrespective of the refolding buffer used. Also, despite the
low protein concentration (0.1mg/ml and 0.2mg/ml), refolding buffer composition still
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plays an important role in influencing protein-refolding kinetics (Figure 4.2). Highest
refolding yield was obtained at the lowest concentration of lysozyme (0.1 mg/lm) in the
presence of both a redox couple and chaotropic agent (Buffer C). This is substantially
higher refolding yield, than that by Raman et al. (1996), who report ca. 75% renaturation
yield in 5 h, upon refolding lysozyme at 0.05 mg/ml (Raman, Ramakrishna, & Rao,
1996).

Figure 4.2 Effect of refolding buffer composition, time (h) and concentration of
protein (mg/ml) on protein refolding yield (%)
Three different buffer systems were investigated. Buffer A: 50 mM HEPES, pH 8.1;
Buffer B: 2 M urea in 50 mM HEPES, pH 8.1; Buffer C: 2 M urea, 0.03 mM Cysteine,
0.3 mM Cystine in 50 mM HEPES, pH 8.1. Refolding yield obtained at different time
points (0.5 h, 1 h and 2 h) was presented as a function of change in composition of buffer
and change in concentration of lysozyme (0.1 mg/ml to 2 mg/ml). The error bars denote
the standard error of mean between triplicates.
Diluting a denatured lysozyme by a solution containing 6 M urea and 32 mM DTT into
refolding buffer containing 2 M urea has an effect on the residual concentration of the
urea in the final reaction mixture. The concentration of residual urea determines which
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protein-refolding intermediates proliferate. For example a 100-fold dilution of denatured
lysozyme solution in refolding buffer A (no urea) would result in 0.01 M urea, while in
buffer C (containing 2 M urea) would produce 2.04 M of urea in the final reaction
mixture. Figure 4.3 shows the effect of residual urea (M) on the refolding yield of
denatured lysozyme (0.2 mg/ml). Figure 4.3 shows that refolding yield of lysozyme is
sensitive to the residual amount of urea.

2 hour

0.5 hour

120.00
Refolding yield (%)

100.00
80.00
60.00
40.00
20.00
0.00
0

0.5

1

1.5

2

2.5

3

Concentration of residual urea (M)

Figure 4.3 Changes in refolding yield due to urea (M) in the reaction mixture at two
different time points, 0.5 h (Δ) and 2 h (☐ ).
At concentration above 2.25 M urea, irrespective of the duration of incubation, very little
activity is regained. This can be explained by the increase in the chaotropic effect of urea.
A chaotropic solute is one that disrupts the structure of macromolecules by interfering
with the intramolecular interactions mediated by non-covalent forces such as hydrogen
bonds, van der Waals forces, and hydrophobic effects. Refolding additives such as urea,
usually at concentrations greater than 2 M, disrupt the micro aqueous environment of the
protein resulting in its denaturation, as has been demonstrated by previous research
findings (Bian, Liang, Yang, & Liu, 2007; Duan et al., 2009; Hou, Hansen, Staby, &
Cramer, 2010).
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4.3.2 Adsorptive refolding of lysozyme in a packed bed ion exchange
system
Figure 4.4 is the chromatograph generated by UNICORN when 16 mg of denatured
lysozyme was passed through the HiTrap SP FF column. Upon injection of the load, as it
passed through the column changes in UV absorption were recorded. The UV peak
obtained between 0 and 20 on the x-axis in Figure 4.4 indicates some amount of the
protein did not bind but instead flowed through. The second UV peak obtained between
40 and 80 on the x-axis in Figure 4.4 is the elution peak.

adsorption denatured ysozyme sept 22nd001:1_UV
adsorption denatured ysozyme sept 22nd001:1_Inject

adsorption denatured ysozyme sept 22nd001:1_Conc

adsorption denatured ysozyme sept 22nd001:1_Fractions
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Figure 4.4 Chromatogram generated by UNICORN upon loading 15 mg of
denatured lysozyme on a pre packed HiTrap SP FF column (5ml).
The blue line represents the change in UV absorption (mAU) at 280nm and the green line
represents the change in concentration of elution buffer from 0:100 to 100:0.

Waste
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Elution fractions C8 to C12 were pooled and analyzed for protein content and refolding
yield. Analysis revealed 90% of the bound protein eluted and the refolding yield of the
eluted peak was 69.34 % with a fractional mass recovery of 0.53 units. Similar
chromatograms were generated, upon varying the amount of load (mg) and the
experimental results obtained are presented in the Table 4.1. It shows the experimental
results obtained by loading varying concentrations of denatured lysozyme on 5 ml HiTrap
Sepharose Fast Flow column and its corresponding effect on the refolding yield and
fractional mass recovery of the protein. Table 4.1 also shows that increased in protein
load resulted in decrease in refolding yield and fractional mass recovery. When the
protein load (mg) onto the column was kept low (2.5 mg), there were enough adsorption
sites for the denatured protein to bind and refold. At the same time, the denatured protein
molecules because of their immobilization at different sites did not interact with each
other. However, as the protein load increased (15 mg), the number of protein molecules
exceeded the number of binding sites on the solid support, especially at the top of the
column. Interaction between the denatured molecules, thus, was inevitable. This
influenced the correct refolding and thereby decreased the fractional mass recovery and
refolding yield of lysozyme.
Table 4.1 Effect of lysozyme load (mg) on the fractional mass recovery and refolding
yield of lysozyme in a packed bed ion exchanger
Adsorbent

HiTrap SP FF (5ml)

Load : Denatured

Refolding Yield

Fractional mass

lysozyme (mg)

(%)

recovery

2.5

80.39

0.59

10

74.23

0.54

15

69.34

0.53

Fractional mass recovery of protein is the ratio of concentration of eluted protein (mg) to
the amount of the protein load (mg). In comparison to dilution refolding, adsorptive
refolding of denatured lysozyme was successful at significantly higher protein load (0.2
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mg in dilution vs 15 mg in packed bed system). This can be explained as follows. During
an on-column ion-exchange refolding process, protein adsorb to the matrix through the
interaction of its amino acid residues with the ion-exchange group on the solid support.
This adsorption minimizes the intermolecular reaction between proteins, thereby
decreasing the possibility of aggregation at higher concentrations of the protein. During
gradient elution, as the concentration of the elution buffer increases (from 0:100 to
100:0), the concentration of the denaturants in the column reduces. This forces the
partial-folded intermediate to move away from its original binding site and rearrange its
structure to its correct native conformation.
In order to meet the economies of scale, and proactively debottleneck the downstream
process, there is a strong demand in the industry for systems that can support high
concentration of protein solutions. Packed bed refolding of lysozyme has already
presented its limitation with regards to protein load (mg); whether this changes favorably
or not, in a fluidized bed system was investigated in the following section.

4.3.3 Refolding of denatured lysozyme in a fluidized bed ion
exchanger
In the fluidized mode of operation, resin particles are continuously “flowing” inside the
column by an upward stream generated by gas, buffers or sample solutions. As result, the
inter-particle porosity increases and mass-transfer between resin media and biological
component is enhanced. This was supported by the experimental results of Trivedi (2006)
who demonstrated the successful adaptation of a liquid-solid circulating fluidized bed for
refolding denatured lysozyme (Trivedi, 2006). Although, 72% refolding yield was
attained the mass recovery was less than 50%, therefore suggesting an improvement in
the design of the fluidized bed column. The Glatt-Powder-Coater-Granulator (GPCG) is
commonly used in the pharmaceutical industry for fluidized bed drying, particle coating,
pelletizing and wet granulation. The fluidized bed system developed in-house for the
purpose of this thesis, adopted the underlying principles of the GPCG while tackling the
design issues raised by Trivedi (2006). Thus, a conical shaped fluidized bed was
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designed, the construction and operation of which has already been described in Chapter
3.
In order to compare the efficiency of the fluidized bed ion-exchange refolding system to
that of the packed bed, series of experiments were conducted (see Section 4.1.1.4).
Samples from each step of the ion exchange process (adsorption, wash, elution) was
collected and analyzed for both protein concentration and enzyme activity. The process
performance indicators, discussed in analytical methods, were used to assess the
efficiency of the system in comparison to the packed bed refolding system. Table 4.2
shows the experimental results obtained. Experimental results obtained by varying the
amount of denatured lysozyme loaded onto the ion-exchange resin and its’ effect on the
refolding yield and fractional mass recovery of the process is presented in Table 4.2. In
comparison to results obtained in Table 4.1, the fractional mass recovery of the eluted
protein and refolding yield was substantially higher, thereby indicating the superior
efficacy of the fluidized bed system. Increasing the protein load to 15 mg of denatured
lysozyme in the packed bed system reduced the fractional mass recovery to almost 50%.
Whereas in the fluidized bed system with the same protein load (mg) the fractional mass
recovery was almost 30% higher (Ferré et al., 2005; Hjorth, 1999).
Table 4.2 Effect of lysozyme load (mg) on the refolding yield of lysozyme in a
fluidized bed ion-exchanger
Sr. No

Load : Denatured
lysozyme (mg)

Fractional Mass
Recovery

Refolding
Yield (%)

1

2.5

0.85

86.48

2

10

0.81

79.98

3

15

0.80

77.21

4

25

0.78

75.43

In the more recent study by, Mazumder et al (2009), with the aid of mathematical
modeling and simulation supported by experimental results, they showed that rate of
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protein production and overall recovery increased with the increase in solid circulation
rate (Mazumder, Zhu, Bassi, & Ray, 2009). Thereby, supporting our theory that increase
in fluidization of resin particles enhances the mass-transfer and protein elution profile and
thereby it’s recovery.

4.4 Conclusion
This study demonstrated the effectiveness of adsorption-based refolding technology to
refold a model protein, lysozyme that contains 4 disulfide bonds, at refolding
concentrations that are not attainable by dilution refolding (> 0.2 mg/ml). The influence
of refolding additives, concentration of feed and mode of operation – packed bed vs
fluidized bed, on lysozyme refolding yield was substantial. Increase in the amount of
protein in the feed during packed bed mode of operation, in comparison to fluidized bed,
resulted in decreased refolding yield and mass recovery. From this study, a potentially
feasible process route based on on-column refolding for large-scale manufacture of
proteins has been identified and demonstrated. The high refolding productivity achieved
by column refolding compared to dilution refolding will translate into more rapid product
delivery to market and a cheaper product, upon adequate optimization of the overall
bioprocess. The ready availability of the chromatographic resin used, coupled with the
simple and readily scalable on-column refolding process employed, indicates the
widespread applicability of this technology for simultaneous refolding and purification of
other protein molecules.

4.5 Nomenclature
Abbreviation
CIP
DTT
EDTA
HEPES
SP FF

Full form
Clean-in-place
Dithiothreitol
ethylene diamine tetraacetic acid
4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid
Sepharose Fast Flow
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Chapter 5

estigation of dilution refolding of lysozyme using imidazolium based ionic
ids
This chapter identifies the ionic liquid parameters, composition and concentrations of
ionic liquid, that influence the refolding yield of lysozyme. Refolding yield is presented
as function of time, with change in concentration and composition of the ionic liquids
tested. Influence of chaotropicity and kosmotropicity of the individual ions of the ionic
liquid on the refolding yield is also discussed.

5.1 Introduction
Proteins are most soluble in aqueous solution when they are in their native, folded state.
It is well established that protein refolding is a kinetically competitive process between
the intermolecular hydrophobic interactions resulting in aggregates versus the intramolecular interactions yielding native proteins. In-vitro the slightest deviation in upstream process and/or product parameters such as pH, concentration of protein,
temperature changes, mechanical stress such as shear strain, surface adsorption or
foaming etc., can alter the structure of the protein and consequently promote ‘salting out’
and/or misfolding or aggregation (Hamada, Arakawa, & Shiraki, 2009; Ito et al., 2012;
Karuppiah & Sharma, 1995; Lin, de Oliveira, & Veith, 2011; Mergili, Eiberle, &
Jungbauer, 2010; Tsumoto, Ejima, Kumagai, & Arakawa, 2003; Yamaguchi, Yamamoto,
Mannen, Nagamune, & Nagamune, 2012; Yang, Dong, & Yan, 2008).
In principle, during refolding, proteins are not promptly converted to the native state;
instead assume a partially folded state for a prolonged period of time. Folding
intermediates are comprised of significant elements of the secondary structure but little of
the native tertiary structure. Due to the expanded volume of these intermediates, the
hydrophobic regions, which are usually buried in the native state, are exposed to the
solvent. When so exposed, hydrophobic regions on separate polypeptide chains can be in
contact with one another and can interact. This causes the intermediates to be diverted
from the correct folding pathway, resulting in aggregate formation and loss of protein.
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Thus, it is apparent that in order to achieve high refolding yield the protein structure must
either be stabilized to minimize deviation and/or the structures that are not in the native
state must be solubilized to avoid protein-protein interaction (aggregation/misfolding).
This can be achieved by addition of solutes/refolding additives. Solution- or refoldingadditives can be classified into two categories a) denaturants – those that indirectly
promote refolding by weakening the inter- and intra- hydrophobic bonding and b)
protein stabilizers- those that enhance protein refolding by modifying the water of
hydration and thereby stabilizing the native structure.
An emerging category of refolding additives is ‘Ionic liquids’, also known as designer
liquids due to their tunable nature. By definition, they are ionic salts that are liquid at
temperatures below 100 °Celsius. Usually, it is the cation in an ionic liquid that has a low
degree of symmetry which tends to reduce the lattice energy of crystalline form of the
salt and thereby it’s melting point (Earle & Seddon, 2000). Since the synthesis of
ethylammonium nitrate (m.p. 12°C) by Paul Walden in 1914, ionic liquids have evolved
substantially and found application as lubricants, catalysts, in organic and in-organic
chemistry, separation technology, and biopharmaceuticals etc (Aparicio, Atilhan, &
Karadas, 2010; Endres et al., 2010; Hough & Rogers, 2007; Ohno & Fukumoto, 2007;
Pham, Cho, & Yun, 2010). So far, studies have shown that anions influence protein
stability and activity via their hydrogen bonding forming capacity and nucleophilicity
properties (Attri, Venkatesu, Kumar, & Byrne, 2011; Buchfink, Tischer, Patil, Rudolph,
& Lange, 2010; Lange, Patil, & Rudolph, 2005; Vidya & Chadha, 2009; Weingärtner,
Cabrele, & Herrmann, 2011).While changes in the alkyl chain length of the cations
influences the viscosity, hydrophobicity and polarity of the ionic liquid, consequently
affecting the solubility, stability and activity of targeted protein molecule (Bae, Chang,
Koo, & Ha, 2012; Baer & Mundy, 2013; Lange et al., 2005; Xiao et al., 2009;
Yamamoto, Yamaguchi, & Nagamune, 2011).
A common trend, in some of the recent studies, has been to study the effect of the ionic
liquid as a refolding additive by using it in lieu of urea or guanidine, in the presence of
redox-couple, such as cysteine/cystine or GSSG/GSH. This has primarily been achieved
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by dilution or dialysis several fold into the refolding buffer, reducing the lysozyme
concentration less than 0.10 mg/ml
In summary, refolding yield of a protein is dependent on several parameters:


Composition of refolding buffer



pH of the refolding buffer



Type of refolding additive (chaotropic agent, redox couple, ionic liquids,
detergents)



Concentration of refolding additive (mM or %w/w)



Concentration of denatured protein (mg/ml)



Incubation time (hours)



Methodology employed (dilution, dialysis, packed-bed, fluidized-bed, expandedbed etc.)

It has already been established that at low concentrations of protein and in presence of
redox couple, ionic liquids enhance refolding yield of denatured protein by suppressing
aggregation of protein and stabilizing the native structure of the protein. However, to the
best of our knowledge, published literature has not assessed the potential of ionic liquids
as protein refolding enhancers without redox couple or in a short duration of time. Thus,
with denatured lysozyme as the target protein, the aim of this study was to investigate the
effect of imidazolium based ionic liquids on its refolding yield.

5.2
5.2.1

Materials and Methods:
Materials

In addition to the common raw-materials presented in Chapter 3, ionic liquids were
purchased from purchased from Sigma-Aldrich (Oakville, Canada) and have been
enlisted in Table 5.1, below. Also, all analytical methods used have been described and
discussed in Chapter 3. The following section discusses the experimental methodology
employed for the study presented in this chapter.
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Table 5.1 List of ionic liquids used in this study
Sr.No.
1

Chemical
1-butyl-3-methylimidazolium

Abbreviation

Chemical Structure

[BMIM]Ac

acetate

2

1-butyl-3-methylimidazolium

[BMIM]Cl

chloride

3

1-butyl-3-methylimidazolium

[BMIM]MS

methylsulfate

4

1-ethyl-3-methylimidazolium

[EMIM]Ac

acetate

5

1-ethyl-3-methylimidazolium

[EMIM]Cl

chloride

6

1-ethyl-3-methylimidazolium

[EMIM] MS

methylsulfate

5.2.2
5.2.2.1

Experimental Methods
Preparation of denatured lysozyme

Native lysozyme was dissolved in 50 mM HEPES, pH 7.0 to prepare a stock solution.
Denaturation buffer contained 6 M urea, 32 mM DTT and 1 mM EDTA in 50 mM
HEPES buffer pH 8.1. Denatured lysozyme was prepared by diluting appropriate volume
of native lysozyme in denaturation buffer and incubating in water bath at 37 ˚C for period
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of 2 hours. The activity of the lysozyme was tested examined after this period to ensure it
is completely denatured.

5.2.2.2

Preparation of refolding buffer

Six different ionic liquids were investigated as refolding additives. Stock solution of each
of the ionic liquids in 50 mM HEPES, pH 8.1 was prepared. This was further diluted with
50 mM HEPES, pH 8.1 to yield refolding buffers with varying concentration of each of
the six ionic liquids. Controls, positive and negative, assure us that the experimental
results obtained are valid, and hence are important in all research-based experiments. A
positive control, gives the desired outcome of the experiment, provided that all the
reagents and equipment are functioning properly. While a negative control, does not give
the desired outcome. Based on the results presented in Chapter 4, buffer containing 2 M
urea, 0.03 mM cysteine, 0.3 mM cystine in 50 mM HEPES, pH 8.1 demonstrated it’s
efficacy in successfully refolding denatured lysozyme. Hence, this was used as positive
control, and henceforth is referred to as ‘conventional buffer’. While, 50 mM HEPES
buffer at pH 8.1 units, show negligible refolding yield (not desirable) and hence was used
as the negative control.

5.2.2.3

Preparation of refolded lysozyme

Denatured lysozyme was diluted with equal volumes of appropriate refolding buffer
(ionic liquid or conventional buffer), in micro-centrifuge tubes (1.5 ml). The tubes were
incubated at room temperature for a period of 3 hours. Sample aliquots were withdrawn
at 30 min and then at 1 h interval. These were analyzed for concentration of lysozyme
and lysozyme activity as described earlier in Chapter 3.

5.2.2.4

Influence of ionic liquids on the protein quantification assay

A solution containing, a sample ionic liquid- [BMIM] acetate, at varying concentrations
from 10 mM to 2.5 M, was prepared in 50 mM HEPES, pH 8.1. It’s absorbance without
any protein content at 280 nm was recorded. Next, native lysozyme was dissolved in each
of the ionic liquid containing buffers and the absorbance of the protein solution at 280 nm
was again recorded. The absorbance of blank (without native lysozyme) was subtracted
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from the absorbance of ionic liquid solutions containing lysozyme. The corrected (optical
density) OD was used for calculation of concentration of lysozyme.

5.2.2.5

Influence of ionic liquids on the lysozyme activity assay

To examine whether ionic liquids have an effect on micrococcus lysodeikticus, buffers
containing 2 M [EMIM]Cl in 50 mM HEPES (pH 8.1) and 2 M [BMIM] Cl in 50 mM
HEPES (pH 8.1), without any protein were treated as the sample solution in the lysozyme
activity assay described earlier. Native lysozyme solution served as positive control.
Change in absorbance at 450 nm representative of the change in turbidity of the cell
suspension was recorded every 5 seconds for a period of 2 minutes. The experimental
results are presented and discussed later.

5.2.2.6

Self-aggregation assay for lysozyme

The self-aggregation of lysozyme was assayed by measuring the light scattering intensity
(Yamaguchi, Yamamoto, Tsukiji, & Nagamune, 2008). Three different refolding buffers
were prepared. Buffer B was conventional buffer containing 2 M urea, 0.03 mM cysteine,
0.3 mM cystine in 50 mM HEPES buffer pH 8.1. This served as positive control. Buffer
C was 100 mM [EMIM] Cl in 50 mM HEPES, pH 8.1 and Buffer A was 50 mM HEPES,
pH 8.1, which served as negative control. The study was conducted in triplicate in microwell plates. Equal volumes of denatured lysozyme and each of the refolding buffers was
mixed and monitored at 450 nm for a period of 2 hours. Absorbance was recorded every
10 min and the change in turbidity of the solution was noted.

5.3
5.3.1

Results & Discussion
Preparation of denatured lysozyme

Lysozyme is a single chain polypeptide of 129 amino acids cross-linked with four
disulfide bridges. It hydrolyzes the ß(14) linkages between N-acetlymuramic acid and
N-acetyl-D-glucosamine residues in the peptidoglycans and between N-acetyl-Dglucosamine residues in chitodextrin (Gorin, Wang, & Papapavlou, 1971). Thus the
natural substrate for lysozyme is the peptidoglycan of layer of bacterial cell wall. Of
these, Micrococcus lysodeikticus is the most popular. An enzyme-substrate reaction is a
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very target-specific and an accurate reaction. Any change in the enzyme structure would
make it inaccessible to its specific substrate.
Lysozyme activity was measured by decrease in turbidity, represented by change in
absorbance at 450 nm due to lysis of Micrococcus lysodeikticus cells. Decrease in
absorbance indicated lysozyme activity and absence thereof implied either the denatured
state of lysozyme or the presence of a blank (solution without protein).
Figure 5.1 illustrates the change in absorbance at 450 nm upon the addition of three
different solutions, native lysozyme in 50 mM HEPES, pH 7.0, denatured lysozyme
solution and blank, i.e., 50 mM HEPES, pH 7.0. Upon addition of native lysozyme the
absorbance of cell suspension decreased linearly, and the initial slope was later used to
compute the specific activity of lysozyme. Addition of blank (50 mM HEPES, pH7.0)
and denatured lysozyme did not affect the micrococcus cell suspension and hence no
change in absorbance was recorded.

Figure 5.1 Graph illustrating the lysis of micrococcus lysodeikticus cell wall as a
function of time (seconds) upon addition of different solutions; native (o) and
denatured (Δ) and 50 mM HEPES pH 7.0(✖)
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5.3.2

Influence of ionic liquid on protein quantification

The influence of ionic liquid on the measurement of protein concentration was
investigated. Solutions containing different concentration of native lysozyme (NL), 0.215
mg/ml, 0.43 mg/ml and 0.86 mg/ml, were prepared in buffers containing increasing
concentration of [BMIM] acetate in 50 mM HEPES pH 8.1. Absorbance of these
solutions at 280 nm was noted and a graphical representation of this data is presented in
Figure 5.2. Increase in concentration of the native lysozyme and ionic liquid in buffer
resulted in a linear increase in the absorbance at 280 nm, as noted in Figure 5.2. There’s a
constant shift, corresponding to the increase in concentration of the protein. Hence, in
order to compensate for ionic liquid, a baseline subtraction was done in all protein
quantification assays.

Absorbance (280nm)

1.5

NL (0.215)
NL (0.43)
NL(0.86)
Blank

1.0

0.5

0.0

0

1

2

3

Conc. of [BMIM] Ac in Buffer (mol/l)

Figure 5.2 Change in A280 with corresponding increase in concentration of native
lysozyme (mg/ml) and [BMIM] Ac.
Absorption of radiation in the near UV region by proteins depends on the Tyrosine and
Tryptophan content and to a very small extent on the amount of Phenylalanine and
disulfide bonds. Recent studies have shown that imidazolium based ionic liquids have
some absorption in the UV region (Katoh, 2007). It was therefore critical and essential
when measuring the concentration of protein in buffers with ionic liquids that the
absorbance of ionic liquid (at 280 nm) be subtracted from that of the solution containing
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the protein and ionic liquid. Figure 5.3 illustrates the increase in optical density of ionic
liquids at 280 nm with corresponding increase in concentration (mol/l) of ionic liquid in
50 mM HEPES pH 7.0.

Absorbance (280nm)

2.5

[BMIM] Cl
[BMIM] MS
[EMIM]Cl
[EMIM] MS
[BMIM] Ac

2.0
1.5
1.0
0.5
0.0

0

1

2

3

Concentration of ionic liquid (mol/l)

Figure 5.3 Change in absorbance at 280 nm as function of change in concentration
of ionic liquid (M).
It was interesting to note, that different ionic liquids, at same concentration (M) had
varying optical density at 280 nm.

5.3.3

Influence of ionic liquids on lysozyme activity assay

Figure 5.4 represents the change in the turbidity of micrococcus cell suspension over a
period of 2 minutes upon the addition of three solutions. One of the solutions contains
active, native lysozyme and hence decreases the optical density of the solution. The other
two contain ionic liquids at high concentration (2 M). No change in absorbance is seen
over period of time, which implies that the ionic liquids have no cell lysis ability of their
own, and hence would not interfere with the assay of lysozyme activity or calculation of
refolding yield.
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2 M [EMIM]Cl

2 M [BMIM] Cl

Native Lysozyme

Absorbance (450 nm)

0.60
0.50
0.40
0.30
0.20
0.10
0.00
0

20

40

60

80

100

120

140

Time (seconds)
Figure 5.4 Graph illustrating the lysis of micrococcus lysodeikticus cell wall as a
function of time (seconds) upon addition of different solutions Native Lysozyme (◊),
2 M [EMIM]Cl in 50 mM HEPES pH 8.1 (Δ) and 2 M [BMIM] Cl in 50 mM
HEPES, pH 8.1 (□).

5.3.4

Effect of ionic liquids as refolding additives for batch dilution
refolding of denatured lysozyme

Miscibility of the ionic liquid or its partition in water has a considerable effect on
aqueous protein solutions. Upon dissociation, the individual component ions of ILs
interact with water via ion-dipole interactions and their hydration state is then dependent
on the type of ion and fraction of water present in the mixture. Consequently, this
determines if the ion is behaving as a kosmotrope or chaotrope. A kosmotropic anion
strongly interacts with water to stabilize the protein while a chaotropic anion exhibits
strong interaction with the protein’s chaotropic moieties and results in destabilization.
The viscosity B-coefficient of Jones-Dole equation measures kosmotropicity of an ion.
Table 5.2 represents the viscosity B-coefficients of certain anions and cations, as
presented in literature.
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Table 5.2 Characterization of ions based on their viscosity B-coefficient values
Viscosity B-

Ion

Coefficient

Acetate (OAc-)

0.246

Kosmotrope/Chaotrope Reference

Kosmotrope

(Jenkins &
Marcus, 1995)
(Jenkins &

Chloride (Cl-)

-0.005

Chaotrope/kosmotrope

Marcus, 1995;
Marcus, 1994)

Methylsulfate
(MeSO4-)

(Jenkins &
0.127

Chaotrope

Marcus, 1995;
Marcus, 1994)

1-ethyl-3methylimidazolium

0.491

Chaotrope

(Zhao, 2006)

0.610

Kosmotrope

(Zhao, 2006)

[Emim]
1-butyl-3methylimidazolium
[BMIM]
For the purpose of this study, a selection of imidazolium based ionic liquids based on
different combination of kosmotropic and chaotropic ions was made. Table 5.3
summarizes the chaotropicity and kosmotropicity of the cation and anion of the ionic
liquid used for the purpose of this study. Thus, [EMIM] methylsuflate is a strong
chaotropic ionic liquid, while [BMIM] acetate is a strong kosmotropic ionic liquid.
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Table 5.3 Characterization of ionic liquids
Anion
Acetate

Chloride

Methylsulfate

Cation
[EMIM]+

C

K

C

K/C

C

C

[BMIM]+

K

K

K

K/C

K

C

Abbreviations: K- kosmotrope, C: chaotrope, K/C : Borderline kosmotrope/chaotrope
Efficiency of the ionic liquid as refolding aid was assessed on the basis of changes in
refolding yield with respect to concentration of ionic liquid and duration of incubation.
Conventional refolding buffer containing urea and cysteine-cystine as the refolding aids
was used a positive control and 50 mM HEPES, pH 8.1 as the negative control. Refolding
yield (mean ± SEM) of independent triplicates is plotted against the concentration of
ionic liquid. The standard error of the mean (SEM) quantifies the precision of the mean
and is a measure of how far the sample mean is likely to be from the true population
mean. It is calculated by the sample standard deviation divided by the square root of the
sample size.
Figures 5.5 and 5.6, compare the effect of different anions of 1-alkyl-3methylimidaozlium based ionic liquid on the refolding of denatured lysozyme. Figure 5.5
A, B and C, represent the change in refolding yield (%) of denatured lysozyme as
function of time (hours) and concentration of [EMIM] based ionic liquid. The maximum
refolding yield under the employed experimental conditions was 97 % in a period of an
hour in the presence of 100 mM [EMIM] Cl. [EMIM] acetate proved to be moderately
effective, with a renaturation yield of about 40% in 3 hours.
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Figure 5.5 Change in refolding yield (%) of denatured lysozyme as a function of
time and concentration of A) [EMIM] Cl, B) [EMIM] Acetate C) [EMIM] MS based
ionic liquids.
Under similar experimental conditions, with a change in the ionic liquid composition to
1-butyl-3-methylimidazolium, a substantial change in refolding yield was observed. This
has been illustrated in Figures 5.6A, B and C. In the presence of 1-butyl-3methylimidazolium based ionic liquids, the maximum refolding yield obtained was in the
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presence of 2.5 M [BMIM]Cl within the first half hour of incubation. Increase in
incubation time resulted in the decrease of refolding yield. An anomaly was observed in
the refolding experiment with 500 mM [BMIM] Cl.
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Figure 5.6 Change in refolding yield (%) of lysozyme as function of time and
concentration of A) [BMIM] Cl, B) [BMIM] MS, C)[BMIM] Acetate
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Ionic liquids are known to affect protein activity by either a) stripping off the internal
water associated with the protein, b) penetrating into the micro-aqueous environment to
interact with the protein by changing protein dynamics, conformational and/or protein’s
active site, or c) by interacting with the substrates and products either by direct reaction
with them or by altering the portioning between the aqueous and non-aqueous phases.
The fact that ionic liquids dissolve and dissociate into individual ions rather than exist as
an intact molecule is an obvious advantage over molecular organic solvents. Miscibility
of the ionic liquid or its partition coefficient in water has a considerable effect on aqueous
protein solutions. Upon dissociation, the individual component ions of ILs interact with
water via ion-dipole interactions and their hydration state is then dependent on the type of
ion and fraction of water present in the mixture. Consequently, this determines if the ion
is behaving as a kosmotrope or chaotrope. Each ion, cation and anion, in solution then
interacts with the protein in solution and either stabilizes or destabilizes the protein
structure and conformation, thereby having an overall effect on the protein stability and
refolding yield.
With respect to the influence of alkyl chain length of the cation, refolding yield was
substantially less with BMIM based ionic liquids as opposed to EMIM based ionic
liquids. In a similar set up, Lange et al. (2005), examined the effect of N-‘alkyl-Nmethylimidazolium chlorides on the denaturation of lysozyme induced by heat and
guanidinium chloride (GuHCl). They observed, at higher concentrations of [BMIM] Cl,
HMIM Cl and OH-[HMIM] Cl, renaturation was effectively suppressed while for
[EMIM] Cl refolding yield was maximized. They suggest imidazolium cation with a
longer hydrophobic alkyl chain, such as [BMIM] Cl, has a higher preference of
destabilizing the enzyme due to (1) its strong interaction with the kosmotropic moieties,
such as the carboxylic groups, on the enzyme surface, and (2) its hydrophobic interaction
with the inner hydrophobic moieties of the enzyme molecule, leading to the disruption of
the enzyme’s native conformation.
In addition, literature review suggests, in comparison to anions of same charge density,
cations are usually observed to show a less dominant effect, because anions are more
polarizable and hydrate more strongly (Schwierz, Horinek, & Netz, 2013). Additionally,
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cations seem to present their impact indirectly via interaction with anions, and the
kosmotropic behavior of anions could be lessened in the presence of kosmotropic cations.
For example, [BMIM] is a kosmotropic cation and acetate a kosmotropic anion. The
refolding yield observed with [BMIM] acetate is the least in comparison to the other five
ionic liquids. It was hypothesized that kosmotropic cations (such as [BMIM]), as opposed
to the chaotropic ones (such as EMIM), have a higher tendency of ion pairing with the
kosmotropic anions (such as acetate), thus reducing the abundance of the free anions in
solution to play their kosmotropic role. This is also supported by the “law of matching
water affinity” which states in aqueous salt solutions, the interactions of ions in the order
of decreasing strength are as follows: kosmotrope–kosmotrope > kosmotrope–water >
water– water>chaotrope–water>chaotrope–chaotrope (Degreve et al., 2004; Hess & van
der Vegt, 2009; Schwierz et al., 2013; Zaccai, 2004).
Figure 5.7 represents the refolding yield of denatured lysozyme in 1hour as function of
change in concentration of ionic liquid in refolding buffer. [EMIM] is a chaotropic cation
and chloride a kosmotropic anion; increase in the concentration of the ionic liquid results
in the increase of refolding yield. Whereas, BMIM a kosmotropic cation when paired
with chloride, increase in its concentration results in decrease of refolding yield; as is
substantiated by the law of matching water affinity.
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The Jone-Dole empirical equation is commonly used to characterize ions based on their
ion-specific effect on the viscosity of the solution. Kosmotropes are often classified as
those that make the solution more viscous and Chaotropes as those that make the water
more fluid. Equation 5.1 expresses the Jones-Dole empirical equation, where η is the
viscosity of the solution and η0 is the viscosity of the solvent for most salts at low
concentrations [(<0.5 M ) or (<0.1 M) for binary strong electrolytes)], the D or higher
coefficients can be omitted, although they are necessary for higher concentrations.
…………………………………………..Equation 5.1
A plot of refolding yield as a function of the viscosity B-coefficient of anion in 100 mM
of EMIM and BMIM based ionic liquid is presented in Figure 5.8. It suggests that an
increase in viscosity-B coefficient of the anion decreases the refolding yield of the
denatured lysozyme. Increase in B-coefficient is usually associated with increase in
kosmotropicity of the ion. However, how this pairs with the cation and affects the overall
refolding yield of the denatured lysozyme, as can been explained the law of matching
water affinity.

Refolding Yield (%) in 1 hour
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Figure 5.8 Graph illustrates the change in refolding yield (%) as a function of
viscosity B-coefficient of anion with corresponding cations- [EMIM] (dark grey bar)
and [BMIM] (light grey bar)
The refolding yield of lysozyme under the influence of six different ionic liquids is plotted. The
X-axis represents the anion with its viscosity B-coefficient quoted in brackets. A positive value of
B-coefficient for an ion represents the intensity of kosmotropic character for the ion. Thus,
graphical results indicate effect of ionic liquid on refolding yield as a function of kosmotropicity
with corresponding changes in cation.

Urea is a chaotropic salt that at low concentrations (less than 3M) solubilizes protein
aggregates and enhances refolding of denatured protein. Results have already indicated
that 100 mM [EMIM]Cl in 50 mM HEPES (pH 8.1) enhances refolding of denatured
lysozyme.
A simple, semi quantitative, aggregation assay was conducted to compare the efficiency
of [EMIM] Cl as an aggregation suppressor in comparison to the conventional refolding
buffer containing urea and the redox couple, cysteine/cystine. The results of Figure 5.9
show that in the absence of any refolding additive (Buffer A), the optical density of
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denatured lysozyme solution increases with time. Thereby implying the denatured
proteins aggregate and come out of solution.
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Figure 5.9 Change in optical density of lysozyme solution over a period of time with
change in composition of buffers. Buffer A (Δ), Buffer B (*) and Buffer C(ο).
Buffer A: 50 mM HEPES, pH 8.1 containing 2 M urea, 0.03 mM cysteine, 0.3 mM cystine.
Buffer B: 100 mM [EMIM] Cl in 50 mM HEPES, pH 8.1 Buffer C: 50 mM HEPES, pH 8.1

In the presence of Buffer B and Buffer C, each of which contains different refolding
additives, the optical density of the denatured lysozyme solution was almost comparable.
And in comparison to Buffer B, [EMIM] Cl in Buffer C had a higher impact on
suppressing the aggregation of denatured protein. These results are corroborated by those
presented by Yamaguchi et al (2008) which revealed that increase in the hydrophobicity
of N’-substituent of the cation augmented the suppression of aggregation but adversely
affected the refolding yield. Hence, a fine balance between the hydrophobicity of the
cation and the kosmotropicity of anion was desirable in an ionic liquid to function as an
effective refolding additive(Yamaguchi et al., 2008).

5.4

Conclusion:

It is evident that the refolding yield of denatured lysozyme in the presence of ionic
liquids is influenced by the alkyl chain length of the cation, anion in the ionic liquid,
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concentration of the ionic liquid as a whole and the duration of incubation. It now
remains to be examined if an optimum for maximized refolding yield can be identified.
To do so, a response surface methodology and central composite design was employed
and is presented in the next chapter.

5.5

Nomenclature

Greek letter
η

viscosity of the solution

η0

viscosity of the solvent

Abbreviation
[BMIM]Ac
[BMIM]Cl
[BMIM]MS
[EMIM] MS
[EMIM]Ac
[EMIM]Cl
OH-HMIM Cl
C
DTT
EDTA
GuHCl)
HEPES
K
K/C

Full form
1-butyl-3-methylimidazolium acetate
1-butyl-3-methylimidazolium chloride
1-butyl-3-methylimidazolium methylsulfate
1-ethyl-3-methylimidazolium methylsulfate
1-ethyl-3-methylimidazolium acetate
1-ethyl-3-methylimidazolium chloride
N-(6-Hydroxyhexyl)-N'-methylimidazolium chloride
Chaotrope
Dithiothreitol
ethylene diamine tetraacetic acid
Guanidine hydrochloride
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
Kosmotrope
borderline kosmotrope, chaotrope

5.6

References

Aparicio, S., Atilhan, M., & Karadas, F. (2010). Thermophysical Properties of Pure Ionic
Liquids: Review of Present Situation. Industrial & Engineering Chemistry Research,
49(20), 9580–9595.
Attri, P., Venkatesu, P., Kumar, A., & Byrne, N. (2011). A protic ionic liquid attenuates
the deleterious actions of urea on alpha-chymotrypsin. Phys Chem Chem Phys,
13(38), 17023–17026.
Bae, S.-W., Chang, W.-J., Koo, Y.-M., & Ha, S. H. (2012). Enhanced refolding of
lysozyme with imidazolium-based room temperature ionic liquids: Effect of
hydrophobicity and sulfur residue. SCIENCE CHINA Chemistry, 55(8), 1657–1662.
Baer, M. D., & Mundy, C. J. (2013). An ab initio approach to understanding the specific
ion effect. Faraday Discuss., 160, 89.
Buchfink, R., Tischer, A., Patil, G., Rudolph, R., & Lange, C. (2010). Ionic liquids as

98

refolding additives: Variation of the anion. Journal of biotechnology, 150(1), 64–72.
Degreve, L., Brancaleoni, G. H., Fuzo, C. A., Lourenzoni, M. R., Mazze, F. M., Namba,
A. M., & Vieira, D. S. (2004). On the Role of Water in the Protein Activity. Brazilian
Journal of Physics, 34(1), 102–115.
Earle, M. J., & Seddon, K. R. (2000). Ionic liquids. Green solvents for the future. Pure
and Applied Chemistry, 72(7), 1391–1398.
Endres, F., Höfft, O., Borisenko, N., Gasparotto, L. H., Prowald, A., Al-Salman, R.,
Carstens, T., et al. (2010). Do solvation layers of ionic liquids influence
electrochemical reactions? Physical Chemistry Chemical Physics, 12(8), 1724.
Gorin, G., Wang, S. F., & Papapavlou, L. (1971). Assay of lysozyme by its lytic action
on M. lysodeikticus cells. Analytical Biochemistry, 39(1), 113–127. Retrieved from
http://journals2.scholarsportal.info/tmp/3479909228815538872.pdf
Hamada, H., Arakawa, T., & Shiraki, K. (2009). Effective of additives on protein
aggregation. Current pharmaceutical biotechnology, 10, 400–407.
Hess, B., & van der Vegt, N. F. A. (2009). Cation specific binding with protein surface
charges. Proceedings of the National Academy of Sciences, 106(32), 13296–13300.
Hough, W. L., & Rogers, R. D. (2007). Ionic liquids then and now : from solvents to
materials to active pharmaceutical ingredients. Bulletin of the Chemical Society of
Japan, 80(12), 2262–2269.
Ito, L., Okumura, M., Tao, K., Kasai, Y., Tomita, S., Oosuka, A., Yamada, H., et al.
(2012). Glutathione Ethylester, a Novel Protein Refolding Reagent, Enhances both
the Efficiency of Refolding and Correct Disulfide Formation. The Protein Journal,
31(6), 499–503.
Jenkins, H. D. B., & Marcus, Y. (1995). Viscosity B-Coefficients of Ions in Solution.
Chemical Reviews, 95(8), 2695–2724.
Karuppiah, N., & Sharma, A. (1995). Cyclodextrins as protein folding aids. Biochemical
and Biophysical Research Communications, 211(1), 60–66.
Katoh, R. (2007). Absorption Spectra of Imidazolium Ionic Liquids. Chemistry Letters,
36(10).
Lange, C., Patil, G., & Rudolph, R. (2005). Ionic liquids as refolding additives : N“-alkyl
and N-”(hydroxyalkyl) N-methylimidazolium chlorides. Protein Science, 14(10),
2693–2701.
Lin, H., de Oliveira, P. W., & Veith, M. (2011). Application of ionic liquids in
photopolymerizable holographic materials. Optical Materials, 33, 759–762.
Marcus, Y. (1994). Viscosity B-coefficients, structural entropies and heat capacities, and
the effects of ions on the structure of water. Journal of Solution Chemistry, 23(7),
831–848. Kluwer Academic Publishers-Plenum Publishers.
Mergili, Eiberle, M. K., & Jungbauer, A. (2010). Technical refolding of proteins: Do we
have freedom to operate? Biotechnology journal, 5(6), 547–559. Retrieved from
http://www.scopus.com/inward/record.url?eid=2-s2.077953168318&partnerID=40&md5=8906a7dd845d5e189955563614536e7b
Ohno, H., & Fukumoto, K. (2007). Amino Acid Ionic Liquids. Accounts of Chemical
Research, 40(11), 1122–1129.
Pham, T. P. T., Cho, C.-W., & Yun, Y.-S. (2010). Environmental fate and toxicity of
ionic liquids: A review. Water Research, 44(2), 352–372.
Schwierz, N., Horinek, D., & Netz, R. R. (2013). Anionic and Cationic Hofmeister

99

Effects on Hydrophobic and Hydrophilic Surfaces. Langmuir, 29(8), 2602–2614.
Tsumoto, K., Ejima, D., Kumagai, I., & Arakawa, T. (2003). Practical considerations in
refolding proteins from inclusion bodies. Protein Expression and Purification, 28(1),
1–8.
Vidya, P., & Chadha, A. (2009). The role of different anions in ionic liquids on
Pseudomonas cepacia lipase catalyzed transesterification and hydrolysis. Journal of
Molecular Catalysis B-Enzymatic, 57(1-4), 145–148.
Weingärtner, H., Cabrele, C., & Herrmann, C. (2011). How ionic liquids can help to
stabilize native proteins. Physical Chemistry Chemical Physics, 14(2), 415.
Xiao, D., Hines, L. G., Li, S., Bartsch, R. A., Quitevis, E. L., Russina, O., & Triolo, A.
(2009). Effect of cation symmetry and alkyl chain length on the structure and
intermolecular dynamics of 1,3-Dialkylimidazolium
Bis(trifluoromethanesulfonyl)amide Ionic liquids. The Journal of Physical Chemistry
B, 113(18), 6426–6433.
Yamaguchi, S. S., Yamamoto, E. E., Tsukiji, S. S., & Nagamune, T. T. (2008).
Successful control of aggregation and folding rates during refolding of denatured
lysozyme by adding N-methylimidazolium cations with various N'-substituents.
Biotechnology Progress, 24(2), 402–408.
Yamaguchi, S., Yamamoto, E., Mannen, T., Nagamune, T., & Nagamune, T. (2012).
Protein refolding using chemical refolding additives. Biotechnology journal, 8(1),
17–31.
Yamamoto, E., Yamaguchi, S., & Nagamune, T. (2011). Protein refolding by Nalkylpyridinium and N-alkyl-N-methylpyrrolidinium ionic liquids. Appl Biochem
Biotechnol, 164(6), 957–967.
Yang, L., Dong, X., & Yan, S. (2008). New development of reverse micelles and
applications in separation and refolding*. Chinese Journal of Chemical Engineering,
16(6), 949–955.
Zaccai, G. (2004). The effect of water on protein dynamics. Philosophical Transactions
of the Royal Society B: Biological Sciences, 359(1448), 1269–1275.
Zhao, H. (2006). Are ionic liquids kosmotropic of chaotropic? An evaluation of available
thermodynamic parameters for quantifying the ion kosmotropicity of ionic liquids.
Journal of Chemical Technology & Biotechnology, 81(6), 877–891.

100

Chapter 6

6 Application of response surface methodology and central
composite design for the optimization of lysozyme refolding
by the ionic liquid [EMIM]Cl
A quick overview on the theory of response surface methodology and central composite
design is provided. Experimental design and results thereof that aid and abet in the
identification of optimal refolding conditions for denatured lysozyme by [EMIM] Cl are
discussed in this chapter. A validated, empirical model based on the results is provided.

6.1 Introduction
Protein refolding, rate limiting step in the downstream processing of bio-therapeutics, is a
kinetically competitive process between correct folding and unproductive side reactions
such as aggregation and misfolding (Gautam, Mukherjee, Roy, & Gupta, 2012; Lange,
Patil, & Rudolph, 2005). Aggregation, considered to be a second- or higher-order
reaction, at high protein concentrations dominates over folding and leads to significant
reduction in the refolding yield. Therefore a logical strategy to improve refolding yield is
to prevent aggregation by adding low molecular weight compounds that interfere with
unwanted protein–protein interactions (Dechavanne et al., 2011). In principle, protein
refolding additives function by either penetrating the micro-aqueous environment of the
protein and stabilizing the protein (chaotropic effect) or by competing with the water
associated the protein thereby limiting its exposure to the solvent and consequently
driving the protein to its native state (kosmotropic effect). Numerous additives such as
chaotropic salts, detergent, polymers and amino acids etc., have been previously shown to
impede aggregation and enhance refolding yield (Alibolandi & Mirzahoseini, 2011;
Arakawa, Tsumoto, Kita, Chang, & Ejima, 2007; Hamada, Arakawa, & Shiraki, 2009;
Meng, Park, & Zhou, 2001; Stumpe & Grubmüller, 2009; West, Guise, & Chaudhuri,
1997). An emerging class of additives is that of ionic liquids. Ionic liquids are known to
affect protein activity by either a) stripping off the internal water associated with the

101

protein, b) penetrating into the micro-aqueous environment to interact with the protein by
changing protein dynamics, conformational and/or protein’s active site, or c) by
interacting with the substrates and products either by direct reaction with them or by
altering the portioning between the aqueous and non-aqueous phases. This dichotomy of
preferential binding/exclusion originates from the Hofmeister series that is explicitly used
to justify the effect of ionic liquids as protein refolding additives.
Optimization refers to improving the performance of a system, a process of a product in
order to obtain the maximum benefit from it (Bezerra, Santelli, Oliveira, Villar, &
Escaleira, 2008). Traditionally, optimization has been carried out, by monitoring the
influence of one-factor-at-a-time on an experimental response. The major disadvantage of
the one-factor-at-a-time approach is that it ignores the interactions among the variables
studied. As a consequence, this technique does not depict the complete effects of the
parameters on the response. Another disadvantage of the one-factor optimization is the
increase in the number of experiments necessary to conduct the research, which leads to
an increase of time and expenses as well as an increase in the consumption of reagents
and materials.
In order to overcome this problem optimization of procedures has been carried out by
using multivariate statistic techniques. Among the most relevant multivariate techniques
used is response surface methodology (RSM). Response surface methodology is a
collection of mathematical and statistical techniques based on the fit of a polynomial
equation to the experimental data, which must describe the behavior of a data set with the
objective of making statistical provisions (Aguirre & Bassi, 2013). It can be applied when
a response or a set of responses of interest are influenced by several variables. The
objective is to simultaneously optimize the levels of these variables to attain the best
system performance.
Protein refolding yield, is affected by several factors. These factors are inherent to the
system itself (chemical composition of refolding buffer, type of refolding additive,
concentration of refolding buffer, pH, viscosity etc.), to the protein (molecular mass,
charge, disulfide bonds) and interactions between the two (Rahimpour, Mamo, Feyzi,
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Maghsoudi, & Hatti-Kaul, 2007). Hence in this study, RSM design was developed to
optimize the refolding yield of denatured lysozyme by ionic liquid, specifically [EMIM]
Cl.
The simplest model, which can be used in RSM, is based on a linear function. For its
application, it is necessary that the responses obtained be well fitted to Equation 6.1 given
below, where k is the number of variables, β0 is the constant term, βi represents the
coefficients of the linear parameters, xi represents the variables, and ε is the residual
associated to the experiments. The residual is the difference between the calculated and
experimental result for a determinate set of conditions. A good mathematical model fitted
to experimental data must present low residuals values.
………………………………………………….Equation 6.1
Interactions among variables are depicted by curvature on the response surface. To
evaluate curvature, a second-order model must be used. Two-level factorial designs are
used in the estimation of first-order effects, but they fail when additional effects, such as
second-order interaction effects, are significant. Among the more known second- order
symmetrical designs are the three-level factorial design, Box–Behnken design, central
composite design, and Doehlert design. These symmetrical designs differ from one
another with respect to their selection of experimental points, number of levels for
variables, and number of runs and blocks. Central composite design is the more popular
and commonly used design for optimization of biological processes (Aguirre & Bassi,
2013; Akbari, Khajeh, Ghaemi, & Salemi, 2010; Branchu, Forbes, York, & Nyqvist,
1999; Steinberg & Bursztyn, 2010).
A central composite design consists of the following parts: (1) a full factorial or fractional
factorial design; (2) an additional design, often a star design in which experimental points
are at a distance α from its center; and (3) a central point.
Figures 6.1 and 6.2 illustrate the full central composite design for the optimization of two
and three variables
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Figure 6.1 Central composite design for the optimization of three variables (alpha =
1.68). Points of Factorial Design (), Axial points () and Central points (☐ ).

Figure 6.2 Central composite design for the optimization of two variables (alpha =
1.41). Points of Factorial Design (), Axial points () and Central points (☐).
A full uniformly rotatable central composite design is desired in circumstances where the
experimenter doesn't know the location of the optimum point within the region of interest
before the experiment is conducted, so it's desirable that all points a given distance (r)
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from the center point in any direction have the same magnitude of prediction error. Such
a central composite design presents the following characteristics:
(1) Requires an experiment number according to N = k2 + 2k + cp , where k is the variable
number and (cp) is the replicate number of the central point;
(2) α -values depend on the number of variables and can be calculated by α

2(k − p)/4 .

For two, three, and four variables, they are, respectively, 1.41, 1.68, and 2.00;
(3) all factors are studied in five levels (− α ,−1, 0, +1, + α).

6.1.1

Definition of key terms

It is pertinent to introduce and define key terms that are employed in the design of
experiments.
Factors or independent variables are experimental variables that can be changed
independently of each other. Typical independent variables comprise the pH,
concentration of ionic liquid, concentration of protein, time and temperature, amongst
others.
Levels of a variable are different values of a variable at which the experiments must be
carried out. The variable pH, for example in this study, has been investigated at five
levels: 6.6, 7, 7.5, 8, and 8.34 units.
Responses or dependent variables are the measured values of the results from
experiments. Typical responses are the recovery of an analytes, resolution among
chromatographic peaks and percentage refolding yield, among others.
There are several factors that affect the refolding of a protein; protein concentration, time,
pH of the buffer, temperature, concentration of refolding additive and type of refolding
additive. For the purpose of this study, two sets of experiments were conducted. First a
three factor, central composite design was used to assess the significant factors that affect
protein refolding. Next, two of the previously examined three factors that had significant
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interaction, were used to optimize the refolding yield of lysozyme using EMIM Cl and
derive an empirical model.

6.2 Materials and Methods
6.2.1

Materials

The ionic liquid of choice for this study, 1-ethyl-3-methylimidazolium chloride,
[EMIM]Cl was purchased from Sigma-Aldrich (Oakville Canada).
UV-Star microplate used for protein quantification and lysozyme activity assay, was
purchased from VWR International, (Mississauga, Canada). The specifications of plate
are described in Appendix, Table 1. Micro centrifuge tubes (1.5ml) use for the purpose of
this study was also purchased from VWR International, (Mississauga, Canada). Tecan
multimode microplate readers, 200 pro and M1000, (Männedorf, Switzerland) were used
for the purpose of the study. All other raw materials and analytical techniques used in this
study have already been discussed in Chapter 3 and hence not reproduced. The follow
section discusses the design of experiment and experimental methodology employed.

6.2.2
6.2.2.1

Design of experiments
Experimental design: RSM 1

Response surface methodology was employed to optimize the concentrations of
denatured lysozyme, concentration of [EMIM]Cl and pH of the refolding buffer that
produces the highest refolding yield. To fit the experimental data to a mathematical
model, the central composite design (CCD) 23 + star was used with three factors and five
levels. The CCD consisted of 17 experiments with three replicates for the central point
(in parenthesis in Table 6.2) and α
factors, which were investigated.

1.68. Table 6.1 represents the range of experimental
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Table 6.1 Range of experimental factors considered for RSM-1
Name

Units

Low

High

A: Amount of Lysozyme

mg

0.25

0.5

B: Ionic Liquid Concentration

mM

75.0

100.0

C: pH

Units

7.0

8.0

The data in table 6.2 represents the experimental conditions for the 17 independent runs.
The experiments appear in the table in the order they were performed. Estimated response
surface contour graphs were used to study to interactive effect of the variables on the
refolding yield of lysozyme. The statistical analysis and optimum values for response
variable was found based on mathematical models using Statgraphics Centurion XVI
(StatPoint Technologies Inc., Warrenton, USA).
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Table 6.2 Experimental matrix for three factor central composite design
Denatured lysozyme
(mg)

Run

Concentration
of [EMIM] Cl (mM)

pH (units)

1

0.37

108.52

7.50

2

0.16

87.50

7.50

3 (Replicate 1)

0.37

87.50

7.50

4

0.37

87.50

6.66

5 (Replicate 2)

0.37

87.50

7.50

6

0.25

75.00

7.00

7

0.50

100.00

7.00

8

0.50

75.00

8.00

9

0.59

87.50

7.50

10

0.38

87.50

8.34

11

0.38

66.47

7.50

12 (Replicate 3)

0.37

87.50

7.50

13

0.50

100.00

8.00

14

0.50

75.00

7.00

15

0.25

100.00

8.00

16

0.25

75.00

8.00

17

0.25

100.00

7.00

6.2.2.2

Experimental Design (RSM -2)

Two significant parameters were identified in Experimental design 1. Response surface
methodology was employed to optimize those factors, concentrations of denatured
lysozyme and concentration of [EMIM] Cl, which produces the highest refolding yield.
To fit the experimental data to a mathematical model, the central composite design
(CCD) 22 + star was used with two factors and five levels. The CCD consisted of three
blocks of 10 experiments and two central point replicates (in parenthesis in Table 6.4),
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per block, and α

1.14. Table 6.3 represents the range of experimental factors, which

was examined.
Table 6.3 Range of experimental factors in RSM 2
Name

Units

Low

High

A: Amount of lysozyme

mg

0.125

0.175

B: Ionic Liquid Concentration

mM

50.0

100.0

Mathematical model describing the relationship between response variable, percentage
refolding yield, and manipulated variables, concentration of denatured lysozyme and
concentration of [EMIM] Cl, was developed by finding the coefficients of a second order
equation. All the calculations were done using the data obtained at time point 2 hours.
The accuracy of the model was calculated by the regression coefficients R2 and adjusted
R2. Significance of regression coefficients was determined with a confidence level of
95%. The statistical analysis and the optimum values for the response variable was found
based on the mathematical model using Statgraphics Centurion XVI (StatPoint
Technologies Inc., Warrenton, USA).
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Table 6.4 Experimental design for RSM 2
Denatured lysozyme
(mg)

Run
1 (Replicate 1)
2
3
4
5
6
7
8
9
10 (Replicate 2)
11 (Replicate 3)
12
13
14
15
16
17
18
19
20 (Replicate 4)
21 (Replicate 5)
22
23
24
25
26
27
28
29
30 (Replicate 6)

6.2.2.3

0.15
0.15
0.13
0.15
0.19
0.18
0.13
0.18
0.12
0.15
0.15
0.15
0.13
0.15
0.19
0.18
0.13
0.18
0.12
0.15
0.15
0.15
0.13
0.15
0.19
0.18
0.13
0.18
0.12
0.15

Concentration of EMIM
Cl
(mM)
75.00
110.00
100.00
39.60
75.00
50.00
50.00
100.00
75.00
75.00
75.00
110.00
100.00
39.60
75.00
50.00
50.00
100.00
75.00
75.00
75.00
110.00
100.00
39.60
75.00
50.00
50.00
100.00
75.00
75.00

Validation of the empirical model

Amount of lysozyme in the final reaction mixture has a more profound effect on the final
refolding yield than the concentration of ionic liquid. Hence, experimental validation of
the model was done under conditions leading to optimal results, by varying the
concentration of the denatured lysozyme (see Table 6.8). The predicted refolding yield
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(%) was computed by an input of three different concentrations of denatured lysozyme,
not previously tested in RSM- 2. Comparing to the observed refolding yield validated the
accuracy of the model.

6.2.3

Experimental methodology

Preparation of native and denatured lysozyme:
Native lysozyme was prepared by dissolving lysozyme in 50 mM HEPES, pH 7.0.
Composition of the denaturation buffer was 6 M urea, 32 mM DTT and 1 mM EDTA in
50 mM HEPES, pH 8.7. Denatured lysozyme was prepared by diluting appropriate
volume of native lysozyme solution in denaturation buffer and incubating in hot-water
bath at 37 °C for a period of 2 hours. Final concentration of the stock denatured lysozyme
was 1 mg/ml.
Preparation of refolding buffers:
A concentration stock solution of [EMIM] Cl in 50mM HEPES was prepared. Refolding
buffer, at its required concentration (mM), was prepared by diluting the stock solution of
with 50 mM HEPES. The final pH (units) of the refolding buffer was adjusted per the
design of experiments previously discussed. Either hydrochloric acid or sodium
hydroxide was used to attain the desired pH value.
Refolding methodology:
Refolding of the denatured lysozyme was studied as per design of experiments (DOE),
previously discussed. The experiments were conducted in micro centrifuge tubes (1.5ml)
at ambient room temperature. The final volume of the reaction mixture was 1ml. Based
on the requirement of DOE and calculations; denatured lysozyme solution (1 mg/ml) was
diluted to a final volume of 1 ml with its corresponding refolding buffer (mM). Once the
reaction mixture was prepared, the micro centrifuge tubes were placed on a shaker at 125
rpm for a period of 2 hours. Sample was carefully aliquoted and analyzed for protein
concentration and refolding yield.
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6.3

Results and Discussion

6.3.1

Refolding yield as a function of composition of refolding
buffer and concentration of lysozyme

Results of the experimental set up, described in RSM-1, are presented in Table 6.5. It is
evident that increase in the amount of denatured lysozyme (mg) adversely affected the
refolding yield. Maximum refolding yield was obtained at the lowest concentration
(0.165 mg) of denatured lysozyme, which was consistent with the results presented in
Chapter 5
Table 6.5 Experimental results of RSM -1
Run
1
2
3 (Replicate 1)
4
5 (Replicate 2)
6
7
8
9
10
11
12 (Replicate 3)
13
14
15
16
17

Denatured
lysozyme
(mg)
0.37
0.16
0.37
0.37
0.37
0.25
0.50
0.50
0.59
0.38
0.38
0.37
0.50
0.50
0.25
0.25
0.25

Concentration
of [EMIM] Cl
(mM)
108.52
87.50
87.50
87.50
87.50
75.00
100.00
75.00
87.50
87.50
66.47
87.50
100.00
75.00
100.00
75.00
100.00

pH
(units)
7.50
7.50
7.50
6.66
7.50
7.00
7.00
8.00
7.50
8.34
7.50
7.50
8.00
7.00
8.00
8.00
7.00

Refolding
Yield
(%)
3.83
56.00
33.50
22.70
33.30
44.00
17.30
4.00
18.70
6.67
17.30
33.20
10.70
12.00
10.40
24.70
20.00

The visualization of the predicted model equation can be obtained by surface response
plot. Based on the results obtained in Table 6.5, Figures 6.3, 6.4 and 6.5 illustrate the
quadratic response surface plot obtained in this study.
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Figure 6.3 Estimated response surface contour graph illustrating the refolding yield
as a function denatured lysozyme (mg) and [EMIM] Cl ( mM) at pH 7.5 units

Figure 6.4 Estimated response surface contour graph of refolding yield as a function
of concentration of [EMIM] Cl (mM) and change in pH (units) at 0.165 mg
lysozyme.
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Figure 6.5 Estimated response surface contour graph of refolding yield as a function
of change in amount of lysozyme (mg) and pH (units) at fixed concentration of
[EMIM] Cl = 75 mM
Maximum refolding yield (56%) was obtained when the concentration of lysozyme was
0.165 mg using refolding buffer 87.5 mM [EMIM]Cl in 50 mM HEPES, pH 7.5. At
constant pH, 7.5 units, increase in the concentration of denatured lysozyme results in a
decrease in the refolding yield from 53 % to 3 %, Figure 6.3. In figure 6.4, change in
refolding yield was presented as function of pH units and concentration of [EMIM] Cl
(mM), at lysozyme concentration, 0.18 mg. A similar response surface contour graph was
obtained when the lysozyme concentration was varied along with pH of the refolding
buffer, but the concentration of [EMIM] Cl was kept constant at 75 mM.

6.3.2

Refolding yield as a function of lysozyme concentration (mg)
and concentration of [EMIM] Cl (mM)

The response surface graphs obtained Figures 6.3, 6.4, and 6.5, show that the maximum
(refolding yield) point was outside the experimental region and hence it was necessary to
displace, if possible, the initial design to test it. Consequently, the RSM-2 design
maintained the pH of the refolding buffer constant at pH 7.5 units but narrowed the range
of denatured lysozyme and [EMIM] Cl. Table 6.6 presents the experimental results of the
RSM-2 design described earlier. The repetition of central runs was carried out to provide
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information on the variation of the responses about the average, the residual variance, and
eventually estimate the pure experimental uncertainty.
Table 6.6 Experimental results of RSM- 2
Run
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Denatured lysozyme
(mg)
0.15
0.15
0.125
0.15
0.185
0.175
0.125
0.175
0.115
0.15
0.15
0.15
0.125
0.15
0.185
0.175
0.125
0.175
0.115
0.15
0.15
0.15
0.125
0.15
0.185
0.175
0.125
0.175
0.115
0.15

Concentration of
EMIM Cl (mM)
75
110
100
39.6
75
50
50
100
75
75
75
110
100
39.6
75
50
50
100
75
75
75
110
100
39.6
75
50
50
100
75
75

Refolding Yield
(%)
80.0
13.7
20.8
4.77
6.79
3.03
9.41
8.27
17.6
76.5
82.7
12.8
22.1
5.51
6.92
2.84
9.74
8.69
14.8
78.0
79.5
14.0
20.7
5.21
7.05
2.88
9.83
8.9
15.1
85.6
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(Bezerra et al., 2008), state in order to find a critical point (maximum, minimum or
saddle), it is necessary for the polynomial function to contain quadratic terms according
to Equation 6.2, where
y β0 +

k
i 1 βi xi +

k
i 1 βii

represents the coefficients of the quadratic parameter.
+

k
1 i

βi

+ ε………………………Equation 6.2

Based on the results presented in Table 6.5, Equation 6.3 is the equation of the fitted
model, where : Y = refolding yield (%), X1 = Amount of denatured lysozyme (mg), X2 =
Concentration of [EMIM]Cl (mM), X1X2 = interaction effect of amount of lysozyme
(mg) and [EMIM]Cl (mM).
- .

.

- .

- .

- .

……

…..Equation 6.3
The quality of the fitted model was evaluated by the application of analysis of variance
(ANOVA). The central idea of ANOVA is to compare the variation due to the treatment
(change in the combination of variable levels) with the variation due to random errors
inherent to the measurements of the generated responses (Bezerra et al., 2008; Hanrahan
and Lu, 2006; Steinberg and Bursztyn, 2010).
The ANOVA table (Table 6.7) partitions the variability in refolding yield into separate
pieces for each of the effects. As replicates of the central point were made, it was possible
to estimate the pure error associated with repetitions. The statistical significance of each
effect by comparing the mean square against an estimate of the experimental error was
evaluated. In this study, 5 effects have P-values less than 0.05, indicating that they are
significantly different from zero at the 95.0% confidence level. As per ANOVA, all
parameters, including the interacting parameters X1X2 are significant
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Table 6.7 Analysis of variance for the response surface quadratic model of refoldind
yield of lysozyme

Source

Sum of
Squares

Degrees
of
freedom

Mean
Square

F-value

P-Value

X1

384

1

384

85.08

0

X2

269

1

269

59.56

0

X12

16185

1

16185

3596.68

0

25.3

1

25.3

5.62

0.0261

17102

1

17102

3800.51

0

Total error

108

24

4.51

Total (corr.)

2.43E+04

29

X1X2
X22

R-squared = 99.6 % , R-squared (adjusted for d.f.) = 99.4 %, Standard Error of Est. =
2.12, Mean absolute error = 1.47, Durbin-Watson statistic = 2.36 (P=0.7300) and Lag 1
residual autocorrelation = -0.307.
The goodness of the model for yield of refolding can be checked by several standards.
The regression coefficient, R2 = 99.6%, table 6.7, indicated that only 0.4% of the
variability of the response was not explained by the model. The adjusted R2 , which was
used to compared model, was 99.4%. These results indicated good accuracy of the model
in the conditions investigated.
Further, Figure 6.6 represented the plot of experimental refolding yield versus the
predicted, based on the model (Equation 6.3). The points cluster around the diagonal line
indicating there was no significant deviation between the corresponding values

117

Figure 6.6 Plot of refolding yield: observed vs. predicted based on empirical model
Figure 6.7 shows the response surface and contour graph for refolding yield (%).
Maximum refolding yield was obtained when the concentration of denatured lysozyme
was 0.15mg and the concentration of EMIM Cl was 75 mM. It is also interesting to note
that, when the amount of lysozyme is set at high value (0.19 mg), the refolding yield (Y)
increases with increase in [EMIM]Cl concentration (from 35 mM to around 70 mM) and
then decreases ([EMIM]Cl concentration from 80 mM to 110 mM).

Figure 6.7 Estimated RSM contour plot of refolding yield (%) as a function of
concentration of [EMIM] Cl (mM) (ionic liquid) and lysozyme (mg)
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The response surface model was validated with a random set of experiments to confirm
the accuracy of the empirical model, equation 6.3. Experimental points, previously not
tested, were examined. The predicted refolding yield was calculated by substituting the
values of the experimental factors in Equation 6.3. Details of the experiment and
obtained results along with predicted results are presented in Table 6.8.
Table 6.8 Validation of empirical model. Experimental conditions, predicted
response calculated from Eq. 6.6 and observed experimental resutls
Denatured
lysozyme (mg)

EMIM Cl
conc. (mM)

Predicted
Refolding Yield (%)

Experimental
Refolding yield (%)

0.13

75

63.76

59.23

0.15

75

83.79

86.89

0.17

75

58.11

49.13

0.19

75

-10.84

0

The optimum concentration of [EMIM]Cl was kept constant and the refolding yield as
function of change in amount of denatured lysozyme was observed, and also predicted
using Equation 6.3. The calculated refolding yield was in close proximity of the predicted
values; thus, validating the model.
Further, aggregation assay was used as means to evaluate the effect of [EMIM] Cl on the
refolding of denatured lysozyme. The parameters were set as described in RSM-2. The
experimental results obtained are presented in Table 6.9.
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Table 6.9 Influence of [EMIM] Cl as protein aggregation suppressor
Lysozyme (mg) Concentration of [EMIM] Cl (mM)
100.00
110.00
75.00
100.00
87.50
75.00
75.00
75.00
87.50

0.13
0.15
0.12
0.18
0.17
0.15
0.19
0.25
0.38

%Refolding

% Turbidity

12.79
13.68
17.62
28.27
42.00
88.27
36.79
34.00
15.72

28.65
29.81
32.69
32.31
21.15
40.00
49.38
11.89

Based on the results obtained in Table 6.9 and optimal conditions obtained earlier, Figure
6.8 is a graphical representation of the effect of 75 mM [EMIM] Cl in 50 mM HEPES as

Percentage,
Refolding yield, Turbidity

a refolding buffer for varying amount of denatured lysozyme (mg).

Refolding Yield
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Turbidity

100
80
60
40
20
0
0.115

0.15

0.19

0.25

Amount of lysozyme (mg)
Figure 6.8 Graphical representation of the effect of 75 mM [EMIM] Cl in 50 mM
HEPEs ,pH 7.5 on lysozyme refolding and aggregation.
Refolding yield (%) (black bar) and aggregation represented by turbidity (%) (grey bar) is
presented a change in amount of lysozyme (mg) in final reaction mixture.
The results of Table 6.9 and Figure 6.8 support the empirical model and elucidate the
effect of [EMIM] Cl on increasing concentration of lysozyme. It was, thus, evident that
increase in the concentration of lysozyme increases the aggregation (%) hence poor
refolding yield.
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6.4 Conclusion
Refolding of denatured lysozyme, evidently, was grossly dependent on the amount of
lysozyme in the final reaction mixture along with the concentration and type of refolding
additive. Table 6.10 summarizes the published research findings of Lange et al (2005,
2010), Bae et al (2012), Buchfink et al (2010) and the results obtained in this thesis
(chapter 4 and 6).
Table 6.10 Summary of experimental results obtained and data published by other
scientists
Protein

Lysozyme

rPA
(recombinant
plasminogen
activator)
Lysozyme

Lysozyme

Lysozyme

Lysozyme

Refolding Buffer

0.3 mM GSH, 0.03
mM GSSG, 1 mM
EDTA, 0.1 M
[EMIM] Cl, 0.1 M
Tris/HCl (pH 8.2)
0.3 mM GSH, 0.03
mM GSSG, 1 mM
EDTA, 3 M
[EMIM] Cl, 0.1 M
Tris/HCl (pH 8.2)
0.3 mM GSH, 0.03
mM GSSG, 1 mM
EDTA, 1 M
[EMIM] BF4, 0.1
M Tris/HCl (pH
8.2)
0.3 mM GSH, 0.03
mM GSSG, 1 mM
EDTA, 1 M
[EMIM] MS, 0.1 M
Tris/HCl (pH 8.2)
2 M urea, 0.03 mM
cysteine, 0.3 mM
cystine 50 mM
HEPES (pH 8.1)
75 mM [EMIM] Cl
50 mM HEPES pH
7.5

Refolding
duration
(h)

Conc. of
denatured
protein
(µg/ml)

Max.
Refolding
Yield (%)

280

80

Lange et
al (2005)

280

16

Buchfink
et al
(2010)

100

80

Bae et al
(2012)

100

90

Bae et al
(2012)

100

90

Chapter
4, Kaur
2013

180

84

Chapter
6, Kaur
2013

1:60
dilution for
24 hours

1:60
dilution for
24 hours

1:100
dilution for
24 hours

1:100
dilution for
8 hours
1:100
dilution for
2 hours
1:6 dilution
for 2 hours

Ref.
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Thus far, only three research groups have published data on the refolding of denatured
proteins using imidazolium based ionic liquids. The maximum refolding yield obtained in
each of the studies is summarized in Table 6.10. None of the studies, by either research
group, reports the exclusive use of ionic liquid as a refolding additive in lieu of
cysteine/cystine. They however, do investigate the impact of ionic liquid as protein
aggregation suppression agents. Also, the duration of the refolding process is almost
always 24 hours, with results of the refolding yield at intermittent time intervals missing.
Whether this yield was achieved within the initial few hours is not clear. The table also
shows results obtained by the author in this thesis and serves as a comparison to
published data.
As is evident from the Table 6.10, to the best of our knowledge, the results presented in
this chapter, is the first report of using imidazolium based ionic liquids without any
additional redox couple (cysteine/cystine) to refold any protein and in particular
denatured lysozyme. This is also the first report of study using response surface
methodology and central composite design to find the conditions that yield optimum
refolding yield for denatured lysozyme using imidazolium based ionic liquids.

6.5 Nomenclature
Greek symbol
xi
βi
cp
k
β0
βi
ε
Abbreviation
[EMIM] Cl
ANOVA
CCD
DTT
EDTA
HEPES
R2
RSM

Variables in a central composite design
Represents the coefficients of the quadratic parameter
Replicate number of the central points
Number of variables
Constant term
Coefficients of linear parameters
Residual associate to the experiments
Full Form
1-ehtyl-3-methyl imidazolium chloride
Analysis of variance
Central composite design
Dithiothreitol
ethylenediaminetetraacetic acid
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
Regression coefficient
Response surface methodology
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X1
X1X2
X2
Y

Concentration of denatured lysozyme (mg)
Interaction effect of concentrations of lysozyme (mg) and [EMIM] Cl (mM)
Concentration of [EMIM] Cl (mM)
Refolding yield (%)
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Chapter 7

7 Adsorptive protein refolding with the aid of [EMIM] Cl in a
packed bed/fluidized bed ion –exchanger
The applicability and influence of [EMIM] Cl as an elution and refolding buffer for
adsorptive refolding of denatured lysozyme is examined. Refolding yield and fractional
mass recovery, due to incorporation of [EMIM] Cl in elution buffer, is presented as
function of mode of operation and increase in concentration of protein load. Comparison
on the efficacy of [EMIM] Cl as a refolding/elution enhancer to other ionic liquids is also
reviewed by means of experimental results.

7.1 Introduction
The bottleneck in biotechnology, in the last decade, has shifted from upstream to
downstream processing of biomolecules. The pressure to develop better separation and
purification protocols that combat the new process- and product-related impurities and
higher titre levels without compromising on the safety, efficacy and quality of the product
is continually increasing. The purification of proteins is steadily moving from poolingelution-fractions-of-multiple-runs on a single column towards development of columns
that can handle higher protein concentrations. In order to do so, it is pertinent to develop
integrated approaches that incorporate clarification, separation, recovery and purification.
The recovery of active protein from inclusion bodies, to date, is the biggest challenge in
downstream processing of proteins.

Protein refolding is a kinetically competitive

process. Aggregation caused by the hydrophobic interaction between folding
intermediates competes with the on-pathway renaturation process, leading to low
refolding yields. A potentially efficient strategy to minimize aggregation is to decrease
this risk of intermolecular interaction by adsorbing the denatured protein molecules to a
solid support, thus, effectively separating the individual protein molecules from each
other during refolding.
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Usually, adsorbent particles are packed in fixed beds which require pre-clarified feed , in
order to avoid plugging particulate material in the packed bed, which can lead to
increased pressure drop and operating failure (Thömmes, 1997). Fluidization of the
protein adsorption media, increases the inter-particle distance of the resin particles ,
thereby allowing the feed to pass freely in the interstitial volume of the matrix. A
significant advantage of this process is the integration of clarification, separation and
recovery of the purified biomolecule in one unit operation.
Refolding additives, enhance refolding yield of a protein, by either suppressing
aggregation or by stabilizing the native structure of the protein. Chaotropic salts at nondenaturing concentrations (for urea below 3 M), anion- and non-ionic detergents, amino
acids and its derivatives, osmolytes, amphiphilic polymers and varying salts have been
used as refolding aids in the past (Arakawa, Tsumoto, Kita, Chang, & Ejima, 2007;
Daugherty, Rozema, Hanson, & Gellman, 1998; Hamada & Shiraki, 2007; Wang, Nema,
& Teagarden, 2010; Yamaguchi, Yamamoto, Mannen, Nagamune, & Nagamune, 2012;
Yasuda, Murakami, Sowa, Ogino, & Ishikawa, 1998). An evolving class of refolding
additives is the “designer liquids” or ionic liquids. Ionic liquids, by definition are salts
that are liquid at temperatures below 100 °C and consist entirely of ionic species. As they
are made up of two components (the anion and cation), which can be varied, the solvents
can be designed with a particular end use in mind, or to possess a particular set of
properties. The effect of ionic liquids in biocatalysis has been previously reviewed by
(van Rantwijk & Sheldon, 2007). In addition to experimental results presented and
discussed in chapters 5 and 6 of this thesis, several other scientist have demonstrated the
efficacy of ionic liquids as refolding additives via dilution refolding of denatured protein
(Bae, Chang, Koo, & Ha, 2012; Buchfink, Tischer, Patil, Rudolph, & Lange, 2010;
Lange, Patil, & Rudolph, 2005; Yamamoto, Yamaguchi, & Nagamune, 2011). The
general consensus, so far, has been to use ionic liquids with a kosmotropic anion and
chaotropic cation to achieve enhanced refolding yields.
The purpose of this work was to investigate the influence of one such imidazolium based
ionic liquid [EMIM] Cl, on the refolding yield of denatured lysozyme in a packed
bed/fluidized mode of operation. Process performance indicators such as refolding yield
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and fractional mass recovery were used to compare and evaluate the efficiency of the
different adsorptive refolding processes.

7.2 Materials and Methods
7.2.1 Materials
All materials and equipment used in this study have already been described in Chapter 3,
with the exception of the ionic liquids 1-ethyl-3-methylimidazolium chloride, 1-butyl-3methylimidazolium chloride and methylimidazolium chloride, which were purchased
from Sigma-Aldrich (Oakville, Canada). The following section discusses the
experimental methodology employed. The reader is requested to refer Chapter 3 for
discussion on the analytical techniques employed.

7.2.2 Experimental methodology
7.2.2.1 Preparation of denatured lysozyme
Native lysozyme was dissolved in 50 mM HEPES, pH 7.0 to prepare a stock solution.
Denaturation buffer contained 6 M urea, 32 mM DTT, 1 mM EDTA in 50 mM HEPES
buffer pH 8.7. Denatured lysozyme was prepared by diluting an appropriate volume of
native lysozyme in denaturation buffer and incubating in a water bath at 37° C for a
period of 2 hours. The activity of the lysozyme was tested to ensure it was completely
denatured.

7.2.2.2 Investigation of adsorption of ionic liquid ([EMIM]Cl) on ionexchange resin
A 5 ml pre-packed HiTrap SP FF column was connected to the AKTA FPLC system
equipped with UV flow cell, conductivity cell and UNICORN version 5.01. The column
was equilibrated with 10 column volumes of 50 mM HEPES, pH 8.7. Two column
volumes of [EMIM] Cl in 50mM HEPES, pH 7.5 at varying concentrations, ranging from
10 mM to 150 mM, were applied to the column. The flow rate was kept constant at 0.4
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ml/min. The load cycle was followed by wash cycle of 5 column volumes with
equilibration buffer. Elution was started by gradually increasing the ratio of elution
buffer/equilibration buffer from 0:100 to 100:00 within 12 column volumes. Composition
of the elution buffer was 50 mM HEPES at pH 8.1. Changes in conductivity and
absorbance were recorded to assess the adsorption-desorption of [EMIM] Cl on the ionexchanger.

7.2.2.3 Investigation

of

the

efficiency

of

[EMIM]

Cl

as

an

elution/refolding buffer
The pre-packed HiTrap SP FF column (5 ml), connected to AKTA FPLC, was
equilibrated with ten column volumes of equilibration buffer (50 mM HEPES, pH 8.7, 2
M urea). A 1ml aliquot of denatured protein (2.5 mg/ml) was loaded on to the column.
After rinsing with five column volumes of equilibration buffer above, the column was
eluted by gradient elution. Elution was started by gradually increasing ratio of elution
buffer/equilibration buffer from 0:100 to 100:0 at 0.4 ml/min within 12 column volumes.
Four different elution buffers were examined. Composition of each elution buffer varied
as follows;
Buffer A: 50 mM HEPES, pH 8.1 (negative control)
Buffer B: 50 mM HEPES, pH 8.1 containing 1M sodium chloride
Buffer C: 50 mM HEPES, pH 7.5 containing 75mM [EMIM] Cl,
Buffer D: 50 mM HEPES, pH 7.5 containing 75mM [EMIM] Cl 1M sodium chloride.
Buffer E: 50 mM HEPES, pH 8.1 containing 2M urea, 0.03mM cysteine, 0.3mM cystine
and 1M sodium chloride
The entire study was conducted at a steady flow rate of 0.4 ml/min. Fractions were
collected and analyzed for both protein concentration and lysozyme activity. The column
was washed, cleaned-in-place (CIP) and regenerated for the next cycle. The study was
conducted in triplicates and average results (mean ± SEM) are presented. The standard
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error of the mean (SEM) quantifies the precision of the mean. It is a measure of how far
the sample mean is likely to be from the true population mean. SEM is computed by
feeding the data to GraphPad Prism Software Inc. (LaJolla CA, USA). It is calculated by
dividing the sample standard deviation by the square root of the sample size.

7.2.2.4 Adsorptive refolding of denatured lysozyme in a packed bed
mode
The pre-packed HiTrap SP FF column (5 ml), connected to AKTA FPLC, was
equilibrated with ten column volumes of equilibration buffer (50 mM HEPES, pH 8.7, 2
M urea). The flow rate throughout the experiment was set at 0.4 ml/min. Denatured
lysozyme solutions, in the range of 1 mg/ml to 10 mg/ml, were prepared. A protein
loading of 2.5 ml of denatured lysozyme (at varying concentrations) was applied on to
the column. After rinsing with five column volumes of equilibration buffer, the column
was eluted by gradient elution. Elution was started by gradually increasing ratio of
elution buffer/equilibration buffer from 0:100 to 100:0 at 0.4ml/min within 12 column
volumes. Composition of elution buffer was 50 mM HEPES, pH 7.5 containing 75 mM
[EMIM] Cl and 1 M sodium chloride. Fractions were collected at every step and analyzed
for protein concentration and lysozyme activity. The column was washed, cleaned-inplace (CIP) and regenerated for the next cycle.

7.2.2.5 Adsorptive refolding of denatured lysozyme in fluidized bed
mode
A volume of exactly 5 ml of the Sepharose Fast Flow resin slurry, suspended in 50 mM
HEPES (pH 7.0), was accurately aliquoted and dispensed in the fluidized bed column.
The resin particles were equilibrated with 50 ml of equilibration buffer (2 M urea in 50
mM HEPES, pH 8.7) for a period of 30 minutes, by a steady-flow of air at 0.01 LPM
flow rate. At the end of equilibration, fluidization was halted and the buffer was
dispensed out of the column with the aid of peristaltic pump. Next, 10 ml of denatured
lysozyme solution, at varying concentrations 1 mg/ml to 10 mg/ml, was loaded onto the
re-fluidized resin particles. After 15 minutes of adsorption, the resin was allowed to settle

129

and the buffer was dispensed out of the column with the aid of the peristaltic pump.
Following this, the re-fluidized resin particles were washed with 25 ml of equilibration
buffer for period of 10 minutes. After separating the washed-resin particles from the
buffer, the resin particles were re-fluidized. Elution of bound lysozyme initiated when the
resin particles were allowed to interact with 100 ml of elution buffer (50 mM HEPES, pH
7.5 containing 75 mM [EMIM]Cl and 1M sodium chloride) for duration of 30 minutes.
The elution pool was collected and analyzed for protein concentration and lysozyme
activity. The resins were cleaned-in-place and regenerated before use in the next cycle.

7.2.2.6 Investigation of [EMIM] Cl as a refolding additive in the elution
buffer in a fluidized bed mode
A 5ml slurry of the Sepharose FF resin, re-suspended in 50 mM HEPES (pH 7.0) was
accurately aliquoted and dispensed in the fluidized bed column. The resin particles were
equilibrated with 50 ml of equilibration buffer (2 M urea in 50 mM HEPES, pH 8.7) for a
period of 30 minutes, by a steady-flow at 0.01 LPM air flow rate. At the end of
equilibration, fluidization was halted and the buffer was dispensed out of the column with
the aid of peristaltic pump. Next, 10 ml of denatured lysozyme solution, at varying
concentrations 1 mg/ml to 10 mg/ml respectively, was loaded onto the re-fluidized resin
particles. After 15 minutes of adsorption, the resin was allowed to settle and the buffer
was dispensed out of the column with the aid of the peristaltic pump. Following this, the
re-fluidized resin particles were washed with 25 ml of equilibration buffer for period of
10 minutes. After separating the washed-resin particles from the buffer, the resin particles
were re-fluidized using the same airflow rate. Elution of bound lysozyme commenced
when the resin particles were allowed to interact with 100 ml of each of the elution
buffers for duration of 30 minutes.
The composition of various elution/refolding buffers examined was as follows:
Buffer D: 50 mM HEPES, pH 7.5 containing 75 mM [EMIM] Cl and 1M sodium
chloride
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Buffer E 50 mM HEPES, pH 8.1 containing 2 M urea, 0.03 mM cysteine, 0.3 mM
cystine and 1M sodium chloride.
Buffer F: 50 mM HEPES, pH 7.5 containing 75 mM [MIM] Cl and 1M sodium chloride
Buffer G: 50 mM HEPES, pH 7.5 containing 75 mM [BMIM] Cl and 1M sodium
chloride.
The elution pool was collected and analyzed for both protein concentration and enzyme
activity. The refolding efficiency and performance parameters were used to assess the
efficiency of the process. The resins were cleaned-in-place and regenerated before next
cycle

7.3 Results and Discussion
The effect of ionic liquids via the on-column adsorptive refolding of denatured lysozyme
is yet, to the best of our knowledge, unexplored. The purpose of this study was to
evaluate investigate the application of ionic liquids, specifically [EMIM] Cl, as a
refolding additive in the adsorptive refolding of denatured lysozyme in both a packed bed
ion exchange system and fluidized bed ion exchange system.

7.3.1 Investigation of adsorption of [EMIM] Cl on ion-exchanger
It has already been established in chapters 5 & 6 that dilution refolding of denatured
lysozyme with the ionic liquid, 1-ethyl-3-methylimidazolium chloride, ([EMIM] Cl) gave
the high refolding yields (ca. 95%) in a short duration of time (1 hour). Imidazolium
based ionic liquids are usually miscible in water. Upon dissolution they dissociate into
individual ions. Therefore, it was essential to assess if [EMIM] Cl bound to the ionexchange resin or not. Different concentrations of [EMIM] Cl were loaded onto the
packed bed column as discussed previously.
Figure 7.1 is the chromatogram generated by UNICORN when 150mM of [EMIM] Cl
was passed through the HiTrap SP FF column. Upon injection of the ionic liquid, as it
flowed through the column, changes in UV (at 280 nm) and conductivity were recorded.
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The UV peak observed between 0 and 5 on the x-axis in Figure 7.1 indicates that none of
the ionic liquid bound to the column but instead flowed through. There is significant
difference in the conductivity of the load (EMIM]Cl in 50 mM HEPES pH 8.1) and
elution buffer (50 mM HEPES, pH 8.1) and was evident in the Figure 7.1. It was thus
noteworthy that [EMIM] Cl increases the conductivity of the buffer. This property was
harnessed and utilized by incorporating [EMIM] Cl in the elution buffer.

Figure 7.1 Chromatograph generated by UNICORN upon loading 150 mM [EMIM]
Cl on to a Hi Trap SP FF column.
The pink line at point 0ml indicates the injection of [EMIM]Cl. The blue line represents
the change in UV absorption at 280 nm, the brown line represents the change in
conductivity and the green line represents the change in concentration of elution buffer.

Ionic liquids tend to be viscous solutions. A real concern when working with packed bed
systems is the column pressure that is generated due to use of viscous solutions or
buffers. However, ionic liquids at concentration below 60 mM act as salts and thus do not
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generate high back pressure in the system. It was therefore interesting to note that at high
concentration of 150 mM [EMIM] Cl, no pressure issues were noted by UNICORN. This
could be attributed to the low flow rate, of 0.4ml/min, at which all the steps of packed
bed ion-exchange system were operated. Hence for all further experimental studies on
packed bed system with ionic liquids, the flow rate was fixed at 0.4 ml/min for a 5 ml pre
packed column.

7.3.2 Examination of [EMIM] Cl as an elution/refolding buffer for
lysozyme
Based on results from previous section (7.3.1), it would be safe to conclude that buffer
containing [EMIM] Cl (up to 150 mM), when run through a 5 ml HiTrap SP FF (or
Sepharose based) ion exchange system at 0.4 ml/min does not bind to the column but
instead flowed through. Thus making it suitable for use with an ion exchange system. It
was now important to investigate its efficacy as a refolding/elution buffer. Figure 7.2
represents the results of the study carried out as described in section 7.8.2. The
concentration of [EMIM] Cl in the buffer was set at 75 mM. This was based on its
efficacy in refolding denatured lysozyme via dilution refolding, as demonstrated earlier in
Chapter 6. The efficiency of [EMIM] Cl as a refolding additive (in dilution refolding) has
been reported in Chapters 5 and 6 of this thesis. The present study, evaluated its efficacy
in packed bed refolding system.
Figure 7.3, shows that the percentage- elution and refolding yield was the least, 2.25%
and 2.14% respectively, with Buffer A, which also served as the negative control in this
experiment. Buffer E, (conventional buffer) containing 2M urea, 0.03mM cysteine,
0.3mM cystine and 1M sodium chloride in 50mM HEPES, pH 8.1 served as the positive
control. In ion exchange based systems, increase in ionic strength of the buffer, the ions
(usually sodium and chloride) compete with the bound protein for charges on the surface
of the ion-exchange medium. This causes bound species to elute. Thus, addition of 1M
sodium chloride to the Buffer A, increased the ionic strength (salt concentration) of the
buffer and its subsequent effect on percentage elution (86.34% elution) was apparent in
Figure 7.3. Sodium chloride is a salt that does not have any direct effect on the denatured
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protein. However, as Buffer B flowed through the column diluting the concentration of
denaturant and simultaneously eluting the protein, it created an environment for some of
the protein to refold. Hence, a slight increase in refolding yield (10.27%) in comparison
to Buffer A was recorded. In comparison to Buffer B, Buffer C containing 75mM
[EMIM]Cl, yielded substantially better refolding (50.22 ), although it’s efficiency as
elution buffer was not as high as in comparison to buffer B. Thus, a combination of
Buffer B and C - Buffer D - was evaluated. A combination of the two salts (sodium
chloride and [EMIM] Cl), considerably improved the elution and had much more
pronounced effect on the refolding yield. Buffer D, containing 75mM [EMIM] Cl,
enhanced the refolding yield of the denatured lysozyme by 62 % in comparison to Buffer
B and improved by 5% in comparison to the positive control (Buffer E). These results are
substantiated by experimental results, as reported by Lange et al (2005).

Elution (%)
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Refolding Yield (%)
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Elution, Refolding Yield
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Figure 7.2 Effect of buffer composition on elution (%) and refolding yield (%) of
adsorbed protein on HiTrap SP FF column.
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Five different buffers are presented. Buffer A (Negative control): 50 mM HEPES, pH 8.1
Buffer B: 50mM HEPES (pH 8.1) containing 1 M sodium chloride Buffer C: 50mM
HEPES (pH 7.5) containing 75mM [EMIM]Cl, Buffer D: 50mM HEPES (pH 7.5)
containing 75mM [EMIM] Cl and 1 M sodium chloride. Buffer E (positive control):
50mM HEPES, pH 8.1 containing 2M urea, 0.03mM cysteine, 0.3mM cystine, 1M
sodium chloride. Protein load : 2.5mg
Lange et al. (2005) examined a series of N-alkyl and N-hydroxyalkyl- Nmethylimidazolium based ionic liquids as refolding additives for two different model
proteins, lysozyme and ScFvOx. They compared the efficacy and efficiency of the ionic
liquids as refolding additives to one of the more popular refolding additives, L-arginine
hydrochloride. And found the results (refolding yield, stability of the protein and
aggregation suppression) were comparable to, and in some instances better than, that
obtained by L-arginine hydrochloride. The enhanced refolding yield was attributed to,
suppression of aggregation coupled with stabilization of native structure of the protein,
by ionic liquids. They also report, increase in the hydrophobicity of the cation and
concentration of ionic liquid (M) adversely affected the refolding yield and aggregation
of the target proteins (Lange et al., 2005).
In summary, elution buffer D, containing 75 mM [EMIM] Cl and 1 M sodium chloride in
50 mM HEPES, pH 7.5 assisted the elution and refolding of adsorbed denatured
lysozyme from a strong cation exchange resin.

7.3.3 Packed Bed refolding of denatured lysozyme
Protein load is an important operational variable in the ion exchange refolding of
denatured lysozyme because it directly affects the fractional mass recovery and
volumetric productivity of the process. Varying concentrations of denatured lysozyme
were loaded onto the pre-packed column, and fractions collected were analyzed to assess
the influence of protein load. The experimental protocol has been discussed in materials
and methods. Figure 7.3, elucidates a typical elution chromatogram of the cationexchange protein refolding experiment when 5 mg of denatured lysozyme was loaded on
to the column.
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Figure 7.3 Chromatogram illustrating the elution of refolded lysozyme.
The blue line represents the change in UV absorption at 280nm, the brown line represents
the change in conductivity and the green line represents the change in concentration of
elution buffer. Load: 5mg of denatured lysozyme. The sharp blue peak represents the
elution peak.
As discussed earlier (in Chapter 4), the nature of the protein load affected the adsorption,
desorption and thereby refolding yield of the protein, and consequently efficiency of the
process. Therefore, native and denatured lysozyme, at similar protein concentrations,
was applied to the ion-exchange system. Experimental results from the series of
experiments are represented in Figure 7.4 and Table 7.1. It was observed that,
irrespective of the nature of the load, approximately 85 to 92% of the load, bound to the
equilibrated ion-exchange resin.
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Figure 7.4 Effect of protein load and feeding state (native or denatured) on the
fractional mass recovery.
Different concentrations o
on to HiTrap SPFF 5ml column.
Figure 7.4 illustrates the effect of protein load (mg) and the feeding state (native or
denatured) on the fractional mass recovery on a pre-packed HiTrap SP FF (5 ml) column.
The results show that the natures of the protein load and the concentration both strongly
affect the fractional mass recovery. As opposed to a native protein, the hydrophobic core
of the denatured protein is exposed making it susceptible to protein-protein interactions
and aggregations. Increase in protein concentration, thereby, increases the probability of
aggregation affecting the fractional mass recovery adversely. Similar result is reported by
Freydell et al., (2010). They examined the effect of feeding state (native or denatured or
denatured-reduced) lysozyme on various cation exchange resins, including Sepharose fast
flow beads (Freydell, Van Der Wielen, Eppink, & Ottens, 2010). A major drawback of
their process and operation conditions was the inefficient elution of denatured lysozyme
from Sepharose beads with sodium chloride. It is noteworthy that, the elution buffer they
used did not contain any ionic liquid.
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Table 7.1 represents the experimental results obtained by loading varying concentrations
of denatured lysozyme on 5 ml HiTrap SP FF column and its corresponding effect on the
refolding yield and fractional mass recovery of the protein.
Table 7.1 Effect of load on refolding yield and fractional mass recovery of lysozyme
in a packed bed ion exchanger
Ion Exchanger

HiTrap Sepharose

Load : denatured

% Refolding

Fractional mass

lysozyme (mg)

Yield

recovery

2.5

84.34

0.79

5

85.39

0.76

10

84.29

0.71

25

54.29

0.53

Fast Flow (5ml)

Fractional mass recovery of the protein is the ratio of concentration of eluted protein (mg)
to the concentration of protein load (mg). It is evident that increase in the protein load, up
to 25 mg, had an adverse effect on the fractional mass recovery of the protein; however
up to 10 mg of load the refolding yield was considerably high, 85%. A plausible
justification for this could be loading under denatured state of protein. The probability of
aggregation in a solution of denatured protein increases with increase in concentration of
protein, by virtue of its exposed hydrophobic patches. This claim is further supported by
similar trends reported by (Freydell et al., 2010; Langenhof, Leong, Pattenden, &
Middelberg, 2005).
In order to meet the economies of scale there is a strong demand in the industry for
systems that can support high concentration of protein solutions. Packed bed refolding of
lysozyme has already presented its limitation with regards to protein concentration.
Whether this changes favorably or not, in a fluidized bed system was investigated in the
following section.
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7.3.4 Protein refolding in a fluidized-bed ion-exchange
chromatographic system
Previously optimized concentrations of refolding additives and buffer compositions were
employed in the batch- refolding of denatured lysozyme in the fluidized bed ionexchange system developed in-house and described earlier.
Similar to packed bed studies, series of experiments were conducted to assess the
efficiency of the fluidized bed ion-exchange refolding system. Samples from each step of
the ion exchange process (adsorption, wash, elution) was collected and analyzed for both
protein concentration and enzyme activity. Process performance indicators, discussed in
analytical methods, Chapter 3, were used to assess the efficiency of the system in
comparison to the packed-bed refolding of denatured lysozyme and use of conventional
refolding buffer containing a redox couple.
One of the main limitations in the use of a packed-bed system has consistently been its
inability to handle higher protein concentration loads, and viscous solutions. Poor masstransfer, resin fouling and saturation of the resin are commonly encountered issues. After
a fixed period of cycles, the ion-exchange resin is often rendered unusable. On the other
hand, in the fluidized mode of operation, resin particles are lifted inside the column by an
upward liquid and/or air stream generated by buffers, sample solutions or air-inlet. As a
result of increased inter-particle porosity, fluidized beads allow for treatment of solution
with considerably higher viscosity without generation of any significant backpressure. It
was therefore our hypothesis that increased mass transfer and inter-particle porosity
would permit a denatured adsorbed protein to elute into an environment conducive for
protein refolding. In order to test this hypothesis, experiments were executed at similar
conditions as a packed bed, only in a fluidized bed system. It is shown here for the first
time that ionic liquid aided adsorptive protein refolding is noticeably better in a fluidized
bed with an efficiency ca. 90% versus 55% for packed-bed a system, for a protein load of
25mg.
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Table 7.2 illustrates the experimental results obtained by varying the concentration of the
denatured lysozyme loaded onto the ion-exchange resin. In comparison to the results
presented in table 7.1, the fractional mass recovery of the eluted protein and the refolding
yield was substantially higher, thereby indicating the superior efficiency of the fluidized
bed.
It is interesting to note, that with increase in the protein load (mg), the refolding yield did
not decrease substantially. Even at high protein load (25 mg), the refolding yield obtained
was 35% higher than that obtained with a packed bed system. Also the fractional mass
recovery was almost consistent through the range of protein load concentrations
examined.
Table 7.2 Effect of load on the refolding yield and fractional mass recovery of
lysozyme in a fluidized bed ion exchanger
Ion
Exchanger

Sepharose

Load: denatured
lysozyme (mg)

Refolding Yield
(%)

Fractional Mass
Recovery

2.5

97.71

0.82

5

93.38

0.80

10

92.04

0.81

25

89.54

0.81

Fast Flow
(5ml)

Comparing the protein elution (%), refolding yield (%) and fractional mass recovery (%)
of two different adsorptive processes – packed bed and fluidized, Figure 7.5, elucidates
the enhanced efficiency of ion-exchange system in a fluidized bed vis-à-vis a packed bed
system. At lower protein concentration range, i.e., 2.5mg, percentage elution and percent
mass recovery in packed bed and fluidized bed was almost similar; indicating the mass
transfer limitations did not vary much. However, the refolding yield in fluidized bed was
greater than packed bed by 14%. Increasing the protein load (mg) ten fold adversely
affected the output in a packed bed system. The refolding yield in packed bed was only
54.29%, while in fluidized bed it was 89.54%. At both higher and lower concentrations of
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protein load, fractional mass recovery in the fluidized bed was substantially higher than
that in a packed bed system. Thereby, exemplifying the tolerance of a fluidized bed to
higher concentrations of protein and its augmented efficiency in refolding denatured

Percentage
Refolding Yield, Elution and Fractional mass recovery

lysozyme.
Elution (%)
Refolding yield (%)
Fractional Mass recovery (%)

120
100
80
60
40
20
0
Packed Bed

Fluidized bed

Packed Bed

2.5 mg

Fluidized bed
25 mg

Load (mg)

Figure 7.5 Effect of mode of operation and protein load (mg) on the refolding yield,
elution and fractional mass recovery of lysozyme.
Percentage elution (black bar), refolding yield (white bar) and fractional mass recovery
(grey bar) are plotted against the load (mg) and mode of operation (packed bed, fluidized
bed).

7.3.5 Comparing the efficiency of [EMIM]Cl as an elution/refolding
buffer
Figure 7.7 describes the experimental results of similar refolding process in a fluidized
bed ion-exchange system using different elution buffers at two different protein loads, 2.5
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mg and 25 mg. It was evident from the previous study that [EMIM]Cl enhances refolding
yield of denatured of lysozyme. How it compared with the conventional buffer containing
the redox couple, cysteine/cystine was evaluated in this study.
Additional elution buffers, Buffer F and G were incorporated to test the efficiency of
[EMIM]Cl in comparison to other imidazolium based ionic liquids, as a refolding
additive. It was interesting to note that with regards to the fractional mass recovery,
Buffer G containing BMIM Cl was almost similar (difference of less than 3%) to that of
Buffer F. However, the refolding yield with the buffer containing the less hydrophobic
ionic liquid, 1-methyl-3-methylimidaozlium chloride (MIM Cl) was at least 25% higher
than that with the buffer containing 1-butyl-3-methylimidazolium chloride (BMIM Cl); at
either concentration of protein load. This could be explained by the increase in
hydrophobicity and chaotropicity of the ionic liquid.
Refolding Yield (%)

Fractional Mass Recovery (%)

Percentage
Refolding yield, fractional mass recovery

120

100

80

60

40

20

0
Buffer D Buffer E Buffer F Buffer G Buffer D Buffer E Buffer F Buffer G
2.5 mg

25 mg

Figure 7.6 Effect of load (mg) and buffer composition on the refolding yield and
fractional mass recovery of lysozyme in a fluidized bed ion-exchanger
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Experimental results of four different buffers are graphically represented in the Figure
7.6. Composition of the buffers is as follows; Buffer D: 50mM HEPES, pH 7.5
containing 75mM [EMIM] Cl and 1M sodium chloride and buffer E: 50mM HEPES, pH
8.1 containing 2M urea, 0.03mM cysteine, 0.3mM cystine and 1M sodium chloride
Buffer F: 50mM HEPES, pH 7.5 containing 75mM [MIM] Cl and 1M sodium chloride,
Buffer G: 50mM HEPES, pH 7.5 containing 75mM [BMIM] Cl and 1M sodium chloride,
Studies have shown that a kosmotropic anion has low affinity for the amide group of the
protein and instead competes for the water associated with the protein, thereby driving
the protein to its native state. While, a chaotropic cation penetrates the micro aqueous
environment of the protein and forms a protective, stabilizing layer around it (Bae et al.,
2012; Lange et al., 2005a; Zhao, 2006). Thus, in order to achieve better refolding yields it
is often advised that the ionic liquid be designed with a kosmotropic anion and chaotropic
cation. In comparison to [MIM] and [EMIM], [BMIM] interacts poorly with water and
has a destabilizing effect. It is therefore, no surprise that maximum refolding yield was
obtained with Buffer D, containing [EMIM] Cl.

7.4 Conclusions
Proactive debottlenecking the downstream process of proteins is scrupulously dependent
on the development of efficient, cost-effective refolding processes. In order to achieve
this, it is important that the protein is provided with an environment, which promotes
refolding and suppresses aggregation. This is commonly achieved by addition of
refolding additives (L-arginine, 2 M urea, redox couples (cysteine/cystine) and
GSH/GSSG etc) and employing strategies such as dilution, dialysis, or a combination of
the two. Dilution and dialysis, albeit easy to adapt and execute, are plagued with
limitations during scale up. The requirement of large volumes of refolding buffer, holding
tanks, temperature and pH control, mixing and low concentration of denatured protein
(less than 0.5mg/ml), make it inefficient and expensive. On-column adsorptive refolding
of proteins, on the other hand, enhances refolding yield by reversibly binding the protein
to the solid matrix, gradually removing the denaturants from the solution and providing
the protein with sample space to refold to its natural state. The first report of on-column
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protein refolding was by Creighton et al., in 1986 for horse cytochrome c and bovine
pancreatic trypsin inhibitor. Since then, several methods have been developed to increase
refolding yield of denatured-lysozyme for ion exchange refolding matrices, including but
not limiting to, two and three buffer systems and dual gradient chromatography.
Langenhoff et al., (2005) report a maximum refolding yield of 60% with bovine serum
albumin (BSA) at protein load of 2 mg on an anion-exchange system using the redox
couple GSH/GSSG (Langenhof et al., 2005). Li et al (2002), using redox couples
GSH/GSSG and cation exchange system with lysozyme as target protein, demonstrated
that avoiding high salt concentrations for elution, and thus avoiding stronger hydrophobic
interactions, could lead to suppression of aggregation of the folding intermediates and
thereby enhance refolding yield (Li & Su, 2002).
Ionic liquids, is an emerging class of refolding additives, that are gaining popularity due
to their malleable nature and ‘green’ chemistry. Ionic liquids consist of organic cations
such as N-alkyl-N-methylimidaozlium, N-substituted pyridinium, tetraalkylated
ammonium and tetraalkylated phosphonium, and either organic or inorganic anions. They
represent a rather diverse class of organic solvents and co-solvents with a
correspondingly assorted range of physico-chemical properties, which may be readily,
engineered by changes in anion and cation substitution patterns (Austen Angell, Ansari,
& Zhao, 2011). There are several publications that discuss the efficacy of ionic liquids as
protein refolding additives in dilution refolding (Attri & Venkatesu, 2012; Lange et al.,
2005; Summers & Flowers, 2000). However, to the best of our knowledge, none of the
studies published so far, have incorporated ionic liquids as refolding additives for oncolumn adsorptive refolding of proteins.
The work presented in this study demonstrates, the efficacy of [EMIM] Cl as a refolding
additive. When incorporated in the elution buffer, it increased the ionic strength of the
buffer and assisted in the elution and subsequent refolding of the denatured protein. The
presence of a chaotropic cation ([EMIM]) and kosmotropic anion (Cl) in the ionic liquid
suppressed aggregation and enhanced refolding of denatured lysozyme. Further, two
different modes of operation were compared, packed bed and fluidized bed. In
comparison to a packed bed mode of operation, at denatured lysozyme concentration of
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25 mg with the aid of 75mM [EMIM] Cl in the elution buffer, fluidized bed delivered
refolding yield ca. 92%. This could be explained by the increase in the mass transfer and
inter-particle porosity, offered by fluidized mode of operation, which directly translates
into improved efficiency for the system. Where this improves at concentration higher
than 25 mg of denatured lysozyme, is adaptable to different proteins and ionic liquids,
remains to be examined. At present, these results pave the way for incorporation of ionic
liquids as refolding additives in adsorptive refolding of denatured lysozyme, and for the
development of economic, efficient refolding processes at an industrial scale.

7.5 Nomenclature
Abbreviation
[BMIM] Cl
BSA
DTT
[EMIM] Cl
HEPES
[MIM]Cl

Full form
1-butyl-3-methylimidazolium chloride
Bovine serum albumin
Dithiothrietol
1-ethyl-3-methylimidazolium chloride
2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
Methylimidazolium chloride
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Chapter 8

ncluding remarks and recommendations
Based on the experimental results acquired in this thesis, final concluding remarks and
recommendations are provided.

8.1

Summary

Protein refolding is one of the most severe rate limiting steps in the downstream
processing of proteins. The efficient conditions required for refolding proteins generally
have to meet the following requirements; a) concentration of denaturants should be
reduced to a level where intramolecular non-covalent interactions are retained, b) the
refolding process should be performed under an appropriate environment to form the
disulfide bridges and c) the concentration of the denatured protein should be maintained
at a low level (usually less than 100μg/ml) to avoid intermolecular aggregation.
Low protein concentration, is traditionally accomplished by diluting the solubilized
protein in the refolding buffer. This also results in dilution of the denaturants. A rapid
change in concentration of denaturants, however, may result in the formation of
misfolded protein or aggregates. Due to the ease of automation and ability to handle high
protein concentrations with integrated purification steps, the use of on-column refolding
has gained momentum. However, irrespective of the methodology employed, dilution or
on-column refolding, refolding additives play a significant role in the overall
development of the process. These can be broadly classified into categories based on their
mechanism of action, aggregation inhibitors or stabilizers of native protein structure.
Ionic liquids, are gaining popularity in the biotechnology and pharmaceutical industry,
primarily due to their characteristic low vapor pressure that renders them valuable as
‘green solvents’ in comparison to the other molecular solvents. They have been
successfully applied in biocatalysis, synthesis of active pharmaceutical ingredients and to
enhance protein stability (Austen Angell, Ansari, & Zhao, 2011; Hough & Rogers, 2007;
van Rantwijk & Sheldon, 2007). The effect of ionic liquids on protein structure, at a
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molecular level has been examined, which exposed their role as protein aggregation
suppressors and native structure stabilizers; both ideal characteristics required of a
refolding additive (Endres et al., 2010; Kohno & Ohno, 2012; Mann, McLuskey, &
Atkin, 2009; H. Zhao, 2010).
A thorough, yet comprehensive, review of research findings (with respect to ionic
liquids) has been provided in the literature review section of this thesis. It is apparent
that, although there are numerous papers that discuss the role of ionic liquids as refolding
additives, none so far have examined their worth in adsorptive, on-column refolding of
denatured proteins. Hence the main objective of this thesis was to identify the potential of
ionic liquids as refolding additives for on-column refolding of proteins, specifically
denatured lysozyme. Each ion (cation and anion) of the ionic liquid has a significant
impact on the protein. Dependent on their behavior, they are often classified as
kosmotrope – order makers- or as chaotropes –order breakers. Ideally, for an ionic liquid
to be effective protein refolding additive, the most desirable combination is that of a
kosmotropic anion and a chaotropic cation. We reviewed this theory by using six
different ionic liquids, encompassing a range of kosmotropic and chaotropic ions, for the
refolding studies of denatured lysozyme. The ionic liquids that were investigated as
refolding additives were all imidazolium based ionic liquids with varying alkyl chain
lengths of the cation and varying anions.
It is an established fact that protein-refolding yield is dependent on the type- and concentration -of- protein and refolding additive, duration of incubation, pH and
refolding strategy employed. Successful dilution refolding demands low concentration of
protein. Hence, by maintaining the concentration of denatured lysozyme, the refolding
yield was assessed as a function of change in concentration of ionic liquid and incubation
duration for each of the chosen six ionic liquids. The results showed maximum refolding
yield close to 90% (within an hour of incubation) in the presence of [EMIM] Cl. Next, by
using response surface methodology and central composite design optimized refolding
conditions, for [EMIM] Cl and denatured lysozyme were identified and an empirical
model was developed. The conditions for refolding denatured lysozyme that yield
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optimal results are; 75 mM [EMIM]Cl in 50 mM HEPES, pH 7.5 at denatured lysozyme
concentration 0.18 mg/ml. The model was validated by experimental results.
Ionic liquids dissociate into individual anion and cation when dissolved in water. It was
therefore critical and pertinent to the development of on-column refolding process to test
if [EMIM] Cl in buffer adsorbed to the cation exchange resin, Sepharose Fast Flow. At
the tested concentration of [EMIM] Cl (up to 150 mM in 50 mM HEPES, pH 7.5), there
was no evidence of binding to the resin. Therefore, it was safe to use the ionic liquid in
the elution buffer for the on-column refolding of denatured lysozyme.
Protein load has a significant impact on the fractional mass recovery and refolding yield.
Hence, by varying the concentration of denatured lysozyme load (mg), on the packed bed
and fluidized bed resin, the efficiency of [EMIM] Cl in the elution buffer as a refolding
additive was assessed. Elution buffer containing 75 mM [EMIM] Cl, 1 M NaCl in 50 mM
HEPES, pH 7.5 not only enhanced the elution of the adsorbed protein but also increased
the refolding yield in comparison to conventional refolding buffer tested in Chapter 4.
This was found to be independent of the mode of operation, packed bed vis-a-vis
fluidized bed.
Further, the efficiency of on-column adsorptive refolding of denatured lysozyme in
packed bed was compared to that of that in a fluidized bed. At low protein load (2.5 mg)
the refolding yield and recovery was comparable in both modes of operation. However,
as the protein load increased, the enhanced mass transfer and inter-particle porosity in the
fluidized-bed mode of operation enhanced the elution protein and refolding yield of the
protein. In comparison to fluidized bed, the reduction in the number of available sites for
protein adsorption, especially at the top of the column in the packed bed system resulted
in poor recovery and refolding yield.
In summary, based solely on the experimental results presented in this thesis, it is safe to
that ionic liquids, particularly [EMIM] Cl is an effective refolding additives for refolding
denatured lysozyme. On-column adsorptive refolding of denatured lysozyme is enhanced
in the fluidized bed and by incorporation of [EMIM] Cl in the elution-refolding buffer.
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8.2

Recommendations

Purity, toxicity and economic feasibility of the application of ionic liquids at industrial
scale need to be rigorously evaluated. The reusability of the ionic liquids by suitably
modifying the fluidized bed to a circulating fluidized bed is a proposed plan to combat
the economical and ecological aspects of ionic liquids. The efficacy of the ionic liquid as
a refolding additive in on-column refolding process was demonstrated by inclusion in the
elution buffer. However, the separation of the refolded protein from the ionic liquid
elution pool, remains to be evaluated. Summers and Flowers (2000) did successfully
separate refolded lysozyme from ethylammonium nitrate [EAN] by use of advanced
centrifugal filters (Summers and Flowers, 2000). Whether this is applicable to other ionic
liquids, based on imidazolium, pyrrolidinium or pyridinium etc., is yet to the examined.
Also, how this would translate into economies of scale at the industrial level.
Thus, in summary, while the use of fluidized bed ion exchange refolding system is an
effective means to refold high concentrations of denatured lysozyme, an organized,
systematic assessment of its applicability to other proteins, in the presence of other
refolding additives including different types of ionic liquids, could in the long run help
over come the biggest obstacle in downstream processing today – protein refolding

8.3

Nomenclature

Abbreviation
[EAN]
[EMIM] Cl
HEPES
NaCl

8.4

Full form
Ethyl ammonium nitrate
1-ethyl-3-methylimidazolium chloride
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid )
Sodium chloride
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Appendices
Appendix A Specification of the UV-Star 96 well microplate
1

Description/Specification

1.1

Description

UV-Star® Microplate, 96 well, clear film F-bottom
(flat), alphanumeric well
coding, chimney well

1.2

Plate Length

Plate: length: 127,76 mm (± 0,2 mm)
width: 85,48 mm (± 0,2 mm)
curvature: £ 200 μm
Foil: 135 μm (± 10 μm)

1.3

Volume

Total volume: 392 μl (mathematically calculated)
Working volume: 25 - 340 μl

1.4

Material/ Resin

Plate and foil :Cycloolefine, free of heavy metal

1.5

Color

658801 : Clear

1.6

Sterilisation

No

1.7

Quality Control

Raw Material-Control: physical testing
- Product-Control: testing of attributive and variable
characteristics in
accordance with the valid specification

1.8

Other Information

For single use only

2

Features

2.1

Basic Features

Free of detectable DNase/RNase, human DNA and
pyrogens

2.2

Temperature Range

-20°C to +40°C

2.3

Autoclavability

No

2.4

Centrifugation, max. RCF

4800 x g: swinging-bucket rotor

2.5

Chemical Resistance

See homepage: www.gbo.com/bioscience ®Products
®Literature
®Technical Information ®Chemical Resistance of
Resins

2.6

Shelf Life

Not applicable
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Appendix B Specifications of HiTrap Sepharose Fast Flow columns (1ml and 5ml)
HiTrap SP FF

5ml Column

1ml column

Bed Dimensions

16 × 25 mm

7 × 25 mm

Bed Volume

5 ml

1 ml

Flow rate

<20 ml/min1)

<4 ml/min1)

Flow Rate

< 20 ml/min2)

< 4 ml/min2)

Pressure Max. [Over the
Packed Bed During Operation]

3 bar [0.3 MPa] (42 psi)

3 bar [0.3 MPa] (42 psi)

Storage Conditions

4 to 30°C, 0.2 M Sodium
Acetate in 20% Ethanol

4 to 30°C, 0.2 M Sodium
Acetate in 20% Ethanol

BioProcess Medium

Yes

Yes

Ligand

Sulphopropyl

Sulphopropyl

Average Particle Size

90 µm

90 µm

Ion Exchanger Type

Strong cation exchanger

Strong cation exchanger

Matrix

6% cross-linked agarose

6% cross-linked agarose

Particle Size

45 µm-165 µm

45 µm-165 µm

Ionic Capacity

0.18-0.25 mmol H+/ml
medium

0.18-0.25 mmol H+/ml
medium

pH stability Working Range

4-13

4-13

Pressure/Flow Specification

400-700 cm/h, 100 kPa, XK
50/30 column, bed height 15
cm

400-700 cm/h, 100 kPa, XK
50/30 column, bed height 15
cm

Exclusion Limit [Mr]
[Globular Proteins]

4 x 106

4 x 106

Storage Conditions

4 to 30°C, 20% Ethanol + 0.2
M Sodium Acetate

4 to 30°C, 20% Ethanol + 0.2
M Sodium Acetate

Chemical Stability

Stable to all commonly used
aqueous buffers:1 M NaOH, 8
M urea, 8 M guanidine
hydrochloride, 70% ethanol1)

Stable to all commonly used
aqueous buffers:1 M NaOH, 8
M urea, 8 M guanidine
hydrochloride, 70% ethanol1)

Media
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Appendix C. Clean-in-place protocol for Sepharose Fast Flow resin
Cleaning-in-place (CIP) is a cleaning procedure that removes contaminants such as lipids,
precipitates, or denatured proteins that may remain in the packed column after
regeneration. Such contamination is especially likely when working with crude materials.
Regular CIP also prevents the build-up of these contaminants in the media bed and helps
to maintain the capacity, flow properties and general performance of the media.
Standard CIP protocol followed:
Step 1. Wash with 0.5 column volume of 1 M sodium hydroxide solution, contact time 15
minutes.
Step 2. Wash with 4 column volumes of Milli Q water, contact time 30 minutes.
Step 3. Re-equilibrate Resin : Wash with 5 column volumes of equilibration buffer or
until the base line is stabilized.
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Appendix D. Sample calculation - refolding yield of lysozyme
Preparation of denatured lysozyme solution:
Native Lysozyme solution (10 mg/ml) in 50 mM HEPES, pH 7.0 was prepared by
dissolving 100 mg of lyophilized lysozyme in 10 ml of 50 mM HEPES buffer (pH 7.0).
Next, native lysozyme solution, 1 ml aliquot, is diluted with 9 ml of denaturation buffer
(6 M urea, 32 mM dithiothreitol, 1 mM EDTA in 50 mM HEPES, pH 8.7) and placed in
water bath for 2 hours at 37 °C. At the end of 2 hours, denaturation is confirmed by
lysozyme activity assay.
Concentration of denatured lysozyme: 1 mg/ml
Experimental methodology
Refolding buffer: 75 mM [EMIM] Cl in 50 mM HEPES, pH 7.5
Technique: Fluidized bed refolding.
Load: 2.5 mg of denatured lysozyme (i.e. 2.5 ml)
Raw Data: Lysozyme activity assay
Time
(s)
Elute

0

10

20

30

40

50

60

70

80

90

100

110

120

0.616

0.558

0.516

0.469

0.469

0.405

0.39

0.358

0.334

0.317

0.307

0.295

0.295

Elute

0.615

0.555

0.515

0.468

0.453

0.404

0.4

0.368

0.357

0.333

0.3

0.299

0.293

Elute

0.615

0.557

0.515

0.468

0.433

0.404

0.395

0.363

0.345

0.325

0.304

0.297

0.294

Average Slope (GraphPad Prism, linear regression) -0.002614 ± 0.0001046
Using Equation 3.2, specific activity of elute = -0.105 units mg-1 ml-1
Specific activity of native lysozyme: -0.114 units mg-1 ml-1
Therefore, substitute the values in Equation 3.3, Refolding yield = 92.13 %
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